id	sid	tid	token	lemma	pos
ct-10092	1	1	2015	2015	NUM
ct-10092	1	2	:	:	PUNCT
ct-10092	1	3	use	use	NOUN
ct-10092	1	4	of	of	ADP
ct-10092	1	5	hormones	hormone	NOUN
ct-10092	1	6	in	in	ADP
ct-10092	1	7	equine	equine	NOUN
ct-10092	1	8	breeding	breeding	NOUN
ct-10092	1	9	management	management	NOUN
ct-10092	1	10	use	use	NOUN
ct-10092	1	11	of	of	ADP
ct-10092	1	12	hormones	hormone	NOUN
ct-10092	1	13	in	in	ADP
ct-10092	1	14	equine	equine	NOUN
ct-10092	1	15	breeding	breeding	NOUN
ct-10092	1	16	management	management	NOUN
ct-10092	1	17	carlos	carlos	PROPN
ct-10092	1	18	r.	r.	PROPN
ct-10092	1	19	pinto	pinto	PROPN
ct-10092	1	20	,	,	PUNCT
ct-10092	1	21	a	a	DET
ct-10092	1	22	elizabeth	elizabeth	PROPN
ct-10092	1	23	a.	a.	PROPN
ct-10092	1	24	coffmanb	coffmanb	PROPN
ct-10092	1	25	adepartment	adepartment	PROPN
ct-10092	1	26	of	of	ADP
ct-10092	1	27	veterinary	veterinary	ADJ
ct-10092	1	28	clinical	clinical	ADJ
ct-10092	1	29	sciences	science	NOUN
ct-10092	1	30	,	,	PUNCT
ct-10092	1	31	school	school	NOUN
ct-10092	1	32	of	of	ADP
ct-10092	1	33	veterinary	veterinary	ADJ
ct-10092	1	34	medicine	medicine	NOUN
ct-10092	1	35	,	,	PUNCT
ct-10092	1	36	louisiana	louisiana	PROPN
ct-10092	1	37	state	state	PROPN
ct-10092	1	38	university	university	PROPN
ct-10092	1	39	,	,	PUNCT
ct-10092	1	40	baton	baton	NOUN
ct-10092	1	41	rouge	rouge	NOUN
ct-10092	1	42	,	,	PUNCT
ct-10092	1	43	la	la	NOUN
ct-10092	1	44	;	;	PUNCT
ct-10092	1	45	bdepartment	bdepartment	NOUN
ct-10092	1	46	of	of	ADP
ct-10092	1	47	veterinary	veterinary	ADJ
ct-10092	1	48	clinical	clinical	ADJ
ct-10092	1	49	sciences	science	NOUN
ct-10092	1	50	,	,	PUNCT
ct-10092	1	51	college	college	NOUN
ct-10092	1	52	of	of	ADP
ct-10092	1	53	veterinary	veterinary	ADJ
ct-10092	1	54	medicine	medicine	NOUN
ct-10092	1	55	,	,	PUNCT
ct-10092	1	56	north	north	PROPN
ct-10092	1	57	carolina	carolina	PROPN
ct-10092	1	58	state	state	PROPN
ct-10092	1	59	university	university	PROPN
ct-10092	1	60	,	,	PUNCT
ct-10092	1	61	raleigh	raleigh	PROPN
ct-10092	1	62	,	,	PUNCT
ct-10092	1	63	nc	nc	PROPN
ct-10092	1	64	introduction	introduction	PROPN
ct-10092	1	65	the	the	DET
ct-10092	1	66	administration	administration	NOUN
ct-10092	1	67	of	of	ADP
ct-10092	1	68	hormones	hormone	NOUN
ct-10092	1	69	to	to	ADP
ct-10092	1	70	mares	mare	NOUN
ct-10092	1	71	during	during	ADP
ct-10092	1	72	breeding	breeding	NOUN
ct-10092	1	73	management	management	NOUN
ct-10092	1	74	is	be	AUX
ct-10092	1	75	an	an	DET
ct-10092	1	76	essential	essential	ADJ
ct-10092	1	77	tool	tool	NOUN
ct-10092	1	78	for	for	ADP
ct-10092	1	79	equine	equine	NOUN
ct-10092	1	80	practitioners	practitioner	NOUN
ct-10092	1	81	.	.	PUNCT
ct-10092	2	1	proper	proper	ADJ
ct-10092	2	2	and	and	CCONJ
ct-10092	2	3	timely	timely	ADJ
ct-10092	2	4	administration	administration	NOUN
ct-10092	2	5	of	of	ADP
ct-10092	2	6	specific	specific	ADJ
ct-10092	2	7	hormones	hormone	NOUN
ct-10092	2	8	to	to	ADP
ct-10092	2	9	broodmares	broodmare	NOUN
ct-10092	2	10	may	may	AUX
ct-10092	2	11	be	be	AUX
ct-10092	2	12	targeted	target	VERB
ct-10092	2	13	:	:	PUNCT
ct-10092	2	14	1	1	NUM
ct-10092	2	15	)	)	PUNCT
ct-10092	2	16	to	to	PART
ct-10092	2	17	prevent	prevent	VERB
ct-10092	2	18	reproductive	reproductive	ADJ
ct-10092	2	19	disorders	disorder	NOUN
ct-10092	2	20	,	,	PUNCT
ct-10092	2	21	2	2	NUM
ct-10092	2	22	)	)	PUNCT
ct-10092	2	23	to	to	PART
ct-10092	2	24	aid	aid	VERB
ct-10092	2	25	in	in	ADP
ct-10092	2	26	treating	treat	VERB
ct-10092	2	27	reproductive	reproductive	ADJ
ct-10092	2	28	disorders	disorder	NOUN
ct-10092	2	29	or	or	CCONJ
ct-10092	2	30	hormonal	hormonal	ADJ
ct-10092	2	31	imbalances	imbalance	NOUN
ct-10092	2	32	,	,	PUNCT
ct-10092	2	33	and	and	CCONJ
ct-10092	2	34	3	3	X
ct-10092	2	35	)	)	PUNCT
ct-10092	2	36	to	to	PART
ct-10092	2	37	optimize	optimize	VERB
ct-10092	2	38	reproductive	reproductive	ADJ
ct-10092	2	39	efficiency	efficiency	NOUN
ct-10092	2	40	,	,	PUNCT
ct-10092	2	41	for	for	ADP
ct-10092	2	42	example	example	NOUN
ct-10092	2	43	,	,	PUNCT
ct-10092	2	44	induction	induction	NOUN
ct-10092	2	45	of	of	ADP
ct-10092	2	46	estrus	estrus	NOUN
ct-10092	2	47	or	or	CCONJ
ct-10092	2	48	ovulation	ovulation	NOUN
ct-10092	2	49	.	.	PUNCT
ct-10092	3	1	the	the	DET
ct-10092	3	2	most	most	ADV
ct-10092	3	3	common	common	ADJ
ct-10092	3	4	applications	application	NOUN
ct-10092	3	5	of	of	ADP
ct-10092	3	6	exogenous	exogenous	ADJ
ct-10092	3	7	hormone	hormone	NOUN
ct-10092	3	8	administration	administration	NOUN
ct-10092	3	9	include	include	VERB
ct-10092	3	10	controlling	control	VERB
ct-10092	3	11	the	the	DET
ct-10092	3	12	duration	duration	NOUN
ct-10092	3	13	and	and	CCONJ
ct-10092	3	14	onset	onset	NOUN
ct-10092	3	15	of	of	ADP
ct-10092	3	16	the	the	DET
ct-10092	3	17	different	different	ADJ
ct-10092	3	18	stages	stage	NOUN
ct-10092	3	19	of	of	ADP
ct-10092	3	20	the	the	DET
ct-10092	3	21	estrous	estrous	ADJ
ct-10092	3	22	cycle	cycle	NOUN
ct-10092	3	23	(	(	PUNCT
ct-10092	3	24	specifically	specifically	ADV
ct-10092	3	25	by	by	ADP
ct-10092	3	26	affecting	affect	VERB
ct-10092	3	27	duration	duration	NOUN
ct-10092	3	28	of	of	ADP
ct-10092	3	29	luteal	luteal	ADJ
ct-10092	3	30	function	function	NOUN
ct-10092	3	31	or	or	CCONJ
ct-10092	3	32	hastening	hasten	VERB
ct-10092	3	33	ovulation	ovulation	NOUN
ct-10092	3	34	)	)	PUNCT
ct-10092	3	35	and	and	CCONJ
ct-10092	3	36	stimulating	stimulate	VERB
ct-10092	3	37	myometrial	myometrial	ADJ
ct-10092	3	38	activity	activity	NOUN
ct-10092	3	39	in	in	ADP
ct-10092	3	40	mares	mare	NOUN
ct-10092	3	41	susceptible	susceptible	ADJ
ct-10092	3	42	to	to	ADP
ct-10092	3	43	or	or	CCONJ
ct-10092	3	44	showing	show	VERB
ct-10092	3	45	delayed	delay	VERB
ct-10092	3	46	uterine	uterine	ADJ
ct-10092	3	47	clearance	clearance	NOUN
ct-10092	3	48	.	.	PUNCT
ct-10092	4	1	in	in	ADP
ct-10092	4	2	this	this	DET
ct-10092	4	3	discussion	discussion	NOUN
ct-10092	4	4	,	,	PUNCT
ct-10092	4	5	we	we	PRON
ct-10092	4	6	will	will	AUX
ct-10092	4	7	address	address	VERB
ct-10092	4	8	the	the	DET
ct-10092	4	9	effects	effect	NOUN
ct-10092	4	10	and	and	CCONJ
ct-10092	4	11	potential	potential	ADJ
ct-10092	4	12	indications	indication	NOUN
ct-10092	4	13	for	for	ADP
ct-10092	4	14	the	the	DET
ct-10092	4	15	different	different	ADJ
ct-10092	4	16	hormones	hormone	NOUN
ct-10092	4	17	available	available	ADJ
ct-10092	4	18	to	to	ADP
ct-10092	4	19	the	the	DET
ct-10092	4	20	equine	equine	NOUN
ct-10092	4	21	practitioner	practitioner	NOUN
ct-10092	4	22	working	work	VERB
ct-10092	4	23	with	with	ADP
ct-10092	4	24	broodmare	broodmare	ADJ
ct-10092	4	25	reproduction	reproduction	NOUN
ct-10092	4	26	.	.	PUNCT
ct-10092	5	1	keywords	keyword	NOUN
ct-10092	5	2	:	:	PUNCT
ct-10092	5	3	pgf2α	pgf2α	PROPN
ct-10092	5	4	,	,	PUNCT
ct-10092	5	5	hcg	hcg	PROPN
ct-10092	5	6	,	,	PUNCT
ct-10092	5	7	gnrh	gnrh	NOUN
ct-10092	5	8	,	,	PUNCT
ct-10092	5	9	mare	mare	PROPN
ct-10092	5	10	,	,	PUNCT
ct-10092	5	11	corticosteroids	corticosteroid	VERB
ct-10092	5	12	prostaglandin	prostaglandin	NOUN
ct-10092	5	13	f2α	f2α	PROPN
ct-10092	5	14	(	(	PUNCT
ct-10092	5	15	pgf2α	pgf2α	PROPN
ct-10092	5	16	)	)	PUNCT
ct-10092	5	17	the	the	DET
ct-10092	5	18	administration	administration	NOUN
ct-10092	5	19	of	of	ADP
ct-10092	5	20	natural	natural	ADJ
ct-10092	5	21	or	or	CCONJ
ct-10092	5	22	synthetic	synthetic	ADJ
ct-10092	5	23	pgf2α	pgf2α	NOUN
ct-10092	5	24	analogues	analogue	NOUN
ct-10092	5	25	causes	cause	VERB
ct-10092	5	26	interruption	interruption	NOUN
ct-10092	5	27	of	of	ADP
ct-10092	5	28	luteal	luteal	ADJ
ct-10092	5	29	function	function	NOUN
ct-10092	5	30	by	by	ADP
ct-10092	5	31	inducing	induce	VERB
ct-10092	5	32	luteolysis	luteolysis	NOUN
ct-10092	5	33	.	.	PUNCT
ct-10092	6	1	the	the	DET
ct-10092	6	2	diestrus	diestrus	NOUN
ct-10092	6	3	stage	stage	NOUN
ct-10092	6	4	of	of	ADP
ct-10092	6	5	the	the	DET
ct-10092	6	6	estrous	estrous	ADJ
ct-10092	6	7	cycle	cycle	NOUN
ct-10092	6	8	is	be	AUX
ct-10092	6	9	then	then	ADV
ct-10092	6	10	shortened	shorten	VERB
ct-10092	6	11	,	,	PUNCT
ct-10092	6	12	hastening	hasten	VERB
ct-10092	6	13	onset	onset	NOUN
ct-10092	6	14	of	of	ADP
ct-10092	6	15	estrus	estrus	NOUN
ct-10092	6	16	.	.	PUNCT
ct-10092	7	1	characteristics	characteristic	NOUN
ct-10092	7	2	of	of	ADP
ct-10092	7	3	estrus	estrus	NOUN
ct-10092	7	4	and	and	CCONJ
ct-10092	7	5	ovulation	ovulation	NOUN
ct-10092	7	6	(	(	PUNCT
ct-10092	7	7	e.g.	e.g.	ADV
ct-10092	7	8	,	,	PUNCT
ct-10092	7	9	estrus	estrus	NOUN
ct-10092	7	10	behavior	behavior	NOUN
ct-10092	7	11	,	,	PUNCT
ct-10092	7	12	follicle	follicle	NOUN
ct-10092	7	13	growth	growth	NOUN
ct-10092	7	14	rate	rate	NOUN
ct-10092	7	15	,	,	PUNCT
ct-10092	7	16	ovulation	ovulation	NOUN
ct-10092	7	17	,	,	PUNCT
ct-10092	7	18	fertility	fertility	NOUN
ct-10092	7	19	)	)	PUNCT
ct-10092	7	20	are	be	AUX
ct-10092	7	21	not	not	PART
ct-10092	7	22	different	different	ADJ
ct-10092	7	23	from	from	ADP
ct-10092	7	24	those	those	PRON
ct-10092	7	25	occurring	occur	VERB
ct-10092	7	26	in	in	ADP
ct-10092	7	27	natural	natural	ADJ
ct-10092	7	28	cycles.1	cycles.1	NOUN
ct-10092	7	29	-	-	PUNCT
ct-10092	7	30	3	3	NUM
ct-10092	7	31	however	however	ADV
ct-10092	7	32	,	,	PUNCT
ct-10092	7	33	there	there	PRON
ct-10092	7	34	is	be	VERB
ct-10092	7	35	some	some	DET
ct-10092	7	36	evidence	evidence	NOUN
ct-10092	7	37	of	of	ADP
ct-10092	7	38	increased	increase	VERB
ct-10092	7	39	incidence	incidence	NOUN
ct-10092	7	40	of	of	ADP
ct-10092	7	41	hemorrhagic	hemorrhagic	NOUN
ct-10092	7	42	anovulatory	anovulatory	NOUN
ct-10092	7	43	follicles	follicle	NOUN
ct-10092	7	44	(	(	PUNCT
ct-10092	7	45	haf	haf	NOUN
ct-10092	7	46	)	)	PUNCT
ct-10092	7	47	following	follow	VERB
ct-10092	7	48	exogenous	exogenous	ADJ
ct-10092	7	49	administration	administration	NOUN
ct-10092	7	50	of	of	ADP
ct-10092	7	51	the	the	DET
ct-10092	7	52	synthetic	synthetic	ADJ
ct-10092	7	53	pgf2α	pgf2α	PROPN
ct-10092	7	54	analogue	analogue	NOUN
ct-10092	7	55	cloprostenol.4	cloprostenol.4	PROPN
ct-10092	7	56	-	-	PUNCT
ct-10092	7	57	6	6	NUM
ct-10092	7	58	the	the	DET
ct-10092	7	59	potential	potential	ADJ
ct-10092	7	60	association	association	NOUN
ct-10092	7	61	between	between	ADP
ct-10092	7	62	pgf2α	pgf2α	PROPN
ct-10092	7	63	administration	administration	NOUN
ct-10092	7	64	and	and	CCONJ
ct-10092	7	65	the	the	DET
ct-10092	7	66	incidence	incidence	NOUN
ct-10092	7	67	of	of	ADP
ct-10092	7	68	haf	haf	NOUN
ct-10092	7	69	has	have	AUX
ct-10092	7	70	not	not	PART
ct-10092	7	71	been	be	AUX
ct-10092	7	72	reported	report	VERB
ct-10092	7	73	in	in	ADP
ct-10092	7	74	mares	mare	NOUN
ct-10092	7	75	treated	treat	VERB
ct-10092	7	76	with	with	ADP
ct-10092	7	77	the	the	DET
ct-10092	7	78	natural	natural	ADJ
ct-10092	7	79	analogue	analogue	NOUN
ct-10092	7	80	dinoprost	dinoprost	PROPN
ct-10092	7	81	tromethamine	tromethamine	PROPN
ct-10092	7	82	.	.	PUNCT
ct-10092	8	1	duration	duration	NOUN
ct-10092	8	2	of	of	ADP
ct-10092	8	3	diestrus	diestrus	NOUN
ct-10092	8	4	and	and	CCONJ
ct-10092	8	5	interovulatory	interovulatory	ADJ
ct-10092	8	6	intervals	interval	NOUN
ct-10092	8	7	are	be	AUX
ct-10092	8	8	shortened	shorten	VERB
ct-10092	8	9	following	follow	VERB
ct-10092	8	10	pgf2α	pgf2α	X
ct-10092	8	11	administration.7	administration.7	PROPN
ct-10092	8	12	-	-	PUNCT
ct-10092	8	13	18	18	NUM
ct-10092	8	14	the	the	DET
ct-10092	8	15	equine	equine	NOUN
ct-10092	8	16	corpus	corpus	NOUN
ct-10092	8	17	luteum	luteum	NOUN
ct-10092	8	18	(	(	PUNCT
ct-10092	8	19	cl	cl	NOUN
ct-10092	8	20	)	)	PUNCT
ct-10092	8	21	is	be	AUX
ct-10092	8	22	responsive	responsive	ADJ
ct-10092	8	23	to	to	ADP
ct-10092	8	24	pgf2α	pgf2α	PROPN
ct-10092	8	25	luteolytic	luteolytic	ADJ
ct-10092	8	26	effects	effect	NOUN
ct-10092	8	27	any	any	DET
ct-10092	8	28	day	day	NOUN
ct-10092	8	29	following	follow	VERB
ct-10092	8	30	ovulation	ovulation	NOUN
ct-10092	8	31	;	;	PUNCT
ct-10092	8	32	however	however	ADV
ct-10092	8	33	,	,	PUNCT
ct-10092	8	34	only	only	ADJ
ct-10092	8	35	cl	cl	NOUN
ct-10092	8	36	>	>	SYM
ct-10092	8	37	5	5	NUM
ct-10092	8	38	days	day	NOUN
ct-10092	8	39	are	be	AUX
ct-10092	8	40	consistently	consistently	ADV
ct-10092	8	41	responsive	responsive	ADJ
ct-10092	8	42	to	to	ADP
ct-10092	8	43	the	the	DET
ct-10092	8	44	luteolytic	luteolytic	ADJ
ct-10092	8	45	effects	effect	NOUN
ct-10092	8	46	of	of	ADP
ct-10092	8	47	one	one	NUM
ct-10092	8	48	bolus	bolus	ADJ
ct-10092	8	49	injection	injection	NOUN
ct-10092	8	50	of	of	ADP
ct-10092	8	51	pgf2α.15	pgf2α.15	NOUN
ct-10092	8	52	,	,	PUNCT
ct-10092	8	53	19	19	NUM
ct-10092	8	54	luteolysis	luteolysi	NOUN
ct-10092	8	55	or	or	CCONJ
ct-10092	8	56	antiluteogenesis	antiluteogenesis	NOUN
ct-10092	8	57	can	can	AUX
ct-10092	8	58	be	be	AUX
ct-10092	8	59	reliably	reliably	ADV
ct-10092	8	60	achieved	achieve	VERB
ct-10092	8	61	in	in	ADP
ct-10092	8	62	cl	cl	NOUN
ct-10092	8	63	<	<	NOUN
ct-10092	8	64	5	5	NUM
ct-10092	8	65	days	day	NOUN
ct-10092	8	66	only	only	ADV
ct-10092	8	67	if	if	SCONJ
ct-10092	8	68	multiple	multiple	ADJ
ct-10092	8	69	pgf	pgf	NOUN
ct-10092	8	70	treatments	treatment	NOUN
ct-10092	8	71	are	be	AUX
ct-10092	8	72	administered.14,15,20	administered.14,15,20	PROPN
ct-10092	8	73	for	for	ADP
ct-10092	8	74	that	that	DET
ct-10092	8	75	reason	reason	NOUN
ct-10092	8	76	,	,	PUNCT
ct-10092	8	77	it	it	PRON
ct-10092	8	78	is	be	AUX
ct-10092	8	79	widespread	widespread	ADJ
ct-10092	8	80	practice	practice	NOUN
ct-10092	8	81	to	to	PART
ct-10092	8	82	administer	administer	VERB
ct-10092	8	83	pgf2α	pgf2α	PROPN
ct-10092	8	84	as	as	ADP
ct-10092	8	85	a	a	DET
ct-10092	8	86	single	single	ADJ
ct-10092	8	87	bolus	bolus	ADJ
ct-10092	8	88	injection	injection	NOUN
ct-10092	8	89	(	(	PUNCT
ct-10092	8	90	sc	sc	PROPN
ct-10092	8	91	or	or	CCONJ
ct-10092	8	92	i	i	PRON
ct-10092	8	93	m	m	PROPN
ct-10092	8	94	)	)	PUNCT
ct-10092	8	95	at	at	ADV
ct-10092	8	96	least	least	ADJ
ct-10092	8	97	five	five	NUM
ct-10092	8	98	to	to	PART
ct-10092	8	99	six	six	NUM
ct-10092	8	100	days	day	NOUN
ct-10092	8	101	following	follow	VERB
ct-10092	8	102	ovulation	ovulation	NOUN
ct-10092	8	103	.	.	PUNCT
ct-10092	9	1	this	this	DET
ct-10092	9	2	common	common	ADJ
ct-10092	9	3	practice	practice	NOUN
ct-10092	9	4	perhaps	perhaps	ADV
ct-10092	9	5	contributed	contribute	VERB
ct-10092	9	6	to	to	ADP
ct-10092	9	7	the	the	DET
ct-10092	9	8	prevailing	prevail	VERB
ct-10092	9	9	assumption	assumption	NOUN
ct-10092	9	10	that	that	SCONJ
ct-10092	9	11	pgf2α	pgf2α	PROPN
ct-10092	9	12	treatments	treatment	NOUN
ct-10092	9	13	only	only	ADV
ct-10092	9	14	have	have	AUX
ct-10092	9	15	significant	significant	ADJ
ct-10092	9	16	effects	effect	NOUN
ct-10092	9	17	in	in	ADP
ct-10092	9	18	mares	mare	NOUN
ct-10092	9	19	with	with	ADP
ct-10092	9	20	cl	cl	NOUN
ct-10092	9	21	>	>	SYM
ct-10092	9	22	5	5	NUM
ct-10092	9	23	days	day	NOUN
ct-10092	9	24	old	old	ADJ
ct-10092	9	25	.	.	PUNCT
ct-10092	10	1	mares	mare	NOUN
ct-10092	10	2	with	with	ADP
ct-10092	10	3	a	a	DET
ct-10092	10	4	cl	cl	NOUN
ct-10092	10	5	>	>	SYM
ct-10092	10	6	5	5	NUM
ct-10092	10	7	days	day	NOUN
ct-10092	10	8	old	old	ADJ
ct-10092	10	9	undergo	undergo	VERB
ct-10092	10	10	luteolysis	luteolysis	NOUN
ct-10092	10	11	when	when	SCONJ
ct-10092	10	12	treated	treat	VERB
ct-10092	10	13	with	with	ADP
ct-10092	10	14	a	a	DET
ct-10092	10	15	single	single	ADJ
ct-10092	10	16	injection	injection	NOUN
ct-10092	10	17	(	(	PUNCT
ct-10092	10	18	sc	sc	NOUN
ct-10092	10	19	or	or	CCONJ
ct-10092	10	20	i	i	PRON
ct-10092	10	21	m	m	PROPN
ct-10092	10	22	)	)	PUNCT
ct-10092	10	23	of	of	ADP
ct-10092	10	24	5	5	NUM
ct-10092	10	25	to	to	PART
ct-10092	10	26	10	10	NUM
ct-10092	10	27	mg	mg	NOUN
ct-10092	10	28	of	of	ADP
ct-10092	10	29	dinoprost	dinoprost	PROPN
ct-10092	10	30	tromethamine	tromethamine	NOUN
ct-10092	10	31	or	or	CCONJ
ct-10092	10	32	250	250	NUM
ct-10092	10	33	to	to	PART
ct-10092	10	34	500	500	NUM
ct-10092	10	35	ug	ug	ADP
ct-10092	10	36	of	of	ADP
ct-10092	10	37	cloprostenol	cloprostenol	NOUN
ct-10092	10	38	(	(	PUNCT
ct-10092	10	39	synthetic	synthetic	ADJ
ct-10092	10	40	pgf2α	pgf2α	PROPN
ct-10092	10	41	analogue	analogue	NOUN
ct-10092	10	42	)	)	PUNCT
ct-10092	10	43	.	.	PUNCT
ct-10092	11	1	in	in	ADP
ct-10092	11	2	the	the	DET
ct-10092	11	3	usa	usa	PROPN
ct-10092	11	4	,	,	PUNCT
ct-10092	11	5	dinoprost	dinoprost	PROPN
ct-10092	11	6	tromethamine	tromethamine	PROPN
ct-10092	11	7	*	*	PUNCT
ct-10092	11	8	is	be	AUX
ct-10092	11	9	the	the	DET
ct-10092	11	10	only	only	ADJ
ct-10092	11	11	pgf2α	pgf2α	NOUN
ct-10092	11	12	drug	drug	NOUN
ct-10092	11	13	approved	approve	VERB
ct-10092	11	14	by	by	ADP
ct-10092	11	15	the	the	DET
ct-10092	11	16	food	food	NOUN
ct-10092	11	17	and	and	CCONJ
ct-10092	11	18	drug	drug	PROPN
ct-10092	11	19	administration	administration	PROPN
ct-10092	11	20	(	(	PUNCT
ct-10092	11	21	fda	fda	PROPN
ct-10092	11	22	)	)	PUNCT
ct-10092	11	23	for	for	ADP
ct-10092	11	24	use	use	NOUN
ct-10092	11	25	in	in	ADP
ct-10092	11	26	horses	horse	NOUN
ct-10092	11	27	although	although	SCONJ
ct-10092	11	28	the	the	DET
ct-10092	11	29	use	use	NOUN
ct-10092	11	30	of	of	ADP
ct-10092	11	31	the	the	DET
ct-10092	11	32	racemic	racemic	ADJ
ct-10092	11	33	formulation	formulation	NOUN
ct-10092	11	34	of	of	ADP
ct-10092	11	35	d	d	PROPN
ct-10092	11	36	,	,	PUNCT
ct-10092	11	37	l	l	NOUN
ct-10092	11	38	cloprostenol†	cloprostenol†	NOUN
ct-10092	11	39	is	be	AUX
ct-10092	11	40	fairly	fairly	ADV
ct-10092	11	41	common	common	ADJ
ct-10092	11	42	among	among	ADP
ct-10092	11	43	practitioners	practitioner	NOUN
ct-10092	11	44	working	work	VERB
ct-10092	11	45	with	with	ADP
ct-10092	11	46	horse	horse	NOUN
ct-10092	11	47	breeding	breeding	NOUN
ct-10092	11	48	,	,	PUNCT
ct-10092	11	49	especially	especially	ADV
ct-10092	11	50	owing	owe	VERB
ct-10092	11	51	to	to	ADP
ct-10092	11	52	its	its	PRON
ct-10092	11	53	longer	long	ADJ
ct-10092	11	54	half	half	ADJ
ct-10092	11	55	-	-	PUNCT
ct-10092	11	56	life	life	NOUN
ct-10092	11	57	than	than	SCONJ
ct-10092	11	58	dinoprost	dinoprost	VERB
ct-10092	11	59	tromethamine	tromethamine	NOUN
ct-10092	11	60	salt	salt	NOUN
ct-10092	11	61	preparations	preparation	NOUN
ct-10092	11	62	,	,	PUNCT
ct-10092	11	63	hours	hour	NOUN
ct-10092	11	64	vs.	vs.	ADP
ct-10092	11	65	minutes	minute	NOUN
ct-10092	11	66	,	,	PUNCT
ct-10092	11	67	respectively.21	respectively.21	NOUN
ct-10092	11	68	conversely	conversely	ADV
ct-10092	11	69	,	,	PUNCT
ct-10092	11	70	in	in	ADP
ct-10092	11	71	other	other	ADJ
ct-10092	11	72	countries	country	NOUN
ct-10092	11	73	in	in	ADP
ct-10092	11	74	europe	europe	PROPN
ct-10092	11	75	,	,	PUNCT
ct-10092	11	76	and	and	CCONJ
ct-10092	11	77	south	south	PROPN
ct-10092	11	78	america	america	PROPN
ct-10092	11	79	for	for	ADP
ct-10092	11	80	example	example	NOUN
ct-10092	11	81	,	,	PUNCT
ct-10092	11	82	formulations	formulation	NOUN
ct-10092	11	83	of	of	ADP
ct-10092	11	84	the	the	DET
ct-10092	11	85	synthetic	synthetic	ADJ
ct-10092	11	86	analogue	analogue	NOUN
ct-10092	11	87	cloprostenol	cloprostenol	NOUN
ct-10092	11	88	are	be	AUX
ct-10092	11	89	approved	approve	VERB
ct-10092	11	90	and	and	CCONJ
ct-10092	11	91	available	available	ADJ
ct-10092	11	92	for	for	ADP
ct-10092	11	93	use	use	NOUN
ct-10092	11	94	in	in	ADP
ct-10092	11	95	horses	horse	NOUN
ct-10092	11	96	.	.	PUNCT
ct-10092	12	1	in	in	ADP
ct-10092	12	2	those	those	DET
ct-10092	12	3	countries	country	NOUN
ct-10092	12	4	,	,	PUNCT
ct-10092	12	5	the	the	DET
ct-10092	12	6	racemic	racemic	PROPN
ct-10092	12	7	d	d	PROPN
ct-10092	12	8	,	,	PUNCT
ct-10092	12	9	l	l	NOUN
ct-10092	12	10	cloprostenol	cloprostenol	NOUN
ct-10092	12	11	and	and	CCONJ
ct-10092	12	12	the	the	DET
ct-10092	12	13	more	more	ADV
ct-10092	12	14	potent	potent	ADJ
ct-10092	12	15	formulation	formulation	NOUN
ct-10092	12	16	containing	contain	VERB
ct-10092	12	17	only	only	ADV
ct-10092	12	18	the	the	DET
ct-10092	12	19	d	d	ADJ
ct-10092	12	20	-	-	PUNCT
ct-10092	12	21	enantiomer	enantiomer	ADJ
ct-10092	12	22	cloprostenol‡	cloprostenol‡	NOUN
ct-10092	12	23	are	be	AUX
ct-10092	12	24	available	available	ADJ
ct-10092	12	25	;	;	PUNCT
ct-10092	12	26	only	only	ADV
ct-10092	12	27	25	25	NUM
ct-10092	12	28	to	to	PART
ct-10092	12	29	37.5	37.5	NUM
ct-10092	12	30	ug	ug	ADP
ct-10092	12	31	per	per	ADP
ct-10092	12	32	mare	mare	NOUN
ct-10092	12	33	of	of	ADP
ct-10092	12	34	d	d	NOUN
ct-10092	12	35	-	-	NOUN
ct-10092	12	36	cloprostenol	cloprostenol	NOUN
ct-10092	12	37	is	be	AUX
ct-10092	12	38	needed	need	VERB
ct-10092	12	39	to	to	PART
ct-10092	12	40	induce	induce	VERB
ct-10092	12	41	luteolysis	luteolysis	NOUN
ct-10092	12	42	in	in	ADP
ct-10092	12	43	mares	mare	NOUN
ct-10092	12	44	at	at	ADP
ct-10092	12	45	least	least	ADV
ct-10092	12	46	five	five	NUM
ct-10092	12	47	days	day	NOUN
ct-10092	12	48	after	after	ADP
ct-10092	12	49	ovulation.18	ovulation.18	NOUN
ct-10092	12	50	induction	induction	NOUN
ct-10092	12	51	of	of	ADP
ct-10092	12	52	ovulation	ovulation	NOUN
ct-10092	12	53	the	the	DET
ct-10092	12	54	ability	ability	NOUN
ct-10092	12	55	to	to	PART
ct-10092	12	56	induce	induce	VERB
ct-10092	12	57	ovulation	ovulation	NOUN
ct-10092	12	58	is	be	AUX
ct-10092	12	59	one	one	NUM
ct-10092	12	60	of	of	ADP
ct-10092	12	61	the	the	DET
ct-10092	12	62	most	most	ADV
ct-10092	12	63	important	important	ADJ
ct-10092	12	64	strategies	strategy	NOUN
ct-10092	12	65	utilized	utilize	VERB
ct-10092	12	66	in	in	ADP
ct-10092	12	67	breeding	breeding	NOUN
ct-10092	12	68	management	management	NOUN
ct-10092	12	69	.	.	PUNCT
ct-10092	13	1	ovulation	ovulation	NOUN
ct-10092	13	2	-	-	PUNCT
ct-10092	13	3	inducing	induce	VERB
ct-10092	13	4	agents	agent	NOUN
ct-10092	13	5	typically	typically	ADV
ct-10092	13	6	trigger	trigger	VERB
ct-10092	13	7	ovulation	ovulation	NOUN
ct-10092	13	8	within	within	ADP
ct-10092	13	9	48	48	NUM
ct-10092	13	10	hours	hour	NOUN
ct-10092	13	11	.	.	PUNCT
ct-10092	14	1	in	in	ADP
ct-10092	14	2	mares	mare	NOUN
ct-10092	14	3	monitored	monitor	VERB
ct-10092	14	4	closely	closely	ADV
ct-10092	14	5	via	via	ADP
ct-10092	14	6	palpation	palpation	NOUN
ct-10092	14	7	per	per	ADP
ct-10092	14	8	rectum	rectum	NOUN
ct-10092	14	9	and	and	CCONJ
ct-10092	14	10	ultrasonography	ultrasonography	NOUN
ct-10092	14	11	,	,	PUNCT
ct-10092	14	12	ovulation	ovulation	NOUN
ct-10092	14	13	occurs	occur	VERB
ct-10092	14	14	mainly	mainly	ADV
ct-10092	14	15	within	within	ADP
ct-10092	14	16	36	36	NUM
ct-10092	14	17	to	to	PART
ct-10092	14	18	48	48	NUM
ct-10092	14	19	hours	hour	NOUN
ct-10092	14	20	after	after	ADP
ct-10092	14	21	systemic	systemic	ADJ
ct-10092	14	22	administration	administration	NOUN
ct-10092	14	23	of	of	ADP
ct-10092	14	24	these	these	DET
ct-10092	14	25	agents.22,23	agents.22,23	NOUN
ct-10092	14	26	this	this	DET
ct-10092	14	27	fact	fact	NOUN
ct-10092	14	28	is	be	AUX
ct-10092	14	29	particularly	particularly	ADV
ct-10092	14	30	important	important	ADJ
ct-10092	14	31	for	for	SCONJ
ct-10092	14	32	mares	mare	NOUN
ct-10092	14	33	being	be	AUX
ct-10092	14	34	managed	manage	VERB
ct-10092	14	35	clinical	clinical	ADJ
ct-10092	14	36	theriogenology	theriogenology	NOUN
ct-10092	15	1	•	•	NOUN
ct-10092	15	2	volume	volume	NOUN
ct-10092	15	3	7	7	NUM
ct-10092	15	4	,	,	PUNCT
ct-10092	15	5	number	number	NOUN
ct-10092	15	6	1	1	NUM
ct-10092	15	7	•	•	NUM
ct-10092	15	8	march	march	PROPN
ct-10092	15	9	201545	201545	NUM
ct-10092	15	10	for	for	ADP
ct-10092	15	11	artificial	artificial	ADJ
ct-10092	15	12	insemination	insemination	NOUN
ct-10092	15	13	with	with	ADP
ct-10092	15	14	shipped	ship	VERB
ct-10092	15	15	cooled	cool	VERB
ct-10092	15	16	semen	semen	NOUN
ct-10092	15	17	or	or	CCONJ
ct-10092	15	18	frozen	frozen	ADJ
ct-10092	15	19	-	-	PUNCT
ct-10092	15	20	thawed	thaw	VERB
ct-10092	15	21	semen	semen	NOUN
ct-10092	15	22	.	.	PUNCT
ct-10092	16	1	for	for	ADP
ct-10092	16	2	optimal	optimal	ADJ
ct-10092	16	3	chances	chance	NOUN
ct-10092	16	4	to	to	PART
ct-10092	16	5	predict	predict	VERB
ct-10092	16	6	outcome	outcome	NOUN
ct-10092	16	7	and	and	CCONJ
ct-10092	16	8	increase	increase	VERB
ct-10092	16	9	efficacy	efficacy	NOUN
ct-10092	16	10	of	of	ADP
ct-10092	16	11	the	the	DET
ct-10092	16	12	treatment	treatment	NOUN
ct-10092	16	13	,	,	PUNCT
ct-10092	16	14	regardless	regardless	ADV
ct-10092	16	15	of	of	ADP
ct-10092	16	16	the	the	DET
ct-10092	16	17	ovulation	ovulation	NOUN
ct-10092	16	18	-	-	PUNCT
ct-10092	16	19	inducing	induce	VERB
ct-10092	16	20	agent	agent	NOUN
ct-10092	16	21	being	be	AUX
ct-10092	16	22	used	use	VERB
ct-10092	16	23	,	,	PUNCT
ct-10092	16	24	induction	induction	NOUN
ct-10092	16	25	of	of	ADP
ct-10092	16	26	ovulation	ovulation	NOUN
ct-10092	16	27	should	should	AUX
ct-10092	16	28	be	be	AUX
ct-10092	16	29	attempted	attempt	VERB
ct-10092	16	30	only	only	ADV
ct-10092	16	31	in	in	ADP
ct-10092	16	32	mares	mare	NOUN
ct-10092	16	33	found	find	VERB
ct-10092	16	34	unquestionably	unquestionably	ADV
ct-10092	16	35	to	to	PART
ct-10092	16	36	be	be	AUX
ct-10092	16	37	in	in	ADP
ct-10092	16	38	estrus	estrus	NOUN
ct-10092	16	39	and	and	CCONJ
ct-10092	16	40	with	with	ADP
ct-10092	16	41	a	a	DET
ct-10092	16	42	growing	grow	VERB
ct-10092	16	43	follicle	follicle	NOUN
ct-10092	16	44	≥30	≥30	PROPN
ct-10092	16	45	mm	mm	PROPN
ct-10092	16	46	in	in	ADP
ct-10092	16	47	diameter	diameter	NOUN
ct-10092	16	48	.	.	PUNCT
ct-10092	17	1	the	the	DET
ct-10092	17	2	most	most	ADV
ct-10092	17	3	common	common	ADJ
ct-10092	17	4	hormones	hormone	NOUN
ct-10092	17	5	used	use	VERB
ct-10092	17	6	to	to	PART
ct-10092	17	7	induce	induce	VERB
ct-10092	17	8	ovulation	ovulation	NOUN
ct-10092	17	9	include	include	VERB
ct-10092	17	10	human	human	ADJ
ct-10092	17	11	chorionic	chorionic	ADJ
ct-10092	17	12	gonadotropin	gonadotropin	NOUN
ct-10092	17	13	(	(	PUNCT
ct-10092	17	14	hcg	hcg	PROPN
ct-10092	17	15	)	)	PUNCT
ct-10092	17	16	and	and	CCONJ
ct-10092	17	17	the	the	DET
ct-10092	17	18	gonadotropin	gonadotropin	NOUN
ct-10092	17	19	-	-	PUNCT
ct-10092	17	20	releasing	release	VERB
ct-10092	17	21	hormone	hormone	NOUN
ct-10092	17	22	agonists	agonist	NOUN
ct-10092	17	23	(	(	PUNCT
ct-10092	17	24	gnrh	gnrh	NOUN
ct-10092	17	25	)	)	PUNCT
ct-10092	17	26	,	,	PUNCT
ct-10092	17	27	which	which	PRON
ct-10092	17	28	will	will	AUX
ct-10092	17	29	be	be	AUX
ct-10092	17	30	discussed	discuss	VERB
ct-10092	17	31	below	below	ADV
ct-10092	17	32	.	.	PUNCT
ct-10092	18	1	human	human	ADJ
ct-10092	18	2	chorionic	chorionic	ADJ
ct-10092	18	3	gonadotropin	gonadotropin	PROPN
ct-10092	18	4	human	human	PROPN
ct-10092	18	5	chorionic	chorionic	ADJ
ct-10092	18	6	gonadotropin§	gonadotropin§	PROPN
ct-10092	18	7	has	have	AUX
ct-10092	18	8	been	be	AUX
ct-10092	18	9	widely	widely	ADV
ct-10092	18	10	and	and	CCONJ
ct-10092	18	11	extensively	extensively	ADV
ct-10092	18	12	used	use	VERB
ct-10092	18	13	as	as	ADP
ct-10092	18	14	an	an	DET
ct-10092	18	15	ovulation	ovulation	NOUN
ct-10092	18	16	-	-	PUNCT
ct-10092	18	17	inducing	induce	VERB
ct-10092	18	18	agent	agent	NOUN
ct-10092	18	19	since	since	SCONJ
ct-10092	18	20	the	the	DET
ct-10092	18	21	1930	1930	NUM
ct-10092	18	22	’s	’s	PART
ct-10092	18	23	and	and	CCONJ
ct-10092	18	24	1940’s.24	1940’s.24	NOUN
ct-10092	18	25	-	-	PUNCT
ct-10092	18	26	27	27	NUM
ct-10092	18	27	the	the	DET
ct-10092	18	28	luteinizing	luteinize	VERB
ct-10092	18	29	hormone	hormone	NOUN
ct-10092	18	30	(	(	PUNCT
ct-10092	18	31	lh)-like	lh)-like	ADP
ct-10092	18	32	activity	activity	NOUN
ct-10092	18	33	of	of	ADP
ct-10092	18	34	hcg	hcg	PROPN
ct-10092	18	35	is	be	AUX
ct-10092	18	36	explained	explain	VERB
ct-10092	18	37	by	by	ADP
ct-10092	18	38	its	its	PRON
ct-10092	18	39	85	85	NUM
ct-10092	18	40	%	%	NOUN
ct-10092	18	41	homology	homology	NOUN
ct-10092	18	42	in	in	ADP
ct-10092	18	43	amino	amino	NOUN
ct-10092	18	44	acid	acid	NOUN
ct-10092	18	45	sequence	sequence	NOUN
ct-10092	18	46	in	in	ADP
ct-10092	18	47	the	the	DET
ct-10092	18	48	β	β	NOUN
ct-10092	18	49	-	-	NOUN
ct-10092	18	50	subunit	subunit	NOUN
ct-10092	18	51	and	and	CCONJ
ct-10092	18	52	by	by	ADP
ct-10092	18	53	its	its	PRON
ct-10092	18	54	ability	ability	NOUN
ct-10092	18	55	to	to	PART
ct-10092	18	56	bind	bind	VERB
ct-10092	18	57	to	to	ADP
ct-10092	18	58	the	the	DET
ct-10092	18	59	lh	lh	PROPN
ct-10092	18	60	receptor.28	receptor.28	PROPN
ct-10092	18	61	chemically	chemically	ADV
ct-10092	18	62	,	,	PUNCT
ct-10092	18	63	hcg	hcg	PROPN
ct-10092	18	64	is	be	AUX
ct-10092	18	65	a	a	DET
ct-10092	18	66	glycoprotein	glycoprotein	NOUN
ct-10092	18	67	composed	compose	VERB
ct-10092	18	68	of	of	ADP
ct-10092	18	69	an	an	DET
ct-10092	18	70	α	α	NOUN
ct-10092	18	71	and	and	CCONJ
ct-10092	18	72	a	a	DET
ct-10092	18	73	β	β	NOUN
ct-10092	18	74	subunit	subunit	NOUN
ct-10092	18	75	;	;	PUNCT
ct-10092	18	76	the	the	DET
ct-10092	18	77	α	α	NOUN
ct-10092	18	78	-	-	PUNCT
ct-10092	18	79	subunit	subunit	NOUN
ct-10092	18	80	is	be	AUX
ct-10092	18	81	similar	similar	ADJ
ct-10092	18	82	to	to	ADP
ct-10092	18	83	that	that	PRON
ct-10092	18	84	of	of	ADP
ct-10092	18	85	human	human	ADJ
ct-10092	18	86	follicle	follicle	NOUN
ct-10092	18	87	stimulating	stimulate	VERB
ct-10092	18	88	hormone	hormone	NOUN
ct-10092	18	89	(	(	PUNCT
ct-10092	18	90	fsh	fsh	NOUN
ct-10092	18	91	)	)	PUNCT
ct-10092	18	92	and	and	CCONJ
ct-10092	18	93	lh	lh	PROPN
ct-10092	18	94	;	;	PUNCT
ct-10092	18	95	however	however	ADV
ct-10092	18	96	,	,	PUNCT
ct-10092	18	97	the	the	DET
ct-10092	18	98	hcg	hcg	PROPN
ct-10092	18	99	β	β	NOUN
ct-10092	18	100	-	-	PUNCT
ct-10092	18	101	subunit	subunit	NOUN
ct-10092	18	102	,	,	PUNCT
ct-10092	18	103	despite	despite	SCONJ
ct-10092	18	104	its	its	PRON
ct-10092	18	105	homology	homology	NOUN
ct-10092	18	106	with	with	ADP
ct-10092	18	107	the	the	DET
ct-10092	18	108	lh	lh	PROPN
ct-10092	18	109	β	β	NOUN
ct-10092	18	110	-	-	PUNCT
ct-10092	18	111	subunit	subunit	NOUN
ct-10092	18	112	,	,	PUNCT
ct-10092	18	113	does	do	AUX
ct-10092	18	114	have	have	VERB
ct-10092	18	115	an	an	DET
ct-10092	18	116	additional	additional	ADJ
ct-10092	18	117	carboxyl	carboxyl	NOUN
ct-10092	18	118	-	-	PUNCT
ct-10092	18	119	terminal	terminal	ADJ
ct-10092	18	120	group	group	NOUN
ct-10092	18	121	with	with	ADP
ct-10092	18	122	31	31	NUM
ct-10092	18	123	amino	amino	ADJ
ct-10092	18	124	acids	acid	NOUN
ct-10092	18	125	and	and	CCONJ
ct-10092	18	126	a	a	DET
ct-10092	18	127	high	high	ADJ
ct-10092	18	128	content	content	NOUN
ct-10092	18	129	of	of	ADP
ct-10092	18	130	sialic	sialic	ADJ
ct-10092	18	131	acid	acid	NOUN
ct-10092	18	132	that	that	PRON
ct-10092	18	133	provides	provide	VERB
ct-10092	18	134	a	a	DET
ct-10092	18	135	substrate	substrate	NOUN
ct-10092	18	136	for	for	ADP
ct-10092	18	137	glycosylation	glycosylation	NOUN
ct-10092	18	138	.	.	PUNCT
ct-10092	19	1	glycosylation	glycosylation	NOUN
ct-10092	19	2	is	be	AUX
ct-10092	19	3	the	the	DET
ct-10092	19	4	posttranslational	posttranslational	ADJ
ct-10092	19	5	modification	modification	NOUN
ct-10092	19	6	of	of	ADP
ct-10092	19	7	the	the	DET
ct-10092	19	8	hcg	hcg	PROPN
ct-10092	19	9	molecule	molecule	NOUN
ct-10092	19	10	that	that	PRON
ct-10092	19	11	confers	confer	VERB
ct-10092	19	12	it	it	PRON
ct-10092	19	13	a	a	DET
ct-10092	19	14	longer	long	ADJ
ct-10092	19	15	half	half	ADJ
ct-10092	19	16	-	-	PUNCT
ct-10092	19	17	life	life	NOUN
ct-10092	19	18	(	(	PUNCT
ct-10092	19	19	several	several	ADJ
ct-10092	19	20	hours	hour	NOUN
ct-10092	19	21	)	)	PUNCT
ct-10092	19	22	than	than	ADP
ct-10092	19	23	that	that	PRON
ct-10092	19	24	of	of	ADP
ct-10092	19	25	lh	lh	PROPN
ct-10092	19	26	(	(	PUNCT
ct-10092	19	27	20	20	NUM
ct-10092	19	28	to	to	PART
ct-10092	19	29	30	30	NUM
ct-10092	19	30	minutes	minute	NOUN
ct-10092	19	31	)	)	PUNCT
ct-10092	19	32	.	.	PUNCT
ct-10092	20	1	for	for	ADP
ct-10092	20	2	many	many	ADJ
ct-10092	20	3	years	year	NOUN
ct-10092	20	4	,	,	PUNCT
ct-10092	20	5	the	the	DET
ct-10092	20	6	hormone	hormone	NOUN
ct-10092	20	7	hcg	hcg	PROPN
ct-10092	20	8	was	be	AUX
ct-10092	20	9	only	only	ADV
ct-10092	20	10	produced	produce	VERB
ct-10092	20	11	after	after	ADP
ct-10092	20	12	being	be	AUX
ct-10092	20	13	extracted	extract	VERB
ct-10092	20	14	from	from	ADP
ct-10092	20	15	urine	urine	NOUN
ct-10092	20	16	of	of	ADP
ct-10092	20	17	pregnant	pregnant	ADJ
ct-10092	20	18	women	woman	NOUN
ct-10092	20	19	,	,	PUNCT
ct-10092	20	20	lyophilized	lyophilize	VERB
ct-10092	20	21	and	and	CCONJ
ct-10092	20	22	marketed	market	VERB
ct-10092	20	23	in	in	ADP
ct-10092	20	24	the	the	DET
ct-10092	20	25	usa	usa	PROPN
ct-10092	20	26	in	in	ADP
ct-10092	20	27	vials	vial	NOUN
ct-10092	20	28	containing	contain	VERB
ct-10092	20	29	10,000	10,000	NUM
ct-10092	20	30	international	international	ADJ
ct-10092	20	31	units	unit	NOUN
ct-10092	20	32	(	(	PUNCT
ct-10092	20	33	iu	iu	NOUN
ct-10092	20	34	)	)	PUNCT
ct-10092	20	35	available	available	ADJ
ct-10092	20	36	for	for	ADP
ct-10092	20	37	clinical	clinical	ADJ
ct-10092	20	38	use	use	NOUN
ct-10092	20	39	in	in	ADP
ct-10092	20	40	human	human	ADJ
ct-10092	20	41	and	and	CCONJ
ct-10092	20	42	veterinary	veterinary	ADJ
ct-10092	20	43	medicine	medicine	NOUN
ct-10092	20	44	.	.	PUNCT
ct-10092	21	1	since	since	SCONJ
ct-10092	21	2	the	the	DET
ct-10092	21	3	early	early	ADJ
ct-10092	21	4	2000	2000	NUM
ct-10092	21	5	’s	’	VERB
ct-10092	21	6	a	a	DET
ct-10092	21	7	recombinant	recombinant	ADJ
ct-10092	21	8	form	form	NOUN
ct-10092	21	9	of	of	ADP
ct-10092	21	10	hcg	hcg	PROPN
ct-10092	21	11	produced	produce	VERB
ct-10092	21	12	from	from	ADP
ct-10092	21	13	genetically	genetically	ADV
ct-10092	21	14	modified	modify	VERB
ct-10092	21	15	chinese	chinese	ADJ
ct-10092	21	16	hamster	hamster	NOUN
ct-10092	21	17	ovary	ovary	ADJ
ct-10092	21	18	cells	cell	NOUN
ct-10092	21	19	is	be	AUX
ct-10092	21	20	also	also	ADV
ct-10092	21	21	available	available	ADJ
ct-10092	21	22	commercially	commercially	ADV
ct-10092	21	23	in	in	ADP
ct-10092	21	24	the	the	DET
ct-10092	21	25	usa	usa	PROPN
ct-10092	21	26	for	for	ADP
ct-10092	21	27	treatment	treatment	NOUN
ct-10092	21	28	of	of	ADP
ct-10092	21	29	women	woman	NOUN
ct-10092	21	30	undergoing	undergo	VERB
ct-10092	21	31	fertility	fertility	NOUN
ct-10092	21	32	treatments	treatment	NOUN
ct-10092	21	33	.	.	PUNCT
ct-10092	22	1	there	there	PRON
ct-10092	22	2	are	be	VERB
ct-10092	22	3	no	no	DET
ct-10092	22	4	reports	report	NOUN
ct-10092	22	5	of	of	ADP
ct-10092	22	6	use	use	NOUN
ct-10092	22	7	of	of	ADP
ct-10092	22	8	the	the	DET
ct-10092	22	9	recombinant	recombinant	ADJ
ct-10092	22	10	hcg	hcg	PROPN
ct-10092	22	11	in	in	ADP
ct-10092	22	12	the	the	DET
ct-10092	22	13	horse	horse	NOUN
ct-10092	22	14	.	.	PUNCT
ct-10092	23	1	despite	despite	SCONJ
ct-10092	23	2	reports	report	NOUN
ct-10092	23	3	of	of	ADP
ct-10092	23	4	mares	mare	NOUN
ct-10092	23	5	being	be	AUX
ct-10092	23	6	treated	treat	VERB
ct-10092	23	7	with	with	ADP
ct-10092	23	8	hcg	hcg	PROPN
ct-10092	23	9	since	since	SCONJ
ct-10092	23	10	1939,26	1939,26	NUM
ct-10092	23	11	hcg	hcg	PROPN
ct-10092	23	12	is	be	AUX
ct-10092	23	13	not	not	PART
ct-10092	23	14	approved	approve	VERB
ct-10092	23	15	by	by	ADP
ct-10092	23	16	the	the	DET
ct-10092	23	17	fda	fda	PROPN
ct-10092	23	18	for	for	ADP
ct-10092	23	19	use	use	NOUN
ct-10092	23	20	in	in	ADP
ct-10092	23	21	horses	horse	NOUN
ct-10092	23	22	.	.	PUNCT
ct-10092	24	1	nevertheless	nevertheless	ADV
ct-10092	24	2	,	,	PUNCT
ct-10092	24	3	a	a	DET
ct-10092	24	4	single	single	ADJ
ct-10092	24	5	bolus	bolus	NOUN
ct-10092	24	6	dose	dose	NOUN
ct-10092	24	7	of	of	ADP
ct-10092	24	8	750	750	NUM
ct-10092	24	9	to	to	PART
ct-10092	24	10	3300	3300	NUM
ct-10092	24	11	iu	iu	NOUN
ct-10092	24	12	of	of	ADP
ct-10092	24	13	urinary	urinary	ADJ
ct-10092	24	14	hcg	hcg	PROPN
ct-10092	24	15	is	be	AUX
ct-10092	24	16	typically	typically	ADV
ct-10092	24	17	sufficient	sufficient	ADJ
ct-10092	24	18	to	to	PART
ct-10092	24	19	induce	induce	VERB
ct-10092	24	20	ovulation	ovulation	NOUN
ct-10092	24	21	in	in	ADP
ct-10092	24	22	mares	mare	NOUN
ct-10092	24	23	during	during	ADP
ct-10092	24	24	estrus	estrus	NOUN
ct-10092	24	25	,	,	PUNCT
ct-10092	24	26	with	with	ADP
ct-10092	24	27	distinct	distinct	ADJ
ct-10092	24	28	estrous	estrous	ADJ
ct-10092	24	29	uterine	uterine	ADJ
ct-10092	24	30	edema	edema	NOUN
ct-10092	24	31	and	and	CCONJ
ct-10092	24	32	with	with	ADP
ct-10092	24	33	a	a	DET
ct-10092	24	34	viable	viable	ADJ
ct-10092	24	35	,	,	PUNCT
ct-10092	24	36	growing	grow	VERB
ct-10092	24	37	follicle	follicle	NOUN
ct-10092	24	38	>	>	NOUN
ct-10092	24	39	30	30	NUM
ct-10092	24	40	mm.29,30	mm.29,30	NOUN
ct-10092	24	41	mares	mare	NOUN
ct-10092	24	42	with	with	ADP
ct-10092	24	43	more	more	ADJ
ct-10092	24	44	than	than	ADP
ct-10092	24	45	one	one	NUM
ct-10092	24	46	presumptive	presumptive	ADJ
ct-10092	24	47	preovulatory	preovulatory	ADJ
ct-10092	24	48	follicle	follicle	NOUN
ct-10092	24	49	do	do	AUX
ct-10092	24	50	not	not	PART
ct-10092	24	51	need	need	VERB
ct-10092	24	52	a	a	DET
ct-10092	24	53	double	double	ADJ
ct-10092	24	54	dose	dose	NOUN
ct-10092	24	55	or	or	CCONJ
ct-10092	24	56	a	a	DET
ct-10092	24	57	second	second	ADJ
ct-10092	24	58	injection	injection	NOUN
ct-10092	24	59	during	during	ADP
ct-10092	24	60	that	that	DET
ct-10092	24	61	estrus	estrus	NOUN
ct-10092	24	62	.	.	PUNCT
ct-10092	25	1	in	in	ADP
ct-10092	25	2	our	our	PRON
ct-10092	25	3	experience	experience	NOUN
ct-10092	25	4	,	,	PUNCT
ct-10092	25	5	mares	mare	NOUN
ct-10092	25	6	that	that	PRON
ct-10092	25	7	repeatedly	repeatedly	ADV
ct-10092	25	8	ovulate	ovulate	VERB
ct-10092	25	9	two	two	NUM
ct-10092	25	10	or	or	CCONJ
ct-10092	25	11	three	three	NUM
ct-10092	25	12	follicles	follicle	NOUN
ct-10092	25	13	respond	respond	VERB
ct-10092	25	14	to	to	ADP
ct-10092	25	15	a	a	DET
ct-10092	25	16	single	single	ADJ
ct-10092	25	17	hcg	hcg	PROPN
ct-10092	25	18	treatment	treatment	NOUN
ct-10092	25	19	similarly	similarly	ADV
ct-10092	25	20	to	to	ADP
ct-10092	25	21	mares	mare	NOUN
ct-10092	25	22	ovulating	ovulate	VERB
ct-10092	25	23	only	only	ADV
ct-10092	25	24	one	one	NUM
ct-10092	25	25	follicle	follicle	NOUN
ct-10092	25	26	during	during	ADP
ct-10092	25	27	estrus	estrus	NOUN
ct-10092	25	28	.	.	PUNCT
ct-10092	26	1	because	because	SCONJ
ct-10092	26	2	hcg	hcg	PROPN
ct-10092	26	3	is	be	AUX
ct-10092	26	4	available	available	ADJ
ct-10092	26	5	in	in	ADP
ct-10092	26	6	10,000	10,000	NUM
ct-10092	26	7	iu	iu	ADP
ct-10092	26	8	vials	vial	NOUN
ct-10092	26	9	,	,	PUNCT
ct-10092	26	10	it	it	PRON
ct-10092	26	11	is	be	AUX
ct-10092	26	12	common	common	ADJ
ct-10092	26	13	for	for	SCONJ
ct-10092	26	14	equine	equine	NOUN
ct-10092	26	15	practitioners	practitioner	NOUN
ct-10092	26	16	to	to	PART
ct-10092	26	17	administer	administer	VERB
ct-10092	26	18	bolus	bolus	ADJ
ct-10092	26	19	doses	dose	NOUN
ct-10092	26	20	of	of	ADP
ct-10092	26	21	2,000	2,000	NUM
ct-10092	26	22	or	or	CCONJ
ct-10092	26	23	2,500	2,500	NUM
ct-10092	26	24	iu	iu	NOUN
ct-10092	26	25	to	to	PART
ct-10092	26	26	optimize	optimize	VERB
ct-10092	26	27	the	the	DET
ct-10092	26	28	use	use	NOUN
ct-10092	26	29	of	of	ADP
ct-10092	26	30	each	each	DET
ct-10092	26	31	vial	vial	NOUN
ct-10092	26	32	.	.	PUNCT
ct-10092	27	1	although	although	SCONJ
ct-10092	27	2	the	the	DET
ct-10092	27	3	authors	author	NOUN
ct-10092	27	4	have	have	AUX
ct-10092	27	5	successfully	successfully	ADV
ct-10092	27	6	used	use	VERB
ct-10092	27	7	vials	vial	NOUN
ct-10092	27	8	that	that	PRON
ct-10092	27	9	have	have	AUX
ct-10092	27	10	been	be	AUX
ct-10092	27	11	reconstituted	reconstitute	VERB
ct-10092	27	12	for	for	ADP
ct-10092	27	13	several	several	ADJ
ct-10092	27	14	weeks	week	NOUN
ct-10092	27	15	,	,	PUNCT
ct-10092	27	16	it	it	PRON
ct-10092	27	17	is	be	AUX
ct-10092	27	18	recommended	recommend	VERB
ct-10092	27	19	that	that	SCONJ
ct-10092	27	20	reconstituted	reconstitute	VERB
ct-10092	27	21	vials	vial	NOUN
ct-10092	27	22	be	be	AUX
ct-10092	27	23	used	use	VERB
ct-10092	27	24	within	within	ADP
ct-10092	27	25	two	two	NUM
ct-10092	27	26	weeks	week	NOUN
ct-10092	27	27	and	and	CCONJ
ct-10092	27	28	kept	keep	VERB
ct-10092	27	29	refrigerated	refrigerate	VERB
ct-10092	27	30	during	during	ADP
ct-10092	27	31	that	that	DET
ct-10092	27	32	period	period	NOUN
ct-10092	27	33	.	.	PUNCT
ct-10092	28	1	alternatively	alternatively	ADV
ct-10092	28	2	,	,	PUNCT
ct-10092	28	3	unused	unused	ADJ
ct-10092	28	4	reconstituted	reconstitute	VERB
ct-10092	28	5	hcg	hcg	PROPN
ct-10092	28	6	can	can	AUX
ct-10092	28	7	be	be	AUX
ct-10092	28	8	frozen	freeze	VERB
ct-10092	28	9	in	in	ADP
ct-10092	28	10	separate	separate	ADJ
ct-10092	28	11	doses	dose	NOUN
ct-10092	28	12	for	for	ADP
ct-10092	28	13	future	future	ADJ
ct-10092	28	14	use	use	NOUN
ct-10092	28	15	as	as	SCONJ
ct-10092	28	16	repeated	repeat	VERB
ct-10092	28	17	freezing	freezing	NOUN
ct-10092	28	18	-	-	PUNCT
ct-10092	28	19	thawing	thaw	VERB
ct-10092	28	20	reconstituted	reconstitute	VERB
ct-10092	28	21	vials	vial	NOUN
ct-10092	28	22	is	be	AUX
ct-10092	28	23	not	not	PART
ct-10092	28	24	recommended	recommend	VERB
ct-10092	28	25	.	.	PUNCT
ct-10092	29	1	intramuscular	intramuscular	ADJ
ct-10092	29	2	or	or	CCONJ
ct-10092	29	3	intravenous	intravenous	ADJ
ct-10092	29	4	routes	route	NOUN
ct-10092	29	5	can	can	AUX
ct-10092	29	6	be	be	AUX
ct-10092	29	7	used	use	VERB
ct-10092	29	8	to	to	PART
ct-10092	29	9	administer	administer	VERB
ct-10092	29	10	hcg	hcg	PROPN
ct-10092	29	11	in	in	ADP
ct-10092	29	12	mares	mare	NOUN
ct-10092	29	13	but	but	CCONJ
ct-10092	29	14	it	it	PRON
ct-10092	29	15	seems	seem	VERB
ct-10092	29	16	,	,	PUNCT
ct-10092	29	17	anecdotally	anecdotally	ADV
ct-10092	29	18	,	,	PUNCT
ct-10092	29	19	that	that	SCONJ
ct-10092	29	20	fewer	few	ADJ
ct-10092	29	21	ovulation	ovulation	NOUN
ct-10092	29	22	failures	failure	NOUN
ct-10092	29	23	are	be	AUX
ct-10092	29	24	seen	see	VERB
ct-10092	29	25	in	in	ADP
ct-10092	29	26	mares	mare	NOUN
ct-10092	29	27	receiving	receive	VERB
ct-10092	29	28	hcg	hcg	PROPN
ct-10092	29	29	intravenously	intravenously	ADV
ct-10092	29	30	than	than	ADP
ct-10092	29	31	in	in	ADP
ct-10092	29	32	mares	mare	NOUN
ct-10092	29	33	receiving	receive	VERB
ct-10092	29	34	it	it	PRON
ct-10092	29	35	intramuscularly	intramuscularly	ADV
ct-10092	29	36	.	.	PUNCT
ct-10092	30	1	for	for	ADP
ct-10092	30	2	example	example	NOUN
ct-10092	30	3	,	,	PUNCT
ct-10092	30	4	intramuscular	intramuscular	ADJ
ct-10092	30	5	doses	dose	NOUN
ct-10092	30	6	of	of	ADP
ct-10092	30	7	5,000	5,000	NUM
ct-10092	30	8	to	to	PART
ct-10092	30	9	10,000	10,000	NUM
ct-10092	30	10	iu	iu	NOUN
ct-10092	30	11	should	should	AUX
ct-10092	30	12	be	be	AUX
ct-10092	30	13	avoided	avoid	VERB
ct-10092	30	14	.	.	PUNCT
ct-10092	31	1	mares	mare	NOUN
ct-10092	31	2	do	do	AUX
ct-10092	31	3	develop	develop	VERB
ct-10092	31	4	antibodies	antibody	NOUN
ct-10092	31	5	to	to	ADP
ct-10092	31	6	the	the	DET
ct-10092	31	7	human	human	ADJ
ct-10092	31	8	hormone	hormone	NOUN
ct-10092	31	9	but	but	CCONJ
ct-10092	31	10	the	the	DET
ct-10092	31	11	presence	presence	NOUN
ct-10092	31	12	of	of	ADP
ct-10092	31	13	antibodies	antibody	NOUN
ct-10092	31	14	does	do	AUX
ct-10092	31	15	not	not	PART
ct-10092	31	16	seem	seem	VERB
ct-10092	31	17	to	to	PART
ct-10092	31	18	interfere	interfere	VERB
ct-10092	31	19	with	with	ADP
ct-10092	31	20	ovulation.31	ovulation.31	NOUN
ct-10092	31	21	nevertheless	nevertheless	ADV
ct-10092	31	22	some	some	DET
ct-10092	31	23	authors	author	NOUN
ct-10092	31	24	do	do	AUX
ct-10092	31	25	recommend	recommend	VERB
ct-10092	31	26	not	not	PART
ct-10092	31	27	treating	treat	VERB
ct-10092	31	28	mares	mare	NOUN
ct-10092	31	29	with	with	ADP
ct-10092	31	30	hcg	hcg	PROPN
ct-10092	31	31	more	more	ADV
ct-10092	31	32	than	than	ADP
ct-10092	31	33	once	once	ADV
ct-10092	31	34	or	or	CCONJ
ct-10092	31	35	twice	twice	ADV
ct-10092	31	36	during	during	ADP
ct-10092	31	37	the	the	DET
ct-10092	31	38	same	same	ADJ
ct-10092	31	39	breeding	breeding	NOUN
ct-10092	31	40	season33	season33	NOUN
ct-10092	31	41	whereas	whereas	SCONJ
ct-10092	31	42	others	other	NOUN
ct-10092	31	43	(	(	PUNCT
ct-10092	31	44	including	include	VERB
ct-10092	31	45	the	the	DET
ct-10092	31	46	current	current	ADJ
ct-10092	31	47	authors	author	NOUN
ct-10092	31	48	)	)	PUNCT
ct-10092	31	49	have	have	AUX
ct-10092	31	50	used	use	VERB
ct-10092	31	51	it	it	PRON
ct-10092	31	52	successfully	successfully	ADV
ct-10092	31	53	(	(	PUNCT
ct-10092	31	54	ovulation	ovulation	NOUN
ct-10092	31	55	within	within	ADP
ct-10092	31	56	48	48	NUM
ct-10092	31	57	hours	hour	NOUN
ct-10092	31	58	from	from	ADP
ct-10092	31	59	administration	administration	NOUN
ct-10092	31	60	)	)	PUNCT
ct-10092	31	61	in	in	ADP
ct-10092	31	62	mares	mare	NOUN
ct-10092	31	63	treated	treat	VERB
ct-10092	31	64	four	four	NUM
ct-10092	31	65	to	to	PART
ct-10092	31	66	seven	seven	NUM
ct-10092	31	67	times	time	NOUN
ct-10092	31	68	during	during	ADP
ct-10092	31	69	the	the	DET
ct-10092	31	70	same	same	ADJ
ct-10092	31	71	breeding	breeding	NOUN
ct-10092	31	72	season	season	NOUN
ct-10092	31	73	.	.	PUNCT
ct-10092	32	1	gonadotropin	gonadotropin	NOUN
ct-10092	32	2	-	-	PUNCT
ct-10092	32	3	releasing	release	VERB
ct-10092	32	4	hormones	hormone	NOUN
ct-10092	32	5	administrations	administration	NOUN
ct-10092	32	6	of	of	ADP
ct-10092	32	7	simple	simple	ADJ
ct-10092	32	8	(	(	PUNCT
ct-10092	32	9	relative	relative	ADJ
ct-10092	32	10	potency	potency	NOUN
ct-10092	32	11	=	=	SYM
ct-10092	32	12	1	1	X
ct-10092	32	13	)	)	PUNCT
ct-10092	32	14	gnrh	gnrh	NOUN
ct-10092	32	15	analogues	analogue	NOUN
ct-10092	32	16	(	(	PUNCT
ct-10092	32	17	equivalent	equivalent	ADJ
ct-10092	32	18	to	to	ADP
ct-10092	32	19	the	the	DET
ct-10092	32	20	natural	natural	ADJ
ct-10092	32	21	decapeptide	decapeptide	ADJ
ct-10092	32	22	gnrh	gnrh	NOUN
ct-10092	32	23	)	)	PUNCT
ct-10092	32	24	to	to	ADP
ct-10092	32	25	cycling	cycle	VERB
ct-10092	32	26	mares	mare	NOUN
ct-10092	32	27	have	have	AUX
ct-10092	32	28	failed	fail	VERB
ct-10092	32	29	to	to	PART
ct-10092	32	30	consistently	consistently	ADV
ct-10092	32	31	induce	induce	VERB
ct-10092	32	32	ovulation	ovulation	NOUN
ct-10092	32	33	.	.	PUNCT
ct-10092	33	1	whereas	whereas	SCONJ
ct-10092	33	2	doses	dose	NOUN
ct-10092	33	3	of	of	ADP
ct-10092	33	4	50	50	NUM
ct-10092	33	5	to	to	PART
ct-10092	33	6	100	100	NUM
ct-10092	33	7	ug	ug	ADP
ct-10092	33	8	of	of	ADP
ct-10092	33	9	gnrh	gnrh	NOUN
ct-10092	33	10	are	be	AUX
ct-10092	33	11	sufficient	sufficient	ADJ
ct-10092	33	12	to	to	PART
ct-10092	33	13	induce	induce	VERB
ct-10092	33	14	ovulation	ovulation	NOUN
ct-10092	33	15	in	in	ADP
ct-10092	33	16	cattle	cattle	NOUN
ct-10092	33	17	,	,	PUNCT
ct-10092	33	18	doses	dose	NOUN
ct-10092	33	19	as	as	ADV
ct-10092	33	20	high	high	ADJ
ct-10092	33	21	as	as	ADP
ct-10092	33	22	1	1	NUM
ct-10092	33	23	to	to	PART
ct-10092	33	24	4	4	NUM
ct-10092	33	25	mg	mg	NOUN
ct-10092	33	26	of	of	ADP
ct-10092	33	27	gnrh	gnrh	NOUN
ct-10092	33	28	have	have	AUX
ct-10092	33	29	failed	fail	VERB
ct-10092	33	30	to	to	PART
ct-10092	33	31	reliably	reliably	ADV
ct-10092	33	32	induce	induce	VERB
ct-10092	33	33	ovulation	ovulation	NOUN
ct-10092	33	34	in	in	ADP
ct-10092	33	35	mares	mare	NOUN
ct-10092	33	36	when	when	SCONJ
ct-10092	33	37	administered	administer	VERB
ct-10092	33	38	once	once	ADV
ct-10092	33	39	or	or	CCONJ
ct-10092	33	40	twice	twice	ADV
ct-10092	33	41	daily	daily	ADV
ct-10092	33	42	during	during	ADP
ct-10092	33	43	estrus	estrus	NOUN
ct-10092	33	44	.	.	PUNCT
ct-10092	34	1	furthermore	furthermore	ADV
ct-10092	34	2	,	,	PUNCT
ct-10092	34	3	only	only	ADV
ct-10092	34	4	pulsatile	pulsatile	VERB
ct-10092	34	5	administration	administration	NOUN
ct-10092	34	6	(	(	PUNCT
ct-10092	34	7	every	every	DET
ct-10092	34	8	hour	hour	NOUN
ct-10092	34	9	)	)	PUNCT
ct-10092	34	10	of	of	ADP
ct-10092	34	11	gnrh	gnrh	NOUN
ct-10092	34	12	has	have	AUX
ct-10092	34	13	been	be	AUX
ct-10092	34	14	found	find	VERB
ct-10092	34	15	to	to	PART
ct-10092	34	16	be	be	AUX
ct-10092	34	17	effective	effective	ADJ
ct-10092	34	18	in	in	ADP
ct-10092	34	19	inducing	induce	VERB
ct-10092	34	20	ovulation	ovulation	NOUN
ct-10092	34	21	in	in	ADP
ct-10092	34	22	the	the	DET
ct-10092	34	23	mare;33	mare;33	PROPN
ct-10092	34	24	this	this	DET
ct-10092	34	25	method	method	NOUN
ct-10092	34	26	is	be	AUX
ct-10092	34	27	,	,	PUNCT
ct-10092	34	28	however	however	ADV
ct-10092	34	29	,	,	PUNCT
ct-10092	34	30	not	not	PART
ct-10092	34	31	feasible	feasible	ADJ
ct-10092	34	32	for	for	ADP
ct-10092	34	33	widespread	widespread	ADJ
ct-10092	34	34	clinical	clinical	ADJ
ct-10092	34	35	application	application	NOUN
ct-10092	34	36	.	.	PUNCT
ct-10092	35	1	since	since	SCONJ
ct-10092	35	2	the	the	DET
ct-10092	35	3	chemical	chemical	NOUN
ct-10092	35	4	structure	structure	NOUN
ct-10092	35	5	and	and	CCONJ
ct-10092	35	6	peptide	peptide	NOUN
ct-10092	35	7	identification	identification	NOUN
ct-10092	35	8	was	be	AUX
ct-10092	35	9	reported	report	VERB
ct-10092	35	10	in	in	ADP
ct-10092	35	11	1971,34	1971,34	NUM
ct-10092	35	12	-	-	SYM
ct-10092	35	13	36	36	NUM
ct-10092	35	14	more	more	ADJ
ct-10092	35	15	than	than	ADP
ct-10092	35	16	2,000	2,000	NUM
ct-10092	35	17	gnrh	gnrh	NOUN
ct-10092	35	18	analogues	analogue	NOUN
ct-10092	35	19	were	be	AUX
ct-10092	35	20	synthesized	synthesize	VERB
ct-10092	35	21	in	in	ADP
ct-10092	35	22	the	the	DET
ct-10092	35	23	following	follow	VERB
ct-10092	35	24	15	15	NUM
ct-10092	35	25	years.37	years.37	PROPN
ct-10092	35	26	scientists	scientist	NOUN
ct-10092	35	27	working	work	VERB
ct-10092	35	28	in	in	ADP
ct-10092	35	29	research	research	NOUN
ct-10092	35	30	and	and	CCONJ
ct-10092	35	31	private	private	ADJ
ct-10092	35	32	pharmaceutical	pharmaceutical	ADJ
ct-10092	35	33	institutions	institution	NOUN
ct-10092	35	34	shared	share	VERB
ct-10092	35	35	two	two	NUM
ct-10092	35	36	main	main	ADJ
ct-10092	35	37	aims	aim	NOUN
ct-10092	35	38	:	:	PUNCT
ct-10092	35	39	(	(	PUNCT
ct-10092	35	40	1	1	X
ct-10092	35	41	)	)	PUNCT
ct-10092	35	42	to	to	PART
ct-10092	35	43	create	create	VERB
ct-10092	35	44	an	an	DET
ct-10092	35	45	analogue	analogue	NOUN
ct-10092	35	46	with	with	ADP
ct-10092	35	47	high	high	ADJ
ct-10092	35	48	affinity	affinity	NOUN
ct-10092	35	49	for	for	ADP
ct-10092	35	50	gnrh	gnrh	NOUN
ct-10092	35	51	clinical	clinical	ADJ
ct-10092	35	52	theriogenology	theriogenology	NOUN
ct-10092	35	53	•	•	NOUN
ct-10092	35	54	volume	volume	NOUN
ct-10092	35	55	7	7	NUM
ct-10092	35	56	,	,	PUNCT
ct-10092	35	57	number	number	NOUN
ct-10092	35	58	1	1	NUM
ct-10092	35	59	•	•	NUM
ct-10092	35	60	march	march	PROPN
ct-10092	35	61	2015	2015	NUM
ct-10092	35	62	46	46	NUM
ct-10092	35	63	receptor	receptor	NOUN
ct-10092	35	64	binding	bind	VERB
ct-10092	35	65	;	;	PUNCT
ct-10092	35	66	and	and	CCONJ
ct-10092	35	67	(	(	PUNCT
ct-10092	35	68	2	2	X
ct-10092	35	69	)	)	PUNCT
ct-10092	35	70	to	to	PART
ct-10092	35	71	avoid	avoid	VERB
ct-10092	35	72	or	or	CCONJ
ct-10092	35	73	minimize	minimize	VERB
ct-10092	35	74	enzymatic	enzymatic	ADJ
ct-10092	35	75	degradation	degradation	NOUN
ct-10092	35	76	by	by	ADP
ct-10092	35	77	proteolysis	proteolysis	NOUN
ct-10092	35	78	.	.	PUNCT
ct-10092	36	1	the	the	DET
ct-10092	36	2	gnrh	gnrh	NOUN
ct-10092	36	3	molecule	molecule	NOUN
ct-10092	36	4	is	be	AUX
ct-10092	36	5	susceptible	susceptible	ADJ
ct-10092	36	6	to	to	ADP
ct-10092	36	7	cleavage	cleavage	NOUN
ct-10092	36	8	and	and	CCONJ
ct-10092	36	9	inactivation	inactivation	NOUN
ct-10092	36	10	by	by	ADP
ct-10092	36	11	hypophyseal	hypophyseal	ADJ
ct-10092	36	12	endopeptidases	endopeptidase	NOUN
ct-10092	36	13	especially	especially	ADV
ct-10092	36	14	between	between	ADP
ct-10092	36	15	amino	amino	ADJ
ct-10092	36	16	acids	acid	NOUN
ct-10092	36	17	in	in	ADP
ct-10092	36	18	position	position	NOUN
ct-10092	36	19	5	5	NUM
ct-10092	36	20	and	and	CCONJ
ct-10092	36	21	6	6	NUM
ct-10092	36	22	,	,	PUNCT
ct-10092	36	23	and	and	CCONJ
ct-10092	36	24	between	between	ADP
ct-10092	36	25	6	6	NUM
ct-10092	36	26	and	and	CCONJ
ct-10092	36	27	7	7	NUM
ct-10092	36	28	.	.	PUNCT
ct-10092	37	1	another	another	DET
ct-10092	37	2	enzyme	enzyme	NOUN
ct-10092	37	3	,	,	PUNCT
ct-10092	37	4	carboxypeptidase	carboxypeptidase	NOUN
ct-10092	37	5	targets	target	VERB
ct-10092	37	6	the	the	DET
ct-10092	37	7	bond	bond	NOUN
ct-10092	37	8	between	between	ADP
ct-10092	37	9	amino	amino	ADJ
ct-10092	37	10	acids	acid	NOUN
ct-10092	37	11	in	in	ADP
ct-10092	37	12	positions	position	NOUN
ct-10092	37	13	9	9	NUM
ct-10092	37	14	and	and	CCONJ
ct-10092	37	15	10	10	NUM
ct-10092	37	16	.	.	PUNCT
ct-10092	38	1	for	for	ADP
ct-10092	38	2	these	these	DET
ct-10092	38	3	reasons	reason	NOUN
ct-10092	38	4	,	,	PUNCT
ct-10092	38	5	several	several	ADJ
ct-10092	38	6	gnrh	gnrh	NOUN
ct-10092	38	7	synthetic	synthetic	ADJ
ct-10092	38	8	analogues	analogue	NOUN
ct-10092	38	9	used	use	VERB
ct-10092	38	10	in	in	ADP
ct-10092	38	11	human	human	ADJ
ct-10092	38	12	and	and	CCONJ
ct-10092	38	13	veterinary	veterinary	ADJ
ct-10092	38	14	medicine	medicine	NOUN
ct-10092	38	15	have	have	VERB
ct-10092	38	16	1	1	NUM
ct-10092	38	17	)	)	PUNCT
ct-10092	38	18	d	d	ADJ
ct-10092	38	19	-	-	ADJ
ct-10092	38	20	amino	amino	ADJ
ct-10092	38	21	acids	acid	NOUN
ct-10092	38	22	substitutions	substitution	NOUN
ct-10092	38	23	in	in	ADP
ct-10092	38	24	position	position	NOUN
ct-10092	38	25	6	6	NUM
ct-10092	38	26	(	(	PUNCT
ct-10092	38	27	glycine	glycine	NOUN
ct-10092	38	28	)	)	PUNCT
ct-10092	38	29	,	,	PUNCT
ct-10092	38	30	and	and	CCONJ
ct-10092	38	31	2	2	X
ct-10092	38	32	)	)	PUNCT
ct-10092	38	33	the	the	DET
ct-10092	38	34	amino	amino	NOUN
ct-10092	38	35	acid	acid	NOUN
ct-10092	38	36	in	in	ADP
ct-10092	38	37	position	position	NOUN
ct-10092	38	38	10	10	NUM
ct-10092	38	39	(	(	PUNCT
ct-10092	38	40	another	another	DET
ct-10092	38	41	glycine	glycine	NOUN
ct-10092	38	42	)	)	PUNCT
ct-10092	38	43	and	and	CCONJ
ct-10092	38	44	its	its	PRON
ct-10092	38	45	amide	amide	NOUN
ct-10092	38	46	terminal	terminal	NOUN
ct-10092	38	47	replaced	replace	VERB
ct-10092	38	48	by	by	ADP
ct-10092	38	49	an	an	DET
ct-10092	38	50	ethylamide	ethylamide	ADJ
ct-10092	38	51	residue	residue	NOUN
ct-10092	38	52	that	that	PRON
ct-10092	38	53	is	be	AUX
ct-10092	38	54	linked	link	VERB
ct-10092	38	55	to	to	ADP
ct-10092	38	56	the	the	DET
ct-10092	38	57	aminoacid	aminoacid	NOUN
ct-10092	38	58	9	9	NUM
ct-10092	38	59	proline.38	proline.38	NOUN
ct-10092	38	60	deslorelin	deslorelin	NOUN
ct-10092	38	61	.	.	PUNCT
ct-10092	39	1	in	in	ADP
ct-10092	39	2	contrast	contrast	NOUN
ct-10092	39	3	with	with	ADP
ct-10092	39	4	the	the	DET
ct-10092	39	5	poor	poor	ADJ
ct-10092	39	6	or	or	CCONJ
ct-10092	39	7	limited	limited	ADJ
ct-10092	39	8	efficacy	efficacy	NOUN
ct-10092	39	9	of	of	ADP
ct-10092	39	10	simple	simple	ADJ
ct-10092	39	11	gnrh	gnrh	NOUN
ct-10092	39	12	analogues	analogue	NOUN
ct-10092	39	13	,	,	PUNCT
ct-10092	39	14	more	more	ADV
ct-10092	39	15	potent	potent	ADJ
ct-10092	39	16	gnrh	gnrh	NOUN
ct-10092	39	17	synthetic	synthetic	ADJ
ct-10092	39	18	analogues	analogue	NOUN
ct-10092	39	19	such	such	ADJ
ct-10092	39	20	as	as	ADP
ct-10092	39	21	deslorelin	deslorelin	NOUN
ct-10092	39	22	have	have	VERB
ct-10092	39	23	a	a	DET
ct-10092	39	24	predictable	predictable	ADJ
ct-10092	39	25	effect	effect	NOUN
ct-10092	39	26	in	in	ADP
ct-10092	39	27	inducing	induce	VERB
ct-10092	39	28	ovulation	ovulation	NOUN
ct-10092	39	29	within	within	ADP
ct-10092	39	30	48	48	NUM
ct-10092	39	31	hours	hour	NOUN
ct-10092	39	32	when	when	SCONJ
ct-10092	39	33	administered	administer	VERB
ct-10092	39	34	as	as	ADP
ct-10092	39	35	intramuscular	intramuscular	ADJ
ct-10092	39	36	injections23,39	injections23,39	ADP
ct-10092	39	37	or	or	CCONJ
ct-10092	39	38	subcutaneous	subcutaneous	ADJ
ct-10092	39	39	implants.40	implants.40	NOUN
ct-10092	39	40	-	-	PUNCT
ct-10092	39	41	42	42	NUM
ct-10092	39	42	deslorelin	deslorelin	NOUN
ct-10092	39	43	differs	differ	NOUN
ct-10092	39	44	from	from	ADP
ct-10092	39	45	the	the	DET
ct-10092	39	46	natural	natural	ADJ
ct-10092	39	47	decapeptide	decapeptide	ADJ
ct-10092	39	48	gnrh	gnrh	NOUN
ct-10092	39	49	in	in	ADP
ct-10092	39	50	two	two	NUM
ct-10092	39	51	amino	amino	ADJ
ct-10092	39	52	acid	acid	NOUN
ct-10092	39	53	substitutions	substitution	NOUN
ct-10092	39	54	:	:	PUNCT
ct-10092	39	55	in	in	ADP
ct-10092	39	56	amino	amino	NOUN
ct-10092	39	57	acid	acid	NOUN
ct-10092	39	58	position	position	NOUN
ct-10092	39	59	6	6	NUM
ct-10092	39	60	where	where	SCONJ
ct-10092	39	61	lglycine	lglycine	NOUN
ct-10092	39	62	has	have	AUX
ct-10092	39	63	been	be	AUX
ct-10092	39	64	replaced	replace	VERB
ct-10092	39	65	with	with	ADP
ct-10092	39	66	the	the	DET
ct-10092	39	67	aminoacid	aminoacid	NOUN
ct-10092	39	68	d	d	NOUN
ct-10092	39	69	-	-	PUNCT
ct-10092	39	70	tryptophan	tryptophan	NOUN
ct-10092	39	71	and	and	CCONJ
ct-10092	39	72	in	in	ADP
ct-10092	39	73	position	position	NOUN
ct-10092	39	74	10	10	NUM
ct-10092	39	75	where	where	SCONJ
ct-10092	39	76	glycine	glycine	NOUN
ct-10092	39	77	and	and	CCONJ
ct-10092	39	78	its	its	PRON
ct-10092	39	79	amino	amino	NOUN
ct-10092	39	80	terminal	terminal	NOUN
ct-10092	39	81	have	have	AUX
ct-10092	39	82	been	be	AUX
ct-10092	39	83	replaced	replace	VERB
ct-10092	39	84	by	by	ADP
ct-10092	39	85	n	n	CCONJ
ct-10092	39	86	-	-	PUNCT
ct-10092	39	87	ethylamide	ethylamide	ADJ
ct-10092	39	88	.	.	PUNCT
ct-10092	40	1	ovulation	ovulation	NOUN
ct-10092	40	2	rates	rate	NOUN
ct-10092	40	3	following	follow	VERB
ct-10092	40	4	deslorelin	deslorelin	NOUN
ct-10092	40	5	administration	administration	NOUN
ct-10092	40	6	are	be	AUX
ct-10092	40	7	comparable	comparable	ADJ
ct-10092	40	8	with	with	ADP
ct-10092	40	9	those	those	PRON
ct-10092	40	10	resulting	result	VERB
ct-10092	40	11	from	from	ADP
ct-10092	40	12	hcg	hcg	PROPN
ct-10092	40	13	administration.41	administration.41	PROPN
ct-10092	40	14	commercially	commercially	ADV
ct-10092	40	15	,	,	PUNCT
ct-10092	40	16	deslorelin	deslorelin	NOUN
ct-10092	40	17	became	become	VERB
ct-10092	40	18	available	available	ADJ
ct-10092	40	19	as	as	ADP
ct-10092	40	20	implants	implant	NOUN
ct-10092	40	21	containing	contain	VERB
ct-10092	40	22	2.1	2.1	NUM
ct-10092	40	23	mg	mg	NOUN
ct-10092	40	24	of	of	ADP
ct-10092	40	25	deslorelin	deslorelin	NOUN
ct-10092	40	26	acetate.¶	acetate.¶	PROPN
ct-10092	40	27	after	after	ADP
ct-10092	40	28	being	be	AUX
ct-10092	40	29	first	first	ADV
ct-10092	40	30	available	available	ADJ
ct-10092	40	31	in	in	ADP
ct-10092	40	32	australia	australia	PROPN
ct-10092	40	33	and	and	CCONJ
ct-10092	40	34	other	other	ADJ
ct-10092	40	35	countries	country	NOUN
ct-10092	40	36	,	,	PUNCT
ct-10092	40	37	ovuplant	ovuplant	ADJ
ct-10092	40	38	®	®	NOUN
ct-10092	40	39	became	became	AUX
ct-10092	40	40	fdaapproved	fdaapprove	VERB
ct-10092	40	41	and	and	CCONJ
ct-10092	40	42	available	available	ADJ
ct-10092	40	43	in	in	ADP
ct-10092	40	44	the	the	DET
ct-10092	40	45	usa	usa	PROPN
ct-10092	40	46	in	in	ADP
ct-10092	40	47	1998	1998	NUM
ct-10092	40	48	.	.	PUNCT
ct-10092	41	1	after	after	ADP
ct-10092	41	2	being	be	AUX
ct-10092	41	3	on	on	ADP
ct-10092	41	4	the	the	DET
ct-10092	41	5	market	market	NOUN
ct-10092	41	6	for	for	ADP
ct-10092	41	7	approximately	approximately	ADV
ct-10092	41	8	two	two	NUM
ct-10092	41	9	breeding	breeding	NOUN
ct-10092	41	10	seasons	season	NOUN
ct-10092	41	11	,	,	PUNCT
ct-10092	41	12	it	it	PRON
ct-10092	41	13	was	be	AUX
ct-10092	41	14	anecdotally	anecdotally	ADV
ct-10092	41	15	reported	report	VERB
ct-10092	41	16	that	that	SCONJ
ct-10092	41	17	,	,	PUNCT
ct-10092	41	18	occasionally	occasionally	ADV
ct-10092	41	19	,	,	PUNCT
ct-10092	41	20	mares	mare	NOUN
ct-10092	41	21	treated	treat	VERB
ct-10092	41	22	with	with	ADP
ct-10092	41	23	the	the	DET
ct-10092	41	24	implant	implant	NOUN
ct-10092	41	25	had	have	AUX
ct-10092	41	26	prolonged	prolong	VERB
ct-10092	41	27	interovulatory	interovulatory	ADJ
ct-10092	41	28	intervals	interval	NOUN
ct-10092	41	29	and	and	CCONJ
ct-10092	41	30	some	some	PRON
ct-10092	41	31	actually	actually	ADV
ct-10092	41	32	had	have	VERB
ct-10092	41	33	their	their	PRON
ct-10092	41	34	reproductive	reproductive	ADJ
ct-10092	41	35	cyclicity	cyclicity	NOUN
ct-10092	41	36	downregulated	downregulate	VERB
ct-10092	41	37	for	for	ADP
ct-10092	41	38	months	month	NOUN
ct-10092	41	39	;	;	PUNCT
ct-10092	41	40	this	this	DET
ct-10092	41	41	effect	effect	NOUN
ct-10092	41	42	was	be	AUX
ct-10092	41	43	confirmed	confirm	VERB
ct-10092	41	44	in	in	ADP
ct-10092	41	45	a	a	DET
ct-10092	41	46	controlled	control	VERB
ct-10092	41	47	study.43	study.43	NOUN
ct-10092	41	48	when	when	SCONJ
ct-10092	41	49	investigating	investigate	VERB
ct-10092	41	50	this	this	DET
ct-10092	41	51	issue	issue	NOUN
ct-10092	41	52	,	,	PUNCT
ct-10092	41	53	mccue	mccue	PROPN
ct-10092	41	54	et	et	NOUN
ct-10092	41	55	al	al	PROPN
ct-10092	41	56	reported	report	VERB
ct-10092	41	57	normal	normal	ADJ
ct-10092	41	58	interovulatory	interovulatory	ADJ
ct-10092	41	59	intervals	interval	NOUN
ct-10092	41	60	in	in	ADP
ct-10092	41	61	mares	mare	NOUN
ct-10092	41	62	that	that	PRON
ct-10092	41	63	had	have	VERB
ct-10092	41	64	their	their	PRON
ct-10092	41	65	implant	implant	NOUN
ct-10092	41	66	removed	remove	VERB
ct-10092	41	67	once	once	ADV
ct-10092	41	68	ovulation	ovulation	NOUN
ct-10092	41	69	occurred.44	occurred.44	NOUN
ct-10092	41	70	this	this	DET
ct-10092	41	71	phenomenon	phenomenon	NOUN
ct-10092	41	72	was	be	AUX
ct-10092	41	73	later	later	ADV
ct-10092	41	74	elucidated	elucidate	VERB
ct-10092	41	75	by	by	ADP
ct-10092	41	76	the	the	DET
ct-10092	41	77	fact	fact	NOUN
ct-10092	41	78	that	that	SCONJ
ct-10092	41	79	prolonged	prolonged	ADJ
ct-10092	41	80	delivery	delivery	NOUN
ct-10092	41	81	of	of	ADP
ct-10092	41	82	deslorelin	deslorelin	NOUN
ct-10092	41	83	would	would	AUX
ct-10092	41	84	induce	induce	VERB
ct-10092	41	85	ovulation	ovulation	NOUN
ct-10092	41	86	but	but	CCONJ
ct-10092	41	87	its	its	PRON
ct-10092	41	88	continuous	continuous	ADJ
ct-10092	41	89	release	release	NOUN
ct-10092	41	90	would	would	AUX
ct-10092	41	91	down	down	ADV
ct-10092	41	92	regulate	regulate	VERB
ct-10092	41	93	fsh	fsh	NOUN
ct-10092	41	94	and	and	CCONJ
ct-10092	41	95	lh	lh	PROPN
ct-10092	41	96	secretion	secretion	NOUN
ct-10092	41	97	from	from	ADP
ct-10092	41	98	the	the	DET
ct-10092	41	99	pituitary,45	pituitary,45	NOUN
ct-10092	41	100	resulting	result	VERB
ct-10092	41	101	in	in	ADP
ct-10092	41	102	prolonged	prolonged	ADJ
ct-10092	41	103	interestrous	interestrous	ADJ
ct-10092	41	104	intervals	interval	NOUN
ct-10092	41	105	.	.	PUNCT
ct-10092	42	1	removing	remove	VERB
ct-10092	42	2	the	the	DET
ct-10092	42	3	implant	implant	NOUN
ct-10092	42	4	after	after	SCONJ
ct-10092	42	5	ovulation	ovulation	NOUN
ct-10092	42	6	thus	thus	ADV
ct-10092	42	7	prevented	prevent	VERB
ct-10092	42	8	sustained	sustained	ADJ
ct-10092	42	9	release	release	NOUN
ct-10092	42	10	of	of	ADP
ct-10092	42	11	deslorelin	deslorelin	NOUN
ct-10092	42	12	.	.	PUNCT
ct-10092	43	1	reportedly	reportedly	ADV
ct-10092	43	2	owing	owe	VERB
ct-10092	43	3	to	to	ADP
ct-10092	43	4	problems	problem	NOUN
ct-10092	43	5	in	in	ADP
ct-10092	43	6	manufacturing	manufacturing	NOUN
ct-10092	43	7	logistics	logistic	NOUN
ct-10092	43	8	,	,	PUNCT
ct-10092	43	9	ovuplant	ovuplant	ADJ
ct-10092	43	10	®	®	NOUN
ct-10092	43	11	has	have	AUX
ct-10092	43	12	not	not	PART
ct-10092	43	13	been	be	AUX
ct-10092	43	14	commercially	commercially	ADV
ct-10092	43	15	available	available	ADJ
ct-10092	43	16	in	in	ADP
ct-10092	43	17	the	the	DET
ct-10092	43	18	usa	usa	PROPN
ct-10092	43	19	since	since	SCONJ
ct-10092	43	20	the	the	DET
ct-10092	43	21	early	early	ADJ
ct-10092	43	22	2000	2000	NUM
ct-10092	43	23	’s	’s	NOUN
ct-10092	43	24	.	.	PUNCT
ct-10092	44	1	interestingly	interestingly	ADV
ct-10092	44	2	,	,	PUNCT
ct-10092	44	3	side	side	ADJ
ct-10092	44	4	effects	effect	NOUN
ct-10092	44	5	related	relate	VERB
ct-10092	44	6	to	to	ADP
ct-10092	44	7	sustained	sustain	VERB
ct-10092	44	8	deslorelin	deslorelin	NOUN
ct-10092	44	9	release	release	NOUN
ct-10092	44	10	have	have	AUX
ct-10092	44	11	not	not	PART
ct-10092	44	12	been	be	AUX
ct-10092	44	13	reported	report	VERB
ct-10092	44	14	in	in	ADP
ct-10092	44	15	australia	australia	PROPN
ct-10092	44	16	,	,	PUNCT
ct-10092	44	17	where	where	SCONJ
ct-10092	44	18	the	the	DET
ct-10092	44	19	drug	drug	NOUN
ct-10092	44	20	originated	originate	VERB
ct-10092	44	21	and	and	CCONJ
ct-10092	44	22	still	still	ADV
ct-10092	44	23	remains	remain	VERB
ct-10092	44	24	available	available	ADJ
ct-10092	44	25	(	(	PUNCT
ct-10092	44	26	as	as	ADV
ct-10092	44	27	well	well	ADV
ct-10092	44	28	as	as	ADP
ct-10092	44	29	in	in	ADP
ct-10092	44	30	other	other	ADJ
ct-10092	44	31	countries	country	NOUN
ct-10092	44	32	)	)	PUNCT
ct-10092	44	33	.	.	PUNCT
ct-10092	45	1	for	for	ADP
ct-10092	45	2	several	several	ADJ
ct-10092	45	3	years	year	NOUN
ct-10092	45	4	,	,	PUNCT
ct-10092	45	5	deslorelin	deslorelin	NOUN
ct-10092	45	6	was	be	AUX
ct-10092	45	7	available	available	ADJ
ct-10092	45	8	either	either	ADV
ct-10092	45	9	via	via	ADP
ct-10092	45	10	importation	importation	NOUN
ct-10092	45	11	from	from	ADP
ct-10092	45	12	countries	country	NOUN
ct-10092	45	13	that	that	PRON
ct-10092	45	14	manufactured	manufacture	VERB
ct-10092	45	15	ovuplant	ovuplant	ADJ
ct-10092	45	16	®	®	NOUN
ct-10092	45	17	or	or	CCONJ
ct-10092	45	18	via	via	ADP
ct-10092	45	19	compounding	compounding	NOUN
ct-10092	45	20	of	of	ADP
ct-10092	45	21	injectable	injectable	ADJ
ct-10092	45	22	formulations	formulation	NOUN
ct-10092	45	23	of	of	ADP
ct-10092	45	24	deslorelin	deslorelin	NOUN
ct-10092	45	25	(	(	PUNCT
ct-10092	45	26	1.5	1.5	NUM
ct-10092	45	27	mg/	mg/	NOUN
ct-10092	45	28	ml	ml	NOUN
ct-10092	45	29	;	;	PUNCT
ct-10092	45	30	dose	dose	VERB
ct-10092	45	31	1	1	NUM
ct-10092	45	32	ml	ml	NOUN
ct-10092	45	33	per	per	ADP
ct-10092	45	34	mare	mare	NOUN
ct-10092	45	35	administered	administer	VERB
ct-10092	45	36	intramuscularly	intramuscularly	ADV
ct-10092	45	37	)	)	PUNCT
ct-10092	45	38	.	.	PUNCT
ct-10092	46	1	recently	recently	ADV
ct-10092	46	2	,	,	PUNCT
ct-10092	46	3	an	an	DET
ct-10092	46	4	injectable	injectable	ADJ
ct-10092	46	5	controlled	control	VERB
ct-10092	46	6	release	release	NOUN
ct-10092	46	7	form	form	NOUN
ct-10092	46	8	of	of	ADP
ct-10092	46	9	deslorelin	deslorelin	NOUN
ct-10092	46	10	acetate¶	acetate¶	NOUN
ct-10092	46	11	(	(	PUNCT
ct-10092	46	12	sucromatetm;1.8	sucromatetm;1.8	PROPN
ct-10092	46	13	mg	mg	PROPN
ct-10092	46	14	/	/	SYM
ct-10092	46	15	ml	ml	NOUN
ct-10092	46	16	)	)	PUNCT
ct-10092	46	17	was	be	AUX
ct-10092	46	18	approved	approve	VERB
ct-10092	46	19	by	by	ADP
ct-10092	46	20	the	the	DET
ct-10092	46	21	fda	fda	PROPN
ct-10092	46	22	in	in	ADP
ct-10092	46	23	2010	2010	NUM
ct-10092	46	24	for	for	ADP
ct-10092	46	25	induction	induction	NOUN
ct-10092	46	26	of	of	ADP
ct-10092	46	27	ovulation	ovulation	NOUN
ct-10092	46	28	in	in	ADP
ct-10092	46	29	mares	mare	NOUN
ct-10092	46	30	and	and	CCONJ
ct-10092	46	31	became	become	VERB
ct-10092	46	32	commercially	commercially	ADV
ct-10092	46	33	available	available	ADJ
ct-10092	46	34	in	in	ADP
ct-10092	46	35	the	the	DET
ct-10092	46	36	usa	usa	PROPN
ct-10092	46	37	in	in	ADP
ct-10092	46	38	2011	2011	NUM
ct-10092	46	39	.	.	PUNCT
ct-10092	47	1	sucromatetm	sucromatetm	NOUN
ct-10092	47	2	is	be	AUX
ct-10092	47	3	a	a	DET
ct-10092	47	4	product	product	NOUN
ct-10092	47	5	of	of	ADP
ct-10092	47	6	and	and	CCONJ
ct-10092	47	7	manufactured	manufacture	VERB
ct-10092	47	8	by	by	ADP
ct-10092	47	9	thorn	thorn	NOUN
ct-10092	47	10	bioscience	bioscience	NOUN
ct-10092	47	11	,	,	PUNCT
ct-10092	47	12	louisville	louisville	PROPN
ct-10092	47	13	,	,	PUNCT
ct-10092	47	14	ky	ky	PROPN
ct-10092	47	15	,	,	PUNCT
ct-10092	47	16	a	a	DET
ct-10092	47	17	division	division	NOUN
ct-10092	47	18	of	of	ADP
ct-10092	47	19	creosalus	creosalus	NOUN
ct-10092	48	1	and	and	CCONJ
ct-10092	48	2	it	it	PRON
ct-10092	48	3	is	be	AUX
ct-10092	48	4	marketed	market	VERB
ct-10092	48	5	by	by	ADP
ct-10092	48	6	bioniche	bioniche	NOUN
ct-10092	48	7	animal	animal	PROPN
ct-10092	48	8	health	health	PROPN
ct-10092	48	9	usa	usa	PROPN
ct-10092	48	10	,	,	PUNCT
ct-10092	48	11	inc	inc	PROPN
ct-10092	48	12	.	.	PROPN
ct-10092	48	13	,	,	PUNCT
ct-10092	48	14	athens	athens	PROPN
ct-10092	48	15	,	,	PUNCT
ct-10092	48	16	ga	ga	PROPN
ct-10092	48	17	.	.	PUNCT
ct-10092	49	1	it	it	PRON
ct-10092	49	2	contains	contain	VERB
ct-10092	49	3	1.8	1.8	NUM
ct-10092	49	4	mg	mg	NOUN
ct-10092	49	5	of	of	ADP
ct-10092	49	6	deslorelin	deslorelin	NOUN
ct-10092	49	7	acetate	acetate	NOUN
ct-10092	49	8	equivalent	equivalent	NOUN
ct-10092	49	9	to	to	ADP
ct-10092	49	10	1.7	1.7	NUM
ct-10092	49	11	mg	mg	NOUN
ct-10092	49	12	of	of	ADP
ct-10092	49	13	deslorelin	deslorelin	NOUN
ct-10092	49	14	in	in	ADP
ct-10092	49	15	a	a	DET
ct-10092	49	16	sucrose	sucrose	NOUN
ct-10092	49	17	acetate	acetate	PROPN
ct-10092	49	18	isobutyrate	isobutyrate	NOUN
ct-10092	49	19	and	and	CCONJ
ct-10092	49	20	propylene	propylene	NOUN
ct-10092	49	21	carbonate	carbonate	NOUN
ct-10092	49	22	matrix	matrix	NOUN
ct-10092	49	23	that	that	PRON
ct-10092	49	24	promotes	promote	VERB
ct-10092	49	25	controlled	control	VERB
ct-10092	49	26	release	release	NOUN
ct-10092	49	27	of	of	ADP
ct-10092	49	28	the	the	DET
ct-10092	49	29	drug	drug	NOUN
ct-10092	49	30	.	.	PUNCT
ct-10092	50	1	this	this	DET
ct-10092	50	2	formulation	formulation	NOUN
ct-10092	50	3	has	have	AUX
ct-10092	50	4	been	be	AUX
ct-10092	50	5	shown	show	VERB
ct-10092	50	6	to	to	PART
ct-10092	50	7	induce	induce	VERB
ct-10092	50	8	ovulation	ovulation	NOUN
ct-10092	50	9	at	at	ADP
ct-10092	50	10	comparable	comparable	ADJ
ct-10092	50	11	rates	rate	NOUN
ct-10092	50	12	of	of	ADP
ct-10092	50	13	those	those	PRON
ct-10092	50	14	from	from	ADP
ct-10092	50	15	hcg	hcg	PROPN
ct-10092	50	16	or	or	CCONJ
ct-10092	50	17	deslorelin	deslorelin	ADJ
ct-10092	50	18	implant	implant	ADJ
ct-10092	50	19	administrations	administration	NOUN
ct-10092	50	20	.	.	PUNCT
ct-10092	51	1	in	in	ADP
ct-10092	51	2	the	the	DET
ct-10092	51	3	only	only	ADJ
ct-10092	51	4	published	publish	VERB
ct-10092	51	5	peer	peer	NOUN
ct-10092	51	6	-	-	PUNCT
ct-10092	51	7	reviewed	review	VERB
ct-10092	51	8	report	report	NOUN
ct-10092	51	9	on	on	ADP
ct-10092	51	10	the	the	DET
ct-10092	51	11	efficacy	efficacy	NOUN
ct-10092	51	12	of	of	ADP
ct-10092	51	13	this	this	DET
ct-10092	51	14	fda	fda	PROPN
ct-10092	51	15	-	-	PUNCT
ct-10092	51	16	approved	approve	VERB
ct-10092	51	17	deslorelin	deslorelin	NOUN
ct-10092	51	18	injectable	injectable	ADJ
ct-10092	51	19	formulation	formulation	NOUN
ct-10092	51	20	,	,	PUNCT
ct-10092	51	21	151	151	NUM
ct-10092	51	22	out	out	ADP
ct-10092	51	23	of	of	ADP
ct-10092	51	24	168	168	NUM
ct-10092	51	25	(	(	PUNCT
ct-10092	51	26	~	~	PUNCT
ct-10092	51	27	90	90	NUM
ct-10092	51	28	%	%	NOUN
ct-10092	51	29	)	)	PUNCT
ct-10092	51	30	mares	mare	NOUN
ct-10092	51	31	treated	treat	VERB
ct-10092	51	32	in	in	ADP
ct-10092	51	33	estrus	estrus	NOUN
ct-10092	51	34	with	with	ADP
ct-10092	51	35	sucromatetm	sucromatetm	NOUN
ct-10092	51	36	(	(	PUNCT
ct-10092	51	37	1	1	NUM
ct-10092	51	38	ml	ml	NOUN
ct-10092	51	39	,	,	PUNCT
ct-10092	51	40	i.m	i.m	PROPN
ct-10092	51	41	.	.	PUNCT
ct-10092	51	42	)	)	PUNCT
ct-10092	51	43	ovulated	ovulate	VERB
ct-10092	51	44	on	on	ADP
ct-10092	51	45	average	average	ADJ
ct-10092	51	46	41	41	NUM
ct-10092	51	47	hours	hour	NOUN
ct-10092	51	48	after	after	ADP
ct-10092	51	49	treatment	treatment	NOUN
ct-10092	51	50	whereas	whereas	SCONJ
ct-10092	51	51	,	,	PUNCT
ct-10092	51	52	111	111	NUM
ct-10092	51	53	out	out	ADP
ct-10092	51	54	of	of	ADP
ct-10092	51	55	134	134	NUM
ct-10092	51	56	mares	mare	NOUN
ct-10092	51	57	(	(	PUNCT
ct-10092	51	58	~83	~83	NUM
ct-10092	51	59	%	%	NOUN
ct-10092	51	60	)	)	PUNCT
ct-10092	51	61	treated	treat	VERB
ct-10092	51	62	with	with	ADP
ct-10092	51	63	hcg	hcg	PROPN
ct-10092	51	64	(	(	PUNCT
ct-10092	51	65	2,500	2,500	NUM
ct-10092	51	66	iu	iu	NOUN
ct-10092	51	67	,	,	PUNCT
ct-10092	51	68	i.v	i.v	PROPN
ct-10092	51	69	.	.	PUNCT
ct-10092	51	70	)	)	PUNCT
ct-10092	51	71	ovulated	ovulate	VERB
ct-10092	51	72	on	on	ADP
ct-10092	51	73	average	average	ADJ
ct-10092	51	74	44	44	NUM
ct-10092	51	75	hours	hour	NOUN
ct-10092	51	76	after	after	ADP
ct-10092	51	77	treatment.39	treatment.39	PROPN
ct-10092	51	78	histrelin	histrelin	PROPN
ct-10092	51	79	.	.	PUNCT
ct-10092	52	1	another	another	DET
ct-10092	52	2	synthetic	synthetic	ADJ
ct-10092	52	3	gnrh	gnrh	NOUN
ct-10092	52	4	analogue	analogue	NOUN
ct-10092	52	5	,	,	PUNCT
ct-10092	52	6	histrelin	histrelin	NOUN
ct-10092	52	7	(	(	PUNCT
ct-10092	52	8	or	or	CCONJ
ct-10092	52	9	historelin	historelin	PROPN
ct-10092	52	10	)	)	PUNCT
ct-10092	52	11	is	be	AUX
ct-10092	52	12	available	available	ADJ
ct-10092	52	13	in	in	ADP
ct-10092	52	14	the	the	DET
ct-10092	52	15	usa	usa	PROPN
ct-10092	52	16	from	from	ADP
ct-10092	52	17	compounding	compound	VERB
ct-10092	52	18	pharmacies	pharmacy	NOUN
ct-10092	52	19	.	.	PUNCT
ct-10092	53	1	histrelin	histrelin	PROPN
ct-10092	53	2	is	be	AUX
ct-10092	53	3	an	an	DET
ct-10092	53	4	even	even	ADV
ct-10092	53	5	more	more	ADV
ct-10092	53	6	potent	potent	ADJ
ct-10092	53	7	gnrh	gnrh	NOUN
ct-10092	53	8	analogue	analogue	NOUN
ct-10092	53	9	than	than	ADP
ct-10092	53	10	deslorelin	deslorelin	NOUN
ct-10092	53	11	(	(	PUNCT
ct-10092	53	12	table	table	NOUN
ct-10092	53	13	)	)	PUNCT
ct-10092	53	14	,	,	PUNCT
ct-10092	53	15	but	but	CCONJ
ct-10092	53	16	with	with	ADP
ct-10092	53	17	similar	similar	ADJ
ct-10092	53	18	clinical	clinical	ADJ
ct-10092	53	19	efficacy	efficacy	NOUN
ct-10092	53	20	in	in	ADP
ct-10092	53	21	inducing	induce	VERB
ct-10092	53	22	ovulation	ovulation	NOUN
ct-10092	53	23	in	in	ADP
ct-10092	53	24	horses	horse	NOUN
ct-10092	53	25	as	as	ADP
ct-10092	53	26	deslorelin	deslorelin	NOUN
ct-10092	53	27	or	or	CCONJ
ct-10092	53	28	hcg.46,47	hcg.46,47	PROPN
ct-10092	53	29	histrelin	histrelin	NOUN
ct-10092	53	30	differs	differ	VERB
ct-10092	53	31	from	from	ADP
ct-10092	53	32	the	the	DET
ct-10092	53	33	natural	natural	ADJ
ct-10092	53	34	decapeptide	decapeptide	ADJ
ct-10092	53	35	gnrh	gnrh	NOUN
ct-10092	53	36	in	in	ADP
ct-10092	53	37	two	two	NUM
ct-10092	53	38	amino	amino	ADJ
ct-10092	53	39	acid	acid	NOUN
ct-10092	53	40	substitutions	substitution	NOUN
ct-10092	53	41	:	:	PUNCT
ct-10092	53	42	in	in	ADP
ct-10092	53	43	amino	amino	NOUN
ct-10092	53	44	acid	acid	NOUN
ct-10092	53	45	position	position	NOUN
ct-10092	53	46	6	6	NUM
ct-10092	53	47	where	where	SCONJ
ct-10092	53	48	l	l	NOUN
ct-10092	53	49	-	-	NOUN
ct-10092	53	50	glycine	glycine	NOUN
ct-10092	53	51	has	have	AUX
ct-10092	53	52	been	be	AUX
ct-10092	53	53	replaced	replace	VERB
ct-10092	53	54	with	with	ADP
ct-10092	53	55	the	the	DET
ct-10092	53	56	amino	amino	NOUN
ct-10092	53	57	acid	acid	NOUN
ct-10092	54	1	d	d	PROPN
ct-10092	54	2	-	-	NOUN
ct-10092	54	3	histidine	histidine	ADJ
ct-10092	54	4	and	and	CCONJ
ct-10092	54	5	in	in	ADP
ct-10092	54	6	position	position	NOUN
ct-10092	54	7	10	10	NUM
ct-10092	54	8	where	where	SCONJ
ct-10092	54	9	glycine	glycine	NOUN
ct-10092	54	10	and	and	CCONJ
ct-10092	54	11	its	its	PRON
ct-10092	54	12	amino	amino	NOUN
ct-10092	54	13	terminal	terminal	NOUN
ct-10092	54	14	have	have	AUX
ct-10092	54	15	been	be	AUX
ct-10092	54	16	replaced	replace	VERB
ct-10092	54	17	by	by	ADP
ct-10092	54	18	n	n	CCONJ
ct-10092	54	19	-	-	PUNCT
ct-10092	54	20	ethylamide	ethylamide	ADJ
ct-10092	54	21	.	.	PUNCT
ct-10092	55	1	clinical	clinical	ADJ
ct-10092	55	2	theriogenology	theriogenology	NOUN
ct-10092	55	3	•	•	NOUN
ct-10092	55	4	volume	volume	NOUN
ct-10092	55	5	7	7	NUM
ct-10092	55	6	,	,	PUNCT
ct-10092	55	7	number	number	NOUN
ct-10092	55	8	1	1	NUM
ct-10092	55	9	•	•	NUM
ct-10092	55	10	march	march	PROPN
ct-10092	55	11	201547	201547	NUM
ct-10092	55	12	table	table	NOUN
ct-10092	55	13	.	.	PUNCT
ct-10092	56	1	the	the	DET
ct-10092	56	2	comparative	comparative	ADJ
ct-10092	56	3	rank	rank	NOUN
ct-10092	56	4	order	order	NOUN
ct-10092	56	5	potency	potency	NOUN
ct-10092	56	6	(	(	PUNCT
ct-10092	56	7	affinity	affinity	NOUN
ct-10092	56	8	for	for	ADP
ct-10092	56	9	gnrh	gnrh	NOUN
ct-10092	56	10	receptor	receptor	NOUN
ct-10092	56	11	)	)	PUNCT
ct-10092	56	12	of	of	ADP
ct-10092	56	13	synthetic	synthetic	ADJ
ct-10092	56	14	gnrh	gnrh	NOUN
ct-10092	56	15	analogues	analogue	NOUN
ct-10092	56	16	in	in	ADP
ct-10092	56	17	relation	relation	NOUN
ct-10092	56	18	to	to	ADP
ct-10092	56	19	natural	natural	ADJ
ct-10092	56	20	gnrh	gnrh	NOUN
ct-10092	56	21	gnrh	gnrh	NOUN
ct-10092	56	22	buserelin	buserelin	PROPN
ct-10092	56	23	deslorelin	deslorelin	PROPN
ct-10092	56	24	histrelin	histrelin	PROPN
ct-10092	56	25	relative	relative	ADJ
ct-10092	56	26	potency	potency	NOUN
ct-10092	56	27	1	1	NUM
ct-10092	56	28	20	20	NUM
ct-10092	56	29	144	144	NUM
ct-10092	56	30	210	210	NUM
ct-10092	56	31	recently	recently	ADV
ct-10092	56	32	,	,	PUNCT
ct-10092	56	33	a	a	DET
ct-10092	56	34	sustained	sustained	ADJ
ct-10092	56	35	release	release	NOUN
ct-10092	56	36	(	(	PUNCT
ct-10092	56	37	biorelease	biorelease	NOUN
ct-10092	56	38	)	)	PUNCT
ct-10092	56	39	formulation	formulation	NOUN
ct-10092	56	40	histrelin	histrelin	NOUN
ct-10092	56	41	was	be	AUX
ct-10092	56	42	found	find	VERB
ct-10092	56	43	to	to	PART
ct-10092	56	44	effectively	effectively	ADV
ct-10092	56	45	induce	induce	VERB
ct-10092	56	46	ovulation	ovulation	NOUN
ct-10092	56	47	within	within	ADP
ct-10092	56	48	two	two	NUM
ct-10092	56	49	days	day	NOUN
ct-10092	56	50	following	follow	VERB
ct-10092	56	51	administration.47	administration.47	ADJ
ct-10092	56	52	doses	dose	NOUN
ct-10092	56	53	of	of	ADP
ct-10092	56	54	0.25	0.25	NUM
ct-10092	56	55	-	-	SYM
ct-10092	56	56	1.0	1.0	NUM
ct-10092	56	57	mg	mg	NOUN
ct-10092	56	58	of	of	ADP
ct-10092	56	59	a	a	DET
ct-10092	56	60	sustained	sustained	ADJ
ct-10092	56	61	release	release	NOUN
ct-10092	56	62	(	(	PUNCT
ct-10092	56	63	biorelease	biorelease	NOUN
ct-10092	56	64	)	)	PUNCT
ct-10092	56	65	formulation	formulation	NOUN
ct-10092	56	66	histrelin	histrelin	NOUN
ct-10092	56	67	effectively	effectively	ADV
ct-10092	56	68	induce	induce	VERB
ct-10092	56	69	ovulation	ovulation	NOUN
ct-10092	56	70	within	within	ADP
ct-10092	56	71	two	two	NUM
ct-10092	56	72	days	day	NOUN
ct-10092	56	73	following	follow	VERB
ct-10092	56	74	administration.47	administration.47	NOUN
ct-10092	56	75	-	-	NOUN
ct-10092	56	76	49	49	NUM
ct-10092	56	77	in	in	ADP
ct-10092	56	78	a	a	DET
ct-10092	56	79	more	more	ADV
ct-10092	56	80	recent	recent	ADJ
ct-10092	56	81	study,48	study,48	NOUN
ct-10092	56	82	there	there	PRON
ct-10092	56	83	were	be	VERB
ct-10092	56	84	no	no	DET
ct-10092	56	85	differences	difference	NOUN
ct-10092	56	86	among	among	ADP
ct-10092	56	87	maiden	maiden	ADJ
ct-10092	56	88	,	,	PUNCT
ct-10092	56	89	barren	barren	ADJ
ct-10092	56	90	and	and	CCONJ
ct-10092	56	91	foaling	foal	VERB
ct-10092	56	92	mares	mare	NOUN
ct-10092	56	93	treated	treat	VERB
ct-10092	56	94	throughout	throughout	ADP
ct-10092	56	95	the	the	DET
ct-10092	56	96	ovulatory	ovulatory	ADJ
ct-10092	56	97	seasons	season	NOUN
ct-10092	56	98	;	;	PUNCT
ct-10092	56	99	similarly	similarly	ADV
ct-10092	56	100	there	there	PRON
ct-10092	56	101	were	be	VERB
ct-10092	56	102	no	no	DET
ct-10092	56	103	significant	significant	ADJ
ct-10092	56	104	differences	difference	NOUN
ct-10092	56	105	for	for	ADP
ct-10092	56	106	the	the	DET
ct-10092	56	107	two	two	NUM
ct-10092	56	108	doses	dose	NOUN
ct-10092	56	109	used	use	VERB
ct-10092	56	110	in	in	ADP
ct-10092	56	111	that	that	DET
ct-10092	56	112	study	study	NOUN
ct-10092	56	113	,	,	PUNCT
ct-10092	56	114	0.25	0.25	NUM
ct-10092	56	115	and	and	CCONJ
ct-10092	56	116	0.5	0.5	NUM
ct-10092	56	117	mg	mg	NUM
ct-10092	56	118	,	,	PUNCT
ct-10092	56	119	administered	administer	VERB
ct-10092	56	120	as	as	ADP
ct-10092	56	121	single	single	ADJ
ct-10092	56	122	intramuscular	intramuscular	ADJ
ct-10092	56	123	bolus	bolus	ADJ
ct-10092	56	124	injections	injection	NOUN
ct-10092	56	125	to	to	ADP
ct-10092	56	126	mares	mare	NOUN
ct-10092	56	127	in	in	ADP
ct-10092	56	128	estrus	estrus	NOUN
ct-10092	56	129	.	.	PUNCT
ct-10092	57	1	the	the	DET
ct-10092	57	2	overall	overall	ADJ
ct-10092	57	3	ovulation	ovulation	NOUN
ct-10092	57	4	rate	rate	NOUN
ct-10092	57	5	at	at	ADP
ct-10092	57	6	48	48	NUM
ct-10092	57	7	hours	hour	NOUN
ct-10092	57	8	was	be	AUX
ct-10092	57	9	91	91	NUM
ct-10092	57	10	%	%	NOUN
ct-10092	57	11	(	(	PUNCT
ct-10092	57	12	42/46	42/46	NUM
ct-10092	57	13	)	)	PUNCT
ct-10092	57	14	and	and	CCONJ
ct-10092	57	15	85	85	NUM
ct-10092	57	16	%	%	NOUN
ct-10092	57	17	(	(	PUNCT
ct-10092	57	18	44/52	44/52	NUM
ct-10092	57	19	)	)	PUNCT
ct-10092	57	20	for	for	ADP
ct-10092	57	21	doses	dose	NOUN
ct-10092	57	22	of	of	ADP
ct-10092	57	23	0.5	0.5	NUM
ct-10092	57	24	mg	mg	NOUN
ct-10092	57	25	and	and	CCONJ
ct-10092	57	26	0.25	0.25	NUM
ct-10092	57	27	mg	mg	NOUN
ct-10092	57	28	of	of	ADP
ct-10092	57	29	histrelin	histrelin	PROPN
ct-10092	57	30	,	,	PUNCT
ct-10092	57	31	respectively	respectively	ADV
ct-10092	57	32	.	.	PUNCT
ct-10092	58	1	in	in	ADP
ct-10092	58	2	summary	summary	NOUN
ct-10092	58	3	,	,	PUNCT
ct-10092	58	4	there	there	PRON
ct-10092	58	5	does	do	AUX
ct-10092	58	6	not	not	PART
ct-10092	58	7	appear	appear	VERB
ct-10092	58	8	to	to	PART
ct-10092	58	9	be	be	AUX
ct-10092	58	10	differences	difference	NOUN
ct-10092	58	11	in	in	ADP
ct-10092	58	12	the	the	DET
ct-10092	58	13	efficacy	efficacy	NOUN
ct-10092	58	14	,	,	PUNCT
ct-10092	58	15	relative	relative	ADJ
ct-10092	58	16	to	to	ADP
ct-10092	58	17	ability	ability	NOUN
ct-10092	58	18	to	to	PART
ct-10092	58	19	induce	induce	VERB
ct-10092	58	20	ovulation	ovulation	NOUN
ct-10092	58	21	,	,	PUNCT
ct-10092	58	22	among	among	ADP
ct-10092	58	23	deslorelin	deslorelin	NOUN
ct-10092	58	24	,	,	PUNCT
ct-10092	58	25	histrelin	histrelin	NOUN
ct-10092	58	26	and	and	CCONJ
ct-10092	58	27	hcg	hcg	PROPN
ct-10092	58	28	.	.	PUNCT
ct-10092	59	1	buserelin	buserelin	PROPN
ct-10092	59	2	.	.	PUNCT
ct-10092	60	1	buserelin	buserelin	PROPN
ct-10092	60	2	is	be	AUX
ct-10092	60	3	another	another	DET
ct-10092	60	4	gnrh	gnrh	NOUN
ct-10092	60	5	analogue	analogue	NOUN
ct-10092	60	6	that	that	PRON
ct-10092	60	7	also	also	ADV
ct-10092	60	8	contains	contain	VERB
ct-10092	60	9	modification	modification	NOUN
ct-10092	60	10	in	in	ADP
ct-10092	60	11	the	the	DET
ct-10092	60	12	amino	amino	NOUN
ct-10092	60	13	acid	acid	NOUN
ct-10092	60	14	position	position	NOUN
ct-10092	60	15	6	6	NUM
ct-10092	60	16	by	by	ADP
ct-10092	60	17	having	have	VERB
ct-10092	60	18	the	the	DET
ct-10092	60	19	natural	natural	ADJ
ct-10092	60	20	occurring	occurring	ADJ
ct-10092	60	21	l	l	NOUN
ct-10092	60	22	-	-	NOUN
ct-10092	60	23	glycine	glycine	NOUN
ct-10092	60	24	replaced	replace	VERB
ct-10092	60	25	by	by	ADP
ct-10092	60	26	a	a	DET
ct-10092	60	27	tertiary	tertiary	ADJ
ct-10092	60	28	butylated	butylate	VERB
ct-10092	60	29	d	d	NOUN
ct-10092	60	30	-	-	PUNCT
ct-10092	60	31	serine	serine	NOUN
ct-10092	60	32	and	and	CCONJ
ct-10092	60	33	the	the	DET
ct-10092	60	34	amino	amino	NOUN
ct-10092	60	35	acid	acid	NOUN
ct-10092	60	36	10	10	NUM
ct-10092	60	37	glycine	glycine	NOUN
ct-10092	60	38	and	and	CCONJ
ct-10092	60	39	its	its	PRON
ct-10092	60	40	amino	amino	NOUN
ct-10092	60	41	terminal	terminal	NOUN
ct-10092	60	42	replaced	replace	VERB
ct-10092	60	43	by	by	ADP
ct-10092	60	44	n	n	CCONJ
ct-10092	60	45	-	-	PUNCT
ct-10092	60	46	ethylamide	ethylamide	NOUN
ct-10092	60	47	,	,	PUNCT
ct-10092	60	48	which	which	PRON
ct-10092	60	49	is	be	AUX
ct-10092	60	50	similar	similar	ADJ
ct-10092	60	51	to	to	ADP
ct-10092	60	52	the	the	DET
ct-10092	60	53	amino	amino	NOUN
ct-10092	60	54	terminal	terminal	PROPN
ct-10092	60	55	modification	modification	NOUN
ct-10092	60	56	present	present	NOUN
ct-10092	60	57	in	in	ADP
ct-10092	60	58	deslorelin	deslorelin	NOUN
ct-10092	60	59	and	and	CCONJ
ct-10092	60	60	histrelin	histrelin	PROPN
ct-10092	60	61	.	.	PUNCT
ct-10092	61	1	the	the	DET
ct-10092	61	2	moderate	moderate	ADJ
ct-10092	61	3	potency	potency	NOUN
ct-10092	61	4	of	of	ADP
ct-10092	61	5	buserelin	buserelin	PROPN
ct-10092	61	6	(	(	PUNCT
ct-10092	61	7	see	see	VERB
ct-10092	61	8	table	table	NOUN
ct-10092	61	9	)	)	PUNCT
ct-10092	61	10	perhaps	perhaps	ADV
ct-10092	61	11	may	may	AUX
ct-10092	61	12	explain	explain	VERB
ct-10092	61	13	why	why	SCONJ
ct-10092	61	14	a	a	DET
ct-10092	61	15	single	single	ADJ
ct-10092	61	16	administration	administration	NOUN
ct-10092	61	17	of	of	ADP
ct-10092	61	18	a	a	DET
ct-10092	61	19	labeled	label	VERB
ct-10092	61	20	dose	dose	NOUN
ct-10092	61	21	of	of	ADP
ct-10092	61	22	buserelin	buserelin	PROPN
ct-10092	61	23	(	(	PUNCT
ct-10092	61	24	40	40	NUM
ct-10092	61	25	to	to	PART
ct-10092	61	26	100	100	NUM
ct-10092	61	27	ug	ug	ADP
ct-10092	61	28	per	per	ADP
ct-10092	61	29	mare	mare	NOUN
ct-10092	61	30	)	)	PUNCT
ct-10092	61	31	is	be	AUX
ct-10092	61	32	not	not	PART
ct-10092	61	33	sufficient	sufficient	ADJ
ct-10092	61	34	to	to	PART
ct-10092	61	35	induce	induce	VERB
ct-10092	61	36	ovulation	ovulation	NOUN
ct-10092	61	37	in	in	ADP
ct-10092	61	38	mares	mare	NOUN
ct-10092	61	39	.	.	PUNCT
ct-10092	62	1	for	for	ADP
ct-10092	62	2	many	many	ADJ
ct-10092	62	3	years	year	NOUN
ct-10092	62	4	,	,	PUNCT
ct-10092	62	5	buserelin	buserelin	NOUN
ct-10092	62	6	(	(	PUNCT
ct-10092	62	7	not	not	PART
ct-10092	62	8	available	available	ADJ
ct-10092	62	9	in	in	ADP
ct-10092	62	10	the	the	DET
ct-10092	62	11	usa	usa	PROPN
ct-10092	62	12	,	,	PUNCT
ct-10092	62	13	except	except	SCONJ
ct-10092	62	14	via	via	ADP
ct-10092	62	15	compounding	compound	VERB
ct-10092	62	16	pharmacies	pharmacy	NOUN
ct-10092	62	17	)	)	PUNCT
ct-10092	62	18	has	have	AUX
ct-10092	62	19	had	have	VERB
ct-10092	62	20	limited	limit	VERB
ct-10092	62	21	use	use	NOUN
ct-10092	62	22	and	and	CCONJ
ct-10092	62	23	efficacy	efficacy	NOUN
ct-10092	62	24	in	in	ADP
ct-10092	62	25	inducing	induce	VERB
ct-10092	62	26	ovulation	ovulation	NOUN
ct-10092	62	27	only	only	ADV
ct-10092	62	28	when	when	SCONJ
ct-10092	62	29	used	use	VERB
ct-10092	62	30	in	in	ADP
ct-10092	62	31	daily	daily	ADJ
ct-10092	62	32	or	or	CCONJ
ct-10092	62	33	twice	twice	ADV
ct-10092	62	34	daily	daily	ADJ
ct-10092	62	35	injections	injection	NOUN
ct-10092	62	36	for	for	ADP
ct-10092	62	37	two	two	NUM
ct-10092	62	38	to	to	PART
ct-10092	62	39	four	four	NUM
ct-10092	62	40	days.49,50	days.49,50	NOUN
ct-10092	62	41	this	this	DET
ct-10092	62	42	protocol	protocol	NOUN
ct-10092	62	43	likely	likely	ADV
ct-10092	62	44	has	have	AUX
ct-10092	62	45	prevented	prevent	VERB
ct-10092	62	46	veterinarians	veterinarian	NOUN
ct-10092	62	47	and	and	CCONJ
ct-10092	62	48	horse	horse	NOUN
ct-10092	62	49	owners	owner	NOUN
ct-10092	62	50	from	from	ADP
ct-10092	62	51	favoring	favor	VERB
ct-10092	62	52	its	its	PRON
ct-10092	62	53	use	use	NOUN
ct-10092	62	54	in	in	ADP
ct-10092	62	55	brood	brood	NOUN
ct-10092	62	56	mare	mare	NOUN
ct-10092	62	57	management	management	NOUN
ct-10092	62	58	.	.	PUNCT
ct-10092	63	1	in	in	ADP
ct-10092	63	2	contrast	contrast	NOUN
ct-10092	63	3	with	with	ADP
ct-10092	63	4	this	this	DET
ct-10092	63	5	knowledge	knowledge	NOUN
ct-10092	63	6	,	,	PUNCT
ct-10092	63	7	levy	levy	NOUN
ct-10092	63	8	and	and	CCONJ
ct-10092	63	9	duchamp	duchamp	NOUN
ct-10092	63	10	recently	recently	ADV
ct-10092	63	11	showed	show	VERB
ct-10092	63	12	that	that	SCONJ
ct-10092	63	13	much	much	ADV
ct-10092	63	14	higher	high	ADJ
ct-10092	63	15	doses	dose	NOUN
ct-10092	63	16	than	than	ADP
ct-10092	63	17	those	those	PRON
ct-10092	63	18	originally	originally	ADV
ct-10092	63	19	used	use	VERB
ct-10092	63	20	resulted	result	VERB
ct-10092	63	21	in	in	ADP
ct-10092	63	22	ovulation	ovulation	NOUN
ct-10092	63	23	rates	rate	NOUN
ct-10092	63	24	comparable	comparable	ADJ
ct-10092	63	25	to	to	ADP
ct-10092	63	26	those	those	PRON
ct-10092	63	27	of	of	ADP
ct-10092	63	28	hcg.51	hcg.51	PROPN
ct-10092	63	29	in	in	ADP
ct-10092	63	30	that	that	DET
ct-10092	63	31	study	study	NOUN
ct-10092	63	32	,	,	PUNCT
ct-10092	63	33	6	6	NUM
ct-10092	63	34	mg	mg	NOUN
ct-10092	63	35	of	of	ADP
ct-10092	63	36	buserelin	buserelin	PROPN
ct-10092	63	37	were	be	AUX
ct-10092	63	38	injected	inject	VERB
ct-10092	63	39	subcutaneously	subcutaneously	ADV
ct-10092	63	40	to	to	ADP
ct-10092	63	41	cyclic	cyclic	ADJ
ct-10092	63	42	mares	mare	NOUN
ct-10092	63	43	,	,	PUNCT
ct-10092	63	44	resulting	result	VERB
ct-10092	63	45	in	in	ADP
ct-10092	63	46	89	89	NUM
ct-10092	63	47	%	%	NOUN
ct-10092	63	48	to	to	PART
ct-10092	63	49	95	95	NUM
ct-10092	63	50	%	%	NOUN
ct-10092	63	51	ovulation	ovulation	NOUN
ct-10092	63	52	rates	rate	NOUN
ct-10092	63	53	that	that	PRON
ct-10092	63	54	did	do	AUX
ct-10092	63	55	not	not	PART
ct-10092	63	56	differ	differ	VERB
ct-10092	63	57	from	from	ADP
ct-10092	63	58	hcg	hcg	PROPN
ct-10092	63	59	administration	administration	NOUN
ct-10092	63	60	(	(	PUNCT
ct-10092	63	61	86	86	NUM
ct-10092	63	62	%	%	NOUN
ct-10092	63	63	)	)	PUNCT
ct-10092	63	64	.	.	PUNCT
ct-10092	64	1	considering	consider	VERB
ct-10092	64	2	the	the	DET
ct-10092	64	3	relative	relative	ADJ
ct-10092	64	4	potencies	potency	NOUN
ct-10092	64	5	of	of	ADP
ct-10092	64	6	deslorelin	deslorelin	NOUN
ct-10092	64	7	,	,	PUNCT
ct-10092	64	8	histrelin	histrelin	NOUN
ct-10092	64	9	and	and	CCONJ
ct-10092	64	10	buserelin	buserelin	PROPN
ct-10092	64	11	(	(	PUNCT
ct-10092	64	12	table	table	NOUN
ct-10092	64	13	)	)	PUNCT
ct-10092	64	14	,	,	PUNCT
ct-10092	64	15	we	we	PRON
ct-10092	64	16	calculate	calculate	VERB
ct-10092	64	17	that	that	SCONJ
ct-10092	64	18	buserelin	buserelin	PROPN
ct-10092	64	19	is	be	AUX
ct-10092	64	20	at	at	ADV
ct-10092	64	21	least	least	ADJ
ct-10092	64	22	7	7	NUM
ct-10092	64	23	and	and	CCONJ
ct-10092	64	24	10	10	NUM
ct-10092	64	25	times	time	NOUN
ct-10092	64	26	less	less	ADV
ct-10092	64	27	potent	potent	ADJ
ct-10092	64	28	than	than	ADP
ct-10092	64	29	deslorelin	deslorelin	NOUN
ct-10092	64	30	and	and	CCONJ
ct-10092	64	31	histrelin	histrelin	NOUN
ct-10092	64	32	,	,	PUNCT
ct-10092	64	33	respectively	respectively	ADV
ct-10092	64	34	.	.	PUNCT
ct-10092	65	1	this	this	PRON
ct-10092	65	2	may	may	AUX
ct-10092	65	3	partially	partially	ADV
ct-10092	65	4	explain	explain	VERB
ct-10092	65	5	why	why	SCONJ
ct-10092	65	6	in	in	ADP
ct-10092	65	7	this	this	DET
ct-10092	65	8	study	study	NOUN
ct-10092	65	9	a	a	DET
ct-10092	65	10	buserelin	buserelin	NOUN
ct-10092	65	11	dose	dose	VERB
ct-10092	65	12	≈	≈	PROPN
ct-10092	65	13	60	60	NUM
ct-10092	65	14	times	time	NOUN
ct-10092	65	15	greater	great	ADJ
ct-10092	65	16	(	(	PUNCT
ct-10092	65	17	6000	6000	NUM
ct-10092	65	18	ug	ug	ADP
ct-10092	65	19	vs.	vs.	ADP
ct-10092	65	20	100	100	NUM
ct-10092	65	21	ug	ug	ADP
ct-10092	65	22	)	)	PUNCT
ct-10092	65	23	than	than	SCONJ
ct-10092	65	24	that	that	PRON
ct-10092	65	25	recommended	recommend	VERB
ct-10092	65	26	in	in	ADP
ct-10092	65	27	commercial	commercial	ADJ
ct-10092	65	28	preparations	preparation	NOUN
ct-10092	65	29	of	of	ADP
ct-10092	65	30	buserelin	buserelin	PROPN
ct-10092	65	31	(	(	PUNCT
ct-10092	65	32	receptal	receptal	PROPN
ct-10092	65	33	)	)	PUNCT
ct-10092	65	34	was	be	AUX
ct-10092	65	35	able	able	ADJ
ct-10092	65	36	to	to	PART
ct-10092	65	37	effectively	effectively	ADV
ct-10092	65	38	promote	promote	VERB
ct-10092	65	39	ovulation	ovulation	NOUN
ct-10092	65	40	in	in	ADP
ct-10092	65	41	treated	treat	VERB
ct-10092	65	42	mares	mare	NOUN
ct-10092	65	43	at	at	ADP
ct-10092	65	44	a	a	DET
ct-10092	65	45	similar	similar	ADJ
ct-10092	65	46	rate	rate	NOUN
ct-10092	65	47	reported	report	VERB
ct-10092	65	48	for	for	ADP
ct-10092	65	49	hcg	hcg	PROPN
ct-10092	65	50	,	,	PUNCT
ct-10092	65	51	deslorelin	deslorelin	NOUN
ct-10092	65	52	and	and	CCONJ
ct-10092	65	53	histrelin	histrelin	PROPN
ct-10092	65	54	.	.	PUNCT
ct-10092	66	1	ecbolic	ecbolic	ADJ
ct-10092	66	2	hormones	hormone	NOUN
ct-10092	66	3	for	for	ADP
ct-10092	66	4	treatment	treatment	NOUN
ct-10092	66	5	of	of	ADP
ct-10092	66	6	delayed	delay	VERB
ct-10092	66	7	uterine	uterine	ADJ
ct-10092	66	8	clearance	clearance	NOUN
ct-10092	66	9	in	in	ADP
ct-10092	66	10	general	general	ADJ
ct-10092	66	11	,	,	PUNCT
ct-10092	66	12	the	the	DET
ct-10092	66	13	use	use	NOUN
ct-10092	66	14	of	of	ADP
ct-10092	66	15	ecbolic	ecbolic	ADJ
ct-10092	66	16	hormones	hormone	NOUN
ct-10092	66	17	to	to	PART
ct-10092	66	18	correct	correct	VERB
ct-10092	66	19	deficiencies	deficiency	NOUN
ct-10092	66	20	or	or	CCONJ
ct-10092	66	21	weakness	weakness	NOUN
ct-10092	66	22	in	in	ADP
ct-10092	66	23	myometrial	myometrial	ADJ
ct-10092	66	24	contractions	contraction	NOUN
ct-10092	66	25	commonly	commonly	ADV
ct-10092	66	26	seen	see	VERB
ct-10092	66	27	in	in	ADP
ct-10092	66	28	mares	mare	NOUN
ct-10092	66	29	with	with	ADP
ct-10092	66	30	delayed	delay	VERB
ct-10092	66	31	uterine	uterine	ADJ
ct-10092	66	32	clearance	clearance	NOUN
ct-10092	66	33	and	and	CCONJ
ct-10092	66	34	susceptible	susceptible	ADJ
ct-10092	66	35	to	to	ADP
ct-10092	66	36	endometritis	endometritis	PROPN
ct-10092	66	37	are	be	AUX
ct-10092	66	38	safely	safely	ADV
ct-10092	66	39	initiated	initiate	VERB
ct-10092	66	40	at	at	ADP
ct-10092	66	41	four	four	NUM
ct-10092	66	42	to	to	PART
ct-10092	66	43	eight	eight	NUM
ct-10092	66	44	hours	hour	NOUN
ct-10092	66	45	following	follow	VERB
ct-10092	66	46	artificial	artificial	ADJ
ct-10092	66	47	or	or	CCONJ
ct-10092	66	48	natural	natural	ADJ
ct-10092	66	49	insemination	insemination	NOUN
ct-10092	66	50	to	to	PART
ct-10092	66	51	avoid	avoid	VERB
ct-10092	66	52	interferences	interference	NOUN
ct-10092	66	53	with	with	ADP
ct-10092	66	54	sperm	sperm	NOUN
ct-10092	66	55	transport	transport	NOUN
ct-10092	66	56	that	that	PRON
ct-10092	66	57	could	could	AUX
ct-10092	66	58	potentially	potentially	ADV
ct-10092	66	59	affect	affect	VERB
ct-10092	66	60	fertility.52,53	fertility.52,53	NOUN
ct-10092	66	61	these	these	DET
ct-10092	66	62	treatments	treatment	NOUN
ct-10092	66	63	are	be	AUX
ct-10092	66	64	then	then	ADV
ct-10092	66	65	continued	continue	VERB
ct-10092	66	66	at	at	ADP
ct-10092	66	67	the	the	DET
ct-10092	66	68	discretion	discretion	NOUN
ct-10092	66	69	of	of	ADP
ct-10092	66	70	the	the	DET
ct-10092	66	71	prescribing	prescribe	VERB
ct-10092	66	72	veterinarian	veterinarian	NOUN
ct-10092	66	73	;	;	PUNCT
ct-10092	66	74	ecbolics	ecbolic	NOUN
ct-10092	66	75	are	be	AUX
ct-10092	66	76	often	often	ADV
ct-10092	66	77	administered	administer	VERB
ct-10092	66	78	twice	twice	ADV
ct-10092	66	79	daily	daily	ADV
ct-10092	66	80	or	or	CCONJ
ct-10092	66	81	more	more	ADV
ct-10092	66	82	often	often	ADV
ct-10092	66	83	if	if	SCONJ
ct-10092	66	84	necessary	necessary	ADJ
ct-10092	66	85	and	and	CCONJ
ct-10092	66	86	depending	depend	VERB
ct-10092	66	87	on	on	ADP
ct-10092	66	88	the	the	DET
ct-10092	66	89	recorded	record	VERB
ct-10092	66	90	response	response	NOUN
ct-10092	66	91	for	for	ADP
ct-10092	66	92	an	an	DET
ct-10092	66	93	individual	individual	ADJ
ct-10092	66	94	mare	mare	NOUN
ct-10092	66	95	.	.	PUNCT
ct-10092	67	1	commonly	commonly	ADV
ct-10092	67	2	used	use	VERB
ct-10092	67	3	ecbolics	ecbolic	NOUN
ct-10092	67	4	in	in	ADP
ct-10092	67	5	broodmares	broodmare	NOUN
ct-10092	67	6	include	include	VERB
ct-10092	67	7	oxytocin	oxytocin	NOUN
ct-10092	67	8	and	and	CCONJ
ct-10092	67	9	prostaglandin	prostaglandin	PROPN
ct-10092	67	10	-	-	PUNCT
ct-10092	67	11	f2α	f2α	NOUN
ct-10092	67	12	.	.	PUNCT
ct-10092	68	1	oxytocin	oxytocin	PROPN
ct-10092	68	2	oxytocin	oxytocin	PROPN
ct-10092	68	3	is	be	AUX
ct-10092	68	4	a	a	DET
ct-10092	68	5	nonapeptide	nonapeptide	ADJ
ct-10092	68	6	synthetized	synthetize	VERB
ct-10092	68	7	in	in	ADP
ct-10092	68	8	the	the	DET
ct-10092	68	9	magnocelullar	magnocelullar	ADJ
ct-10092	68	10	neurons	neuron	NOUN
ct-10092	68	11	in	in	ADP
ct-10092	68	12	the	the	DET
ct-10092	68	13	hypothalamus	hypothalamus	NOUN
ct-10092	68	14	that	that	PRON
ct-10092	68	15	extend	extend	VERB
ct-10092	68	16	their	their	PRON
ct-10092	68	17	axons	axon	NOUN
ct-10092	68	18	into	into	ADP
ct-10092	68	19	the	the	DET
ct-10092	68	20	neurohypohysis	neurohypohysis	NOUN
ct-10092	68	21	where	where	SCONJ
ct-10092	68	22	it	it	PRON
ct-10092	68	23	is	be	AUX
ct-10092	68	24	stored	store	VERB
ct-10092	68	25	until	until	SCONJ
ct-10092	68	26	released	release	VERB
ct-10092	68	27	into	into	ADP
ct-10092	68	28	the	the	DET
ct-10092	68	29	blood	blood	NOUN
ct-10092	68	30	stream	stream	NOUN
ct-10092	68	31	for	for	ADP
ct-10092	68	32	biological	biological	ADJ
ct-10092	68	33	action	action	NOUN
ct-10092	68	34	in	in	ADP
ct-10092	68	35	the	the	DET
ct-10092	68	36	mare	mare	NOUN
ct-10092	68	37	.	.	PUNCT
ct-10092	69	1	oxytocin	oxytocin	PROPN
ct-10092	69	2	has	have	VERB
ct-10092	69	3	several	several	ADJ
ct-10092	69	4	known	know	VERB
ct-10092	69	5	physiologic	physiologic	ADJ
ct-10092	69	6	effects	effect	NOUN
ct-10092	69	7	,	,	PUNCT
ct-10092	69	8	such	such	ADJ
ct-10092	69	9	as	as	ADP
ct-10092	69	10	milk	milk	NOUN
ct-10092	69	11	ejection	ejection	NOUN
ct-10092	69	12	,	,	PUNCT
ct-10092	69	13	promotion	promotion	NOUN
ct-10092	69	14	of	of	ADP
ct-10092	69	15	maternal	maternal	ADJ
ct-10092	69	16	behavior	behavior	NOUN
ct-10092	69	17	,	,	PUNCT
ct-10092	69	18	and	and	CCONJ
ct-10092	69	19	induction	induction	NOUN
ct-10092	69	20	of	of	ADP
ct-10092	69	21	myometrial	myometrial	ADJ
ct-10092	69	22	contractions	contraction	NOUN
ct-10092	69	23	.	.	PUNCT
ct-10092	70	1	because	because	SCONJ
ct-10092	70	2	delayed	delay	VERB
ct-10092	70	3	uterine	uterine	ADJ
ct-10092	70	4	clearance	clearance	NOUN
ct-10092	70	5	is	be	AUX
ct-10092	70	6	commonly	commonly	ADV
ct-10092	70	7	seen	see	VERB
ct-10092	70	8	in	in	ADP
ct-10092	70	9	mares	mare	NOUN
ct-10092	70	10	experiencing	experience	VERB
ct-10092	70	11	persistent	persistent	ADJ
ct-10092	70	12	mating	mating	NOUN
ct-10092	70	13	-	-	PUNCT
ct-10092	70	14	induced	induce	VERB
ct-10092	70	15	endometritis	endometritis	NOUN
ct-10092	70	16	,	,	PUNCT
ct-10092	70	17	oxytocin	oxytocin	PROPN
ct-10092	70	18	is	be	AUX
ct-10092	70	19	one	one	NUM
ct-10092	70	20	important	important	ADJ
ct-10092	70	21	therapeutic	therapeutic	ADJ
ct-10092	70	22	option	option	NOUN
ct-10092	70	23	for	for	ADP
ct-10092	70	24	treating	treat	VERB
ct-10092	70	25	abnormal	abnormal	ADJ
ct-10092	70	26	intrauterine	intrauterine	ADJ
ct-10092	70	27	accumulation	accumulation	NOUN
ct-10092	70	28	of	of	ADP
ct-10092	70	29	fluid	fluid	NOUN
ct-10092	70	30	.	.	PUNCT
ct-10092	71	1	despite	despite	SCONJ
ct-10092	71	2	clinical	clinical	ADJ
ct-10092	71	3	theriogenology	theriogenology	NOUN
ct-10092	71	4	•	•	NOUN
ct-10092	71	5	volume	volume	NOUN
ct-10092	71	6	7	7	NUM
ct-10092	71	7	,	,	PUNCT
ct-10092	71	8	number	number	NOUN
ct-10092	71	9	1	1	NUM
ct-10092	71	10	•	•	NUM
ct-10092	71	11	march	march	PROPN
ct-10092	71	12	2015	2015	NUM
ct-10092	71	13	48	48	NUM
ct-10092	71	14	oxytocin	oxytocin	PROPN
ct-10092	71	15	’s	’s	PART
ct-10092	71	16	relatively	relatively	ADV
ct-10092	71	17	short	short	ADJ
ct-10092	71	18	-	-	PUNCT
ct-10092	71	19	life	life	NOUN
ct-10092	71	20	of	of	ADP
ct-10092	71	21	≈	≈	PROPN
ct-10092	71	22	7	7	NUM
ct-10092	71	23	minutes,54	minutes,54	NOUN
ct-10092	71	24	it	it	PRON
ct-10092	71	25	seems	seem	VERB
ct-10092	71	26	that	that	SCONJ
ct-10092	71	27	its	its	PRON
ct-10092	71	28	biological	biological	ADJ
ct-10092	71	29	effect	effect	NOUN
ct-10092	71	30	far	far	ADV
ct-10092	71	31	exceeds	exceed	VERB
ct-10092	71	32	this	this	DET
ct-10092	71	33	time	time	NOUN
ct-10092	71	34	.	.	PUNCT
ct-10092	72	1	for	for	ADP
ct-10092	72	2	that	that	DET
ct-10092	72	3	reason	reason	NOUN
ct-10092	72	4	,	,	PUNCT
ct-10092	72	5	treatment	treatment	NOUN
ct-10092	72	6	protocols	protocol	NOUN
ct-10092	72	7	varying	vary	VERB
ct-10092	72	8	from	from	ADP
ct-10092	72	9	two	two	NUM
ct-10092	72	10	to	to	PART
ct-10092	72	11	four	four	NUM
ct-10092	72	12	daily	daily	ADJ
ct-10092	72	13	treatments	treatment	NOUN
ct-10092	72	14	have	have	AUX
ct-10092	72	15	been	be	AUX
ct-10092	72	16	shown	show	VERB
ct-10092	72	17	to	to	PART
ct-10092	72	18	be	be	AUX
ct-10092	72	19	relatively	relatively	ADV
ct-10092	72	20	efficacious	efficacious	ADJ
ct-10092	72	21	in	in	ADP
ct-10092	72	22	promoting	promote	VERB
ct-10092	72	23	uterine	uterine	ADJ
ct-10092	72	24	clearance	clearance	NOUN
ct-10092	72	25	.	.	PUNCT
ct-10092	73	1	boluses	boluse	VERB
ct-10092	73	2	doses	dose	NOUN
ct-10092	73	3	of	of	ADP
ct-10092	73	4	10	10	NUM
ct-10092	73	5	to	to	PART
ct-10092	73	6	20	20	NUM
ct-10092	73	7	iu	iu	ADV
ct-10092	73	8	administered	administer	VERB
ct-10092	73	9	subcutaneously	subcutaneously	ADV
ct-10092	73	10	,	,	PUNCT
ct-10092	73	11	intramuscularly	intramuscularly	ADV
ct-10092	73	12	or	or	CCONJ
ct-10092	73	13	intravenously	intravenously	ADV
ct-10092	73	14	are	be	AUX
ct-10092	73	15	frequently	frequently	ADV
ct-10092	73	16	used	use	VERB
ct-10092	73	17	to	to	PART
ct-10092	73	18	treat	treat	VERB
ct-10092	73	19	mares	mare	NOUN
ct-10092	73	20	with	with	ADP
ct-10092	73	21	mating	mate	VERB
ct-10092	73	22	-	-	PUNCT
ct-10092	73	23	induced	induce	VERB
ct-10092	73	24	intrauterine	intrauterine	ADJ
ct-10092	73	25	fluid	fluid	ADJ
ct-10092	73	26	accumulation	accumulation	NOUN
ct-10092	73	27	.	.	PUNCT
ct-10092	74	1	oxytocin	oxytocin	PROPN
ct-10092	74	2	treatments	treatment	NOUN
ct-10092	74	3	are	be	AUX
ct-10092	74	4	administered	administer	VERB
ct-10092	74	5	during	during	ADP
ct-10092	74	6	estrus	estrus	NOUN
ct-10092	74	7	before	before	ADP
ct-10092	74	8	or	or	CCONJ
ct-10092	74	9	after	after	ADP
ct-10092	74	10	ovulation	ovulation	NOUN
ct-10092	74	11	,	,	PUNCT
ct-10092	74	12	with	with	ADP
ct-10092	74	13	treatments	treatment	NOUN
ct-10092	74	14	scheduled	schedule	VERB
ct-10092	74	15	to	to	PART
ct-10092	74	16	not	not	PART
ct-10092	74	17	coincide	coincide	VERB
ct-10092	74	18	with	with	ADP
ct-10092	74	19	breeding	breeding	NOUN
ct-10092	74	20	to	to	PART
ct-10092	74	21	avoid	avoid	VERB
ct-10092	74	22	interfering	interfere	VERB
ct-10092	74	23	with	with	ADP
ct-10092	74	24	sperm	sperm	NOUN
ct-10092	74	25	transport	transport	NOUN
ct-10092	74	26	,	,	PUNCT
ct-10092	74	27	especially	especially	ADV
ct-10092	74	28	if	if	SCONJ
ct-10092	74	29	given	give	VERB
ct-10092	74	30	shortly	shortly	ADV
ct-10092	74	31	after	after	ADP
ct-10092	74	32	artificial	artificial	ADJ
ct-10092	74	33	insemination	insemination	NOUN
ct-10092	74	34	,	,	PUNCT
ct-10092	74	35	i.e.	i.e.	X
ct-10092	74	36	,	,	PUNCT
ct-10092	74	37	<	<	X
ct-10092	74	38	4	4	NUM
ct-10092	74	39	hours.55	hours.55	NOUN
ct-10092	74	40	recently	recently	ADV
ct-10092	74	41	,	,	PUNCT
ct-10092	74	42	our	our	PRON
ct-10092	74	43	laboratory	laboratory	NOUN
ct-10092	74	44	reported	report	VERB
ct-10092	74	45	on	on	ADP
ct-10092	74	46	the	the	DET
ct-10092	74	47	pharmacokinetics	pharmacokinetic	NOUN
ct-10092	74	48	of	of	ADP
ct-10092	74	49	carbetocin	carbetocin	PROPN
ct-10092	74	50	,	,	PUNCT
ct-10092	74	51	a	a	DET
ct-10092	74	52	long	long	ADV
ct-10092	74	53	-	-	PUNCT
ct-10092	74	54	acting	act	VERB
ct-10092	74	55	oxytocin	oxytocin	NOUN
ct-10092	74	56	analogue.56	analogue.56	SCONJ
ct-10092	74	57	carbetocin	carbetocin	PROPN
ct-10092	74	58	has	have	VERB
ct-10092	74	59	a	a	DET
ct-10092	74	60	half	half	ADJ
ct-10092	74	61	-	-	PUNCT
ct-10092	74	62	life	life	NOUN
ct-10092	74	63	of	of	ADP
ct-10092	74	64	≈	≈	PROPN
ct-10092	74	65	17	17	NUM
ct-10092	74	66	minutes	minute	NOUN
ct-10092	74	67	.	.	PUNCT
ct-10092	75	1	carbetocin	carbetocin	PROPN
ct-10092	75	2	is	be	AUX
ct-10092	75	3	available	available	ADJ
ct-10092	75	4	and	and	CCONJ
ct-10092	75	5	approved	approve	VERB
ct-10092	75	6	for	for	ADP
ct-10092	75	7	use	use	NOUN
ct-10092	75	8	in	in	ADP
ct-10092	75	9	horses	horse	NOUN
ct-10092	75	10	in	in	ADP
ct-10092	75	11	several	several	ADJ
ct-10092	75	12	countries	country	NOUN
ct-10092	75	13	but	but	CCONJ
ct-10092	75	14	not	not	PART
ct-10092	75	15	in	in	ADP
ct-10092	75	16	the	the	DET
ct-10092	75	17	usa	usa	PROPN
ct-10092	75	18	.	.	PROPN
ct-10092	76	1	despite	despite	SCONJ
ct-10092	76	2	its	its	PRON
ct-10092	76	3	longer	long	ADJ
ct-10092	76	4	half	half	ADJ
ct-10092	76	5	-	-	PUNCT
ct-10092	76	6	life	life	NOUN
ct-10092	76	7	than	than	ADP
ct-10092	76	8	oxytocin	oxytocin	NOUN
ct-10092	76	9	,	,	PUNCT
ct-10092	76	10	multiple	multiple	ADJ
ct-10092	76	11	daily	daily	ADJ
ct-10092	76	12	treatments	treatment	NOUN
ct-10092	76	13	may	may	AUX
ct-10092	76	14	still	still	ADV
ct-10092	76	15	be	be	AUX
ct-10092	76	16	required	require	VERB
ct-10092	76	17	for	for	ADP
ct-10092	76	18	optimal	optimal	ADJ
ct-10092	76	19	effects	effect	NOUN
ct-10092	76	20	in	in	ADP
ct-10092	76	21	promoting	promote	VERB
ct-10092	76	22	uterine	uterine	ADJ
ct-10092	76	23	clearance	clearance	NOUN
ct-10092	76	24	as	as	SCONJ
ct-10092	76	25	is	be	AUX
ct-10092	76	26	required	require	VERB
ct-10092	76	27	with	with	ADP
ct-10092	76	28	oxytocin	oxytocin	NOUN
ct-10092	76	29	or	or	CCONJ
ct-10092	76	30	pgf2α	pgf2α	PROPN
ct-10092	76	31	.	.	PUNCT
ct-10092	77	1	a	a	DET
ct-10092	77	2	direct	direct	ADJ
ct-10092	77	3	comparison	comparison	NOUN
ct-10092	77	4	between	between	ADP
ct-10092	77	5	the	the	DET
ct-10092	77	6	ability	ability	NOUN
ct-10092	77	7	of	of	ADP
ct-10092	77	8	oxytocin	oxytocin	NOUN
ct-10092	77	9	and	and	CCONJ
ct-10092	77	10	carbetocin	carbetocin	NOUN
ct-10092	77	11	to	to	PART
ct-10092	77	12	promote	promote	VERB
ct-10092	77	13	uterine	uterine	ADJ
ct-10092	77	14	clearance	clearance	NOUN
ct-10092	77	15	has	have	AUX
ct-10092	77	16	not	not	PART
ct-10092	77	17	been	be	AUX
ct-10092	77	18	reported	report	VERB
ct-10092	77	19	for	for	ADP
ct-10092	77	20	in	in	ADP
ct-10092	77	21	vivo	vivo	ADJ
ct-10092	77	22	treatment	treatment	NOUN
ct-10092	77	23	in	in	ADP
ct-10092	77	24	mares	mare	NOUN
ct-10092	77	25	.	.	PUNCT
ct-10092	78	1	currently	currently	ADV
ct-10092	78	2	,	,	PUNCT
ct-10092	78	3	it	it	PRON
ct-10092	78	4	is	be	AUX
ct-10092	78	5	not	not	PART
ct-10092	78	6	known	know	VERB
ct-10092	78	7	whether	whether	SCONJ
ct-10092	78	8	the	the	DET
ct-10092	78	9	reported	report	VERB
ct-10092	78	10	prolonged	prolonged	ADJ
ct-10092	78	11	half	half	ADJ
ct-10092	78	12	-	-	PUNCT
ct-10092	78	13	life	life	NOUN
ct-10092	78	14	of	of	ADP
ct-10092	78	15	carbetocin	carbetocin	PROPN
ct-10092	78	16	would	would	AUX
ct-10092	78	17	translate	translate	VERB
ct-10092	78	18	into	into	ADP
ct-10092	78	19	a	a	DET
ct-10092	78	20	greater	great	ADJ
ct-10092	78	21	and/or	and/or	CCONJ
ct-10092	78	22	more	more	ADV
ct-10092	78	23	productive	productive	ADJ
ct-10092	78	24	biologic	biologic	NOUN
ct-10092	78	25	response	response	NOUN
ct-10092	78	26	than	than	ADP
ct-10092	78	27	oxytocin	oxytocin	NOUN
ct-10092	78	28	in	in	ADP
ct-10092	78	29	mares	mare	NOUN
ct-10092	78	30	that	that	PRON
ct-10092	78	31	may	may	AUX
ct-10092	78	32	require	require	VERB
ct-10092	78	33	prolonged	prolonged	ADJ
ct-10092	78	34	myometrial	myometrial	ADJ
ct-10092	78	35	stimulation	stimulation	NOUN
ct-10092	78	36	.	.	PUNCT
ct-10092	79	1	steckler	steckler	NOUN
ct-10092	79	2	et	et	NOUN
ct-10092	79	3	al	al	PROPN
ct-10092	79	4	have	have	AUX
ct-10092	79	5	recently	recently	ADV
ct-10092	79	6	reported	report	VERB
ct-10092	79	7	on	on	ADP
ct-10092	79	8	the	the	DET
ct-10092	79	9	results	result	NOUN
ct-10092	79	10	of	of	ADP
ct-10092	79	11	a	a	DET
ct-10092	79	12	comparison	comparison	NOUN
ct-10092	79	13	of	of	ADP
ct-10092	79	14	oxytocin	oxytocin	NOUN
ct-10092	79	15	vs.	vs.	ADP
ct-10092	79	16	carbetocin	carbetocin	NOUN
ct-10092	79	17	in	in	ADP
ct-10092	79	18	eliciting	elicit	VERB
ct-10092	79	19	contractions	contraction	NOUN
ct-10092	79	20	in	in	ADP
ct-10092	79	21	ex	ex	PRON
ct-10092	79	22	vivo	vivo	ADJ
ct-10092	79	23	uterine	uterine	ADJ
ct-10092	79	24	tissues	tissue	NOUN
ct-10092	79	25	collected	collect	VERB
ct-10092	79	26	from	from	ADP
ct-10092	79	27	mares	mare	NOUN
ct-10092	79	28	at	at	ADP
ct-10092	79	29	different	different	ADJ
ct-10092	79	30	reproductive	reproductive	ADJ
ct-10092	79	31	stages	stage	NOUN
ct-10092	79	32	(	(	PUNCT
ct-10092	79	33	e.g.	e.g.	ADV
ct-10092	79	34	,	,	PUNCT
ct-10092	79	35	anestrus	anestrus	NOUN
ct-10092	79	36	,	,	PUNCT
ct-10092	79	37	estrus	estrus	NOUN
ct-10092	79	38	and	and	CCONJ
ct-10092	79	39	diestrus).57	diestrus).57	PROPN
ct-10092	79	40	the	the	DET
ct-10092	79	41	results	result	NOUN
ct-10092	79	42	indicated	indicate	VERB
ct-10092	79	43	that	that	SCONJ
ct-10092	79	44	the	the	DET
ct-10092	79	45	effect	effect	NOUN
ct-10092	79	46	of	of	ADP
ct-10092	79	47	oxytocin	oxytocin	NOUN
ct-10092	79	48	on	on	ADP
ct-10092	79	49	equine	equine	NOUN
ct-10092	79	50	myometrial	myometrial	ADJ
ct-10092	79	51	tissue	tissue	NOUN
ct-10092	79	52	was	be	AUX
ct-10092	79	53	greater	great	ADJ
ct-10092	79	54	during	during	ADP
ct-10092	79	55	anestrus	anestrus	NOUN
ct-10092	79	56	and	and	CCONJ
ct-10092	79	57	diestrus	diestrus	NOUN
ct-10092	79	58	than	than	ADP
ct-10092	79	59	during	during	ADP
ct-10092	79	60	estrus	estrus	NOUN
ct-10092	79	61	,	,	PUNCT
ct-10092	79	62	whereas	whereas	SCONJ
ct-10092	79	63	carbetocin	carbetocin	NOUN
ct-10092	79	64	seemed	seem	VERB
ct-10092	79	65	to	to	PART
ct-10092	79	66	elicit	elicit	VERB
ct-10092	79	67	myometrial	myometrial	ADJ
ct-10092	79	68	contractions	contraction	NOUN
ct-10092	79	69	independent	independent	ADJ
ct-10092	79	70	of	of	ADP
ct-10092	79	71	the	the	DET
ct-10092	79	72	reproductive	reproductive	ADJ
ct-10092	79	73	status	status	NOUN
ct-10092	79	74	;	;	PUNCT
ct-10092	79	75	however	however	ADV
ct-10092	79	76	,	,	PUNCT
ct-10092	79	77	there	there	PRON
ct-10092	79	78	were	be	VERB
ct-10092	79	79	no	no	DET
ct-10092	79	80	differences	difference	NOUN
ct-10092	79	81	between	between	ADP
ct-10092	79	82	their	their	PRON
ct-10092	79	83	ability	ability	NOUN
ct-10092	79	84	to	to	PART
ct-10092	79	85	induce	induce	VERB
ct-10092	79	86	myometrial	myometrial	ADJ
ct-10092	79	87	contractions	contraction	NOUN
ct-10092	79	88	in	in	ADP
ct-10092	79	89	the	the	DET
ct-10092	79	90	ex	ex	ADJ
ct-10092	79	91	vivo	vivo	NOUN
ct-10092	79	92	strips	strip	NOUN
ct-10092	79	93	of	of	ADP
ct-10092	79	94	myometrial	myometrial	ADJ
ct-10092	79	95	tissues	tissue	NOUN
ct-10092	79	96	.	.	PUNCT
ct-10092	80	1	prostaglandin	prostaglandin	VERB
ct-10092	80	2	f2α	f2α	PRON
ct-10092	80	3	in	in	ADP
ct-10092	80	4	addition	addition	NOUN
ct-10092	80	5	to	to	ADP
ct-10092	80	6	being	be	AUX
ct-10092	80	7	known	know	VERB
ct-10092	80	8	for	for	ADP
ct-10092	80	9	its	its	PRON
ct-10092	80	10	luteolytic	luteolytic	ADJ
ct-10092	80	11	actions	action	NOUN
ct-10092	80	12	,	,	PUNCT
ct-10092	80	13	pgf2α	pgf2α	PROPN
ct-10092	80	14	is	be	AUX
ct-10092	80	15	also	also	ADV
ct-10092	80	16	an	an	DET
ct-10092	80	17	effective	effective	ADJ
ct-10092	80	18	promoter	promoter	NOUN
ct-10092	80	19	of	of	ADP
ct-10092	80	20	myometrial	myometrial	ADJ
ct-10092	80	21	contractions	contraction	NOUN
ct-10092	80	22	.	.	PUNCT
ct-10092	81	1	owing	owe	VERB
ct-10092	81	2	to	to	ADP
ct-10092	81	3	its	its	PRON
ct-10092	81	4	longer	long	ADJ
ct-10092	81	5	half	half	ADJ
ct-10092	81	6	-	-	PUNCT
ct-10092	81	7	life	life	NOUN
ct-10092	81	8	than	than	ADP
ct-10092	81	9	oxytocin	oxytocin	NOUN
ct-10092	81	10	,	,	PUNCT
ct-10092	81	11	especially	especially	ADV
ct-10092	81	12	the	the	DET
ct-10092	81	13	synthetic	synthetic	ADJ
ct-10092	81	14	pgf2α	pgf2α	PROPN
ct-10092	81	15	analogue	analogue	NOUN
ct-10092	81	16	cloprostenol	cloprostenol	NOUN
ct-10092	81	17	(	(	PUNCT
ct-10092	81	18	≈	≈	PROPN
ct-10092	81	19	2	2	NUM
ct-10092	81	20	-	-	SYM
ct-10092	81	21	3	3	NUM
ct-10092	81	22	hours	hour	NOUN
ct-10092	81	23	)	)	PUNCT
ct-10092	81	24	,	,	PUNCT
ct-10092	81	25	pgf2α	pgf2α	PROPN
ct-10092	81	26	has	have	AUX
ct-10092	81	27	been	be	AUX
ct-10092	81	28	favored	favor	VERB
ct-10092	81	29	by	by	ADP
ct-10092	81	30	equine	equine	NOUN
ct-10092	81	31	practitioners	practitioner	NOUN
ct-10092	81	32	,	,	PUNCT
ct-10092	81	33	especially	especially	ADV
ct-10092	81	34	for	for	ADP
ct-10092	81	35	use	use	NOUN
ct-10092	81	36	in	in	ADP
ct-10092	81	37	mares	mare	NOUN
ct-10092	81	38	that	that	PRON
ct-10092	81	39	anecdotally	anecdotally	ADV
ct-10092	81	40	seem	seem	VERB
ct-10092	81	41	refractory	refractory	NOUN
ct-10092	81	42	or	or	CCONJ
ct-10092	81	43	do	do	AUX
ct-10092	81	44	not	not	PART
ct-10092	81	45	respond	respond	VERB
ct-10092	81	46	appropriately	appropriately	ADV
ct-10092	81	47	to	to	ADP
ct-10092	81	48	oxytocin	oxytocin	PROPN
ct-10092	81	49	treatment	treatment	NOUN
ct-10092	81	50	.	.	PUNCT
ct-10092	82	1	cloprostenol	cloprostenol	NOUN
ct-10092	82	2	does	do	AUX
ct-10092	82	3	elicit	elicit	VERB
ct-10092	82	4	less	less	ADV
ct-10092	82	5	vigorous	vigorous	ADJ
ct-10092	82	6	myometrial	myometrial	ADJ
ct-10092	82	7	contractions	contraction	NOUN
ct-10092	82	8	than	than	ADP
ct-10092	82	9	oxytocin	oxytocin	PROPN
ct-10092	82	10	but	but	CCONJ
ct-10092	82	11	for	for	ADP
ct-10092	82	12	prolonged	prolonged	ADJ
ct-10092	82	13	periods	period	NOUN
ct-10092	82	14	.	.	PUNCT
ct-10092	83	1	for	for	ADP
ct-10092	83	2	example	example	NOUN
ct-10092	83	3	,	,	PUNCT
ct-10092	83	4	one	one	NUM
ct-10092	83	5	study	study	NOUN
ct-10092	83	6	found	find	VERB
ct-10092	83	7	that	that	SCONJ
ct-10092	83	8	oxytocin	oxytocin	NOUN
ct-10092	83	9	induced	induce	VERB
ct-10092	83	10	strong	strong	ADJ
ct-10092	83	11	myometrial	myometrial	ADJ
ct-10092	83	12	contractions	contraction	NOUN
ct-10092	83	13	that	that	PRON
ct-10092	83	14	lasted	last	VERB
ct-10092	83	15	approximately	approximately	ADV
ct-10092	83	16	one	one	NUM
ct-10092	83	17	hour	hour	NOUN
ct-10092	83	18	;	;	PUNCT
ct-10092	83	19	whereas	whereas	ADV
ct-10092	83	20	,	,	PUNCT
ct-10092	83	21	cloprostenol	cloprostenol	NOUN
ct-10092	83	22	induced	induce	VERB
ct-10092	83	23	low	low	ADJ
ct-10092	83	24	-	-	PUNCT
ct-10092	83	25	amplitude	amplitude	NOUN
ct-10092	83	26	myometrial	myometrial	ADJ
ct-10092	83	27	contractions	contraction	NOUN
ct-10092	83	28	that	that	PRON
ct-10092	83	29	lasted	last	VERB
ct-10092	83	30	four	four	NUM
ct-10092	83	31	to	to	PART
ct-10092	83	32	five	five	NUM
ct-10092	83	33	hours.59	hours.59	NOUN
ct-10092	83	34	this	this	DET
ct-10092	83	35	sustained	sustained	ADJ
ct-10092	83	36	effect	effect	NOUN
ct-10092	83	37	is	be	AUX
ct-10092	83	38	particularly	particularly	ADV
ct-10092	83	39	desirable	desirable	ADJ
ct-10092	83	40	to	to	PART
ct-10092	83	41	enhance	enhance	VERB
ct-10092	83	42	lymph	lymph	NOUN
ct-10092	83	43	flow	flow	NOUN
ct-10092	83	44	and	and	CCONJ
ct-10092	83	45	consistent	consistent	ADJ
ct-10092	83	46	intraluminal	intraluminal	ADJ
ct-10092	83	47	evacuation	evacuation	NOUN
ct-10092	83	48	of	of	ADP
ct-10092	83	49	accumulated	accumulate	VERB
ct-10092	83	50	fluid	fluid	NOUN
ct-10092	83	51	(	(	PUNCT
ct-10092	83	52	inflammatory	inflammatory	ADJ
ct-10092	83	53	transudate	transudate	NOUN
ct-10092	83	54	)	)	PUNCT
ct-10092	83	55	.	.	PUNCT
ct-10092	84	1	despite	despite	SCONJ
ct-10092	84	2	its	its	PRON
ct-10092	84	3	indisputable	indisputable	ADJ
ct-10092	84	4	efficacy	efficacy	NOUN
ct-10092	84	5	as	as	ADP
ct-10092	84	6	an	an	DET
ct-10092	84	7	ecbolic	ecbolic	ADJ
ct-10092	84	8	hormone	hormone	NOUN
ct-10092	84	9	,	,	PUNCT
ct-10092	84	10	the	the	DET
ct-10092	84	11	use	use	NOUN
ct-10092	84	12	of	of	ADP
ct-10092	84	13	pgf2α	pgf2α	PROPN
ct-10092	84	14	during	during	ADP
ct-10092	84	15	estrus	estrus	NOUN
ct-10092	84	16	,	,	PUNCT
ct-10092	84	17	especially	especially	ADV
ct-10092	84	18	in	in	ADP
ct-10092	84	19	the	the	DET
ct-10092	84	20	early	early	ADJ
ct-10092	84	21	postovulatory	postovulatory	ADJ
ct-10092	84	22	period	period	NOUN
ct-10092	84	23	,	,	PUNCT
ct-10092	84	24	was	be	AUX
ct-10092	84	25	found	find	VERB
ct-10092	84	26	to	to	PART
ct-10092	84	27	transiently	transiently	ADV
ct-10092	84	28	affect	affect	VERB
ct-10092	84	29	luteal	luteal	ADJ
ct-10092	84	30	function	function	NOUN
ct-10092	84	31	followed	follow	VERB
ct-10092	84	32	by	by	ADP
ct-10092	84	33	resurgence	resurgence	NOUN
ct-10092	84	34	in	in	ADP
ct-10092	84	35	cl	cl	NOUN
ct-10092	84	36	function.59,60	function.59,60	NOUN
ct-10092	84	37	however	however	ADV
ct-10092	84	38	,	,	PUNCT
ct-10092	84	39	these	these	DET
ct-10092	84	40	studies	study	NOUN
ct-10092	84	41	had	have	VERB
ct-10092	84	42	conflicting	conflicting	ADJ
ct-10092	84	43	results	result	NOUN
ct-10092	84	44	on	on	ADP
ct-10092	84	45	the	the	DET
ct-10092	84	46	effect	effect	NOUN
ct-10092	84	47	of	of	ADP
ct-10092	84	48	such	such	ADJ
ct-10092	84	49	treatment	treatment	NOUN
ct-10092	84	50	on	on	ADP
ct-10092	84	51	the	the	DET
ct-10092	84	52	resulting	result	VERB
ct-10092	84	53	fertility	fertility	NOUN
ct-10092	84	54	of	of	ADP
ct-10092	84	55	treated	treat	VERB
ct-10092	84	56	mares	mare	NOUN
ct-10092	84	57	.	.	PUNCT
ct-10092	85	1	for	for	ADP
ct-10092	85	2	this	this	DET
ct-10092	85	3	reason	reason	NOUN
ct-10092	85	4	,	,	PUNCT
ct-10092	85	5	if	if	SCONJ
ct-10092	85	6	pgf2α	pgf2α	PROPN
ct-10092	85	7	is	be	AUX
ct-10092	85	8	to	to	PART
ct-10092	85	9	be	be	AUX
ct-10092	85	10	used	use	VERB
ct-10092	85	11	as	as	ADP
ct-10092	85	12	an	an	DET
ct-10092	85	13	ecbolic	ecbolic	NOUN
ct-10092	85	14	to	to	PART
ct-10092	85	15	treat	treat	VERB
ct-10092	85	16	delayed	delay	VERB
ct-10092	85	17	clearance	clearance	NOUN
ct-10092	85	18	during	during	ADP
ct-10092	85	19	pre	pre	ADJ
ct-10092	85	20	-	-	ADJ
ct-10092	85	21	ovulatory	ovulatory	ADJ
ct-10092	85	22	estrus	estrus	NOUN
ct-10092	85	23	and	and	CCONJ
ct-10092	85	24	early	early	ADJ
ct-10092	85	25	postovulatory	postovulatory	ADJ
ct-10092	85	26	period	period	NOUN
ct-10092	85	27	,	,	PUNCT
ct-10092	85	28	it	it	PRON
ct-10092	85	29	is	be	AUX
ct-10092	85	30	important	important	ADJ
ct-10092	85	31	that	that	SCONJ
ct-10092	85	32	equine	equine	NOUN
ct-10092	85	33	practitioners	practitioner	NOUN
ct-10092	85	34	remain	remain	VERB
ct-10092	85	35	cognizant	cognizant	ADJ
ct-10092	85	36	of	of	ADP
ct-10092	85	37	its	its	PRON
ct-10092	85	38	effects	effect	NOUN
ct-10092	85	39	on	on	ADP
ct-10092	85	40	luteal	luteal	ADJ
ct-10092	85	41	function	function	NOUN
ct-10092	85	42	.	.	PUNCT
ct-10092	86	1	most	most	ADJ
ct-10092	86	2	mares	mare	NOUN
ct-10092	86	3	so	so	ADV
ct-10092	86	4	treated	treat	VERB
ct-10092	86	5	should	should	AUX
ct-10092	86	6	experience	experience	VERB
ct-10092	86	7	resurgence	resurgence	NOUN
ct-10092	86	8	in	in	ADP
ct-10092	86	9	luteal	luteal	ADJ
ct-10092	86	10	function61	function61	NOUN
ct-10092	86	11	and	and	CCONJ
ct-10092	86	12	may	may	AUX
ct-10092	86	13	not	not	PART
ct-10092	86	14	suffer	suffer	VERB
ct-10092	86	15	deleterious	deleterious	ADJ
ct-10092	86	16	effects	effect	NOUN
ct-10092	86	17	on	on	ADP
ct-10092	86	18	their	their	PRON
ct-10092	86	19	long	long	ADJ
ct-10092	86	20	-	-	PUNCT
ct-10092	86	21	term	term	NOUN
ct-10092	86	22	luteal	luteal	ADJ
ct-10092	86	23	function	function	NOUN
ct-10092	86	24	and	and	CCONJ
ct-10092	86	25	subsequent	subsequent	ADJ
ct-10092	86	26	fertility	fertility	NOUN
ct-10092	86	27	.	.	PUNCT
ct-10092	87	1	moreover	moreover	ADV
ct-10092	87	2	,	,	PUNCT
ct-10092	87	3	our	our	PRON
ct-10092	87	4	laboratory	laboratory	NOUN
ct-10092	87	5	has	have	AUX
ct-10092	87	6	recently	recently	ADV
ct-10092	87	7	reported	report	VERB
ct-10092	87	8	that	that	SCONJ
ct-10092	87	9	the	the	DET
ct-10092	87	10	effect	effect	NOUN
ct-10092	87	11	of	of	ADP
ct-10092	87	12	pgf2α	pgf2α	PROPN
ct-10092	87	13	administration	administration	NOUN
ct-10092	87	14	on	on	ADP
ct-10092	87	15	early	early	ADJ
ct-10092	87	16	luteal	luteal	ADJ
ct-10092	87	17	function	function	NOUN
ct-10092	87	18	can	can	AUX
ct-10092	87	19	induce	induce	VERB
ct-10092	87	20	luteolysis	luteolysis	NOUN
ct-10092	87	21	or	or	CCONJ
ct-10092	87	22	antiluteogenesis	antiluteogenesis	NOUN
ct-10092	87	23	,	,	PUNCT
ct-10092	87	24	depending	depend	VERB
ct-10092	87	25	on	on	ADP
ct-10092	87	26	the	the	DET
ct-10092	87	27	duration	duration	NOUN
ct-10092	87	28	,	,	PUNCT
ct-10092	87	29	timing	timing	NOUN
ct-10092	87	30	,	,	PUNCT
ct-10092	87	31	and	and	CCONJ
ct-10092	87	32	dosage	dosage	VERB
ct-10092	87	33	utilized.15,20	utilized.15,20	NOUN
ct-10092	87	34	for	for	ADP
ct-10092	87	35	these	these	DET
ct-10092	87	36	reasons	reason	NOUN
ct-10092	87	37	,	,	PUNCT
ct-10092	87	38	treatments	treatment	NOUN
ct-10092	87	39	with	with	ADP
ct-10092	87	40	pgf2α	pgf2α	PROPN
ct-10092	87	41	during	during	ADP
ct-10092	87	42	estrus	estrus	NOUN
ct-10092	87	43	should	should	AUX
ct-10092	87	44	not	not	PART
ct-10092	87	45	continue	continue	VERB
ct-10092	87	46	after	after	ADP
ct-10092	87	47	ovulation	ovulation	NOUN
ct-10092	87	48	.	.	PUNCT
ct-10092	88	1	blood	blood	NOUN
ct-10092	88	2	sampling	sample	VERB
ct-10092	88	3	for	for	ADP
ct-10092	88	4	monitoring	monitoring	NOUN
ct-10092	88	5	of	of	ADP
ct-10092	88	6	progesterone	progesterone	NOUN
ct-10092	88	7	secretion	secretion	NOUN
ct-10092	88	8	and	and	CCONJ
ct-10092	88	9	supplementation	supplementation	NOUN
ct-10092	88	10	with	with	ADP
ct-10092	88	11	exogenous	exogenous	ADJ
ct-10092	88	12	progestagens	progestagen	NOUN
ct-10092	88	13	may	may	AUX
ct-10092	88	14	be	be	AUX
ct-10092	88	15	considered	consider	VERB
ct-10092	88	16	during	during	ADP
ct-10092	88	17	that	that	DET
ct-10092	88	18	period	period	NOUN
ct-10092	88	19	.	.	PUNCT
ct-10092	89	1	modulation	modulation	NOUN
ct-10092	89	2	of	of	ADP
ct-10092	89	3	mating	mating	NOUN
ct-10092	89	4	-	-	PUNCT
ct-10092	89	5	induced	induce	VERB
ct-10092	89	6	endometritis	endometritis	NOUN
ct-10092	89	7	with	with	ADP
ct-10092	89	8	steroids	steroid	NOUN
ct-10092	89	9	endometritis	endometritis	PROPN
ct-10092	89	10	following	follow	VERB
ct-10092	89	11	artificial	artificial	ADJ
ct-10092	89	12	insemination	insemination	NOUN
ct-10092	89	13	or	or	CCONJ
ct-10092	89	14	mating	mating	NOUN
ct-10092	89	15	is	be	AUX
ct-10092	89	16	one	one	NUM
ct-10092	89	17	important	important	ADJ
ct-10092	89	18	cause	cause	NOUN
ct-10092	89	19	of	of	ADP
ct-10092	89	20	infertility	infertility	NOUN
ct-10092	89	21	especially	especially	ADV
ct-10092	89	22	in	in	ADP
ct-10092	89	23	mares	mare	NOUN
ct-10092	89	24	susceptible	susceptible	ADJ
ct-10092	89	25	to	to	ADP
ct-10092	89	26	persistent	persistent	ADJ
ct-10092	89	27	mating	mating	NOUN
ct-10092	89	28	-	-	PUNCT
ct-10092	89	29	induced	induce	VERB
ct-10092	89	30	endometritis	endometritis	NOUN
ct-10092	89	31	.	.	PUNCT
ct-10092	90	1	in	in	ADP
ct-10092	90	2	addition	addition	NOUN
ct-10092	90	3	to	to	ADP
ct-10092	90	4	therapies	therapy	NOUN
ct-10092	90	5	aiming	aim	VERB
ct-10092	90	6	at	at	ADP
ct-10092	90	7	combating	combat	VERB
ct-10092	90	8	endometritis	endometritis	NOUN
ct-10092	90	9	by	by	ADP
ct-10092	90	10	utilization	utilization	NOUN
ct-10092	90	11	of	of	ADP
ct-10092	90	12	intrauterine	intrauterine	ADJ
ct-10092	90	13	or	or	CCONJ
ct-10092	90	14	systemic	systemic	ADJ
ct-10092	90	15	antibiotic	antibiotic	ADJ
ct-10092	90	16	treatment	treatment	NOUN
ct-10092	90	17	and	and	CCONJ
ct-10092	90	18	stimulation	stimulation	NOUN
ct-10092	90	19	of	of	ADP
ct-10092	90	20	myometrial	myometrial	ADJ
ct-10092	90	21	function	function	NOUN
ct-10092	90	22	via	via	ADP
ct-10092	90	23	administration	administration	NOUN
ct-10092	90	24	of	of	ADP
ct-10092	90	25	ecbolic	ecbolic	ADJ
ct-10092	90	26	hormones	hormone	NOUN
ct-10092	90	27	(	(	PUNCT
ct-10092	90	28	mainly	mainly	ADV
ct-10092	90	29	oxytocin	oxytocin	PROPN
ct-10092	90	30	and	and	CCONJ
ct-10092	90	31	pgf2α	pgf2α	PROPN
ct-10092	90	32	)	)	PUNCT
ct-10092	90	33	,	,	PUNCT
ct-10092	90	34	another	another	DET
ct-10092	90	35	strategy	strategy	NOUN
ct-10092	90	36	is	be	AUX
ct-10092	90	37	to	to	PART
ct-10092	90	38	control	control	VERB
ct-10092	90	39	or	or	CCONJ
ct-10092	90	40	modulate	modulate	VERB
ct-10092	90	41	the	the	DET
ct-10092	90	42	exacerbated	exacerbate	VERB
ct-10092	90	43	inflammation	inflammation	ADJ
ct-10092	90	44	response	response	NOUN
ct-10092	90	45	seen	see	VERB
ct-10092	90	46	in	in	ADP
ct-10092	90	47	these	these	DET
ct-10092	90	48	mares	mare	NOUN
ct-10092	90	49	.	.	PUNCT
ct-10092	91	1	dell’aqua	dell’aqua	NOUN
ct-10092	91	2	clinical	clinical	ADJ
ct-10092	91	3	theriogenology	theriogenology	NOUN
ct-10092	91	4	•	•	NOUN
ct-10092	91	5	volume	volume	NOUN
ct-10092	91	6	7	7	NUM
ct-10092	91	7	,	,	PUNCT
ct-10092	91	8	number	number	NOUN
ct-10092	91	9	1	1	NUM
ct-10092	91	10	•	•	NUM
ct-10092	91	11	march	march	PROPN
ct-10092	91	12	201549	201549	NUM
ct-10092	91	13	et	et	NOUN
ct-10092	91	14	al	al	PROPN
ct-10092	91	15	first	first	PROPN
ct-10092	91	16	reported	report	VERB
ct-10092	91	17	on	on	ADP
ct-10092	91	18	the	the	DET
ct-10092	91	19	efficacy	efficacy	NOUN
ct-10092	91	20	of	of	ADP
ct-10092	91	21	prednisolone	prednisolone	PROPN
ct-10092	91	22	treatment	treatment	NOUN
ct-10092	91	23	of	of	ADP
ct-10092	91	24	mares	mare	NOUN
ct-10092	91	25	during	during	ADP
ct-10092	91	26	estrus	estrus	NOUN
ct-10092	91	27	that	that	PRON
ct-10092	91	28	benefited	benefit	VERB
ct-10092	91	29	from	from	ADP
ct-10092	91	30	the	the	DET
ct-10092	91	31	glucocorticoid	glucocorticoid	ADJ
ct-10092	91	32	modulatory	modulatory	NOUN
ct-10092	91	33	effects	effect	NOUN
ct-10092	91	34	on	on	ADP
ct-10092	91	35	barren	barren	ADJ
ct-10092	91	36	mares	mare	NOUN
ct-10092	91	37	afflicted	afflict	VERB
ct-10092	91	38	with	with	ADP
ct-10092	91	39	endometritis.62	endometritis.62	PROPN
ct-10092	91	40	a	a	DET
ct-10092	91	41	significantly	significantly	ADV
ct-10092	91	42	higher	high	ADJ
ct-10092	91	43	pregnancy	pregnancy	NOUN
ct-10092	91	44	rate	rate	NOUN
ct-10092	91	45	was	be	AUX
ct-10092	91	46	seen	see	VERB
ct-10092	91	47	in	in	ADP
ct-10092	91	48	barren	barren	ADJ
ct-10092	91	49	mares	mare	NOUN
ct-10092	91	50	treated	treat	VERB
ct-10092	91	51	five	five	NUM
ct-10092	91	52	times	time	NOUN
ct-10092	91	53	with	with	ADP
ct-10092	91	54	0.1	0.1	NUM
ct-10092	91	55	mg	mg	PROPN
ct-10092	91	56	/	/	SYM
ct-10092	91	57	kg	kg	PROPN
ct-10092	91	58	of	of	ADP
ct-10092	91	59	prednisolone	prednisolone	PROPN
ct-10092	91	60	acetate	acetate	NOUN
ct-10092	91	61	(	(	PUNCT
ct-10092	91	62	≈	≈	PROPN
ct-10092	91	63	50	50	NUM
ct-10092	91	64	mg	mg	NOUN
ct-10092	91	65	per	per	ADP
ct-10092	91	66	mare	mare	NOUN
ct-10092	91	67	)	)	PUNCT
ct-10092	91	68	administered	administer	VERB
ct-10092	91	69	every	every	DET
ct-10092	91	70	12	12	NUM
ct-10092	91	71	hours	hour	NOUN
ct-10092	91	72	with	with	ADP
ct-10092	91	73	four	four	NUM
ct-10092	91	74	treatments	treatment	NOUN
ct-10092	91	75	occurring	occur	VERB
ct-10092	91	76	before	before	ADP
ct-10092	91	77	artificial	artificial	ADJ
ct-10092	91	78	insemination	insemination	NOUN
ct-10092	91	79	and	and	CCONJ
ct-10092	91	80	one	one	NUM
ct-10092	91	81	at	at	ADP
ct-10092	91	82	the	the	DET
ct-10092	91	83	time	time	NOUN
ct-10092	91	84	of	of	ADP
ct-10092	91	85	insemination	insemination	NOUN
ct-10092	91	86	.	.	PUNCT
ct-10092	92	1	more	more	ADV
ct-10092	92	2	recently	recently	ADV
ct-10092	92	3	,	,	PUNCT
ct-10092	92	4	bucca	bucca	NOUN
ct-10092	92	5	et	et	PROPN
ct-10092	92	6	al	al	PROPN
ct-10092	92	7	reported	report	VERB
ct-10092	92	8	the	the	DET
ct-10092	92	9	use	use	NOUN
ct-10092	92	10	dexamethasone	dexamethasone	NOUN
ct-10092	92	11	given	give	VERB
ct-10092	92	12	as	as	ADP
ct-10092	92	13	a	a	DET
ct-10092	92	14	single	single	ADJ
ct-10092	92	15	bolus	bolus	PROPN
ct-10092	92	16	administration	administration	NOUN
ct-10092	92	17	of	of	ADP
ct-10092	92	18	50	50	NUM
ct-10092	92	19	mg	mg	NOUN
ct-10092	92	20	per	per	ADP
ct-10092	92	21	mare	mare	NOUN
ct-10092	92	22	at	at	ADP
ct-10092	92	23	time	time	NOUN
ct-10092	92	24	of	of	ADP
ct-10092	92	25	breeding.63	breeding.63	NOUN
ct-10092	92	26	in	in	ADP
ct-10092	92	27	that	that	DET
ct-10092	92	28	study	study	NOUN
ct-10092	92	29	,	,	PUNCT
ct-10092	92	30	the	the	DET
ct-10092	92	31	authors	author	NOUN
ct-10092	92	32	concluded	conclude	VERB
ct-10092	92	33	that	that	SCONJ
ct-10092	92	34	dexamethasone	dexamethasone	NOUN
ct-10092	92	35	administered	administer	VERB
ct-10092	92	36	at	at	ADP
ct-10092	92	37	the	the	DET
ct-10092	92	38	time	time	NOUN
ct-10092	92	39	of	of	ADP
ct-10092	92	40	artificial	artificial	ADJ
ct-10092	92	41	insemination	insemination	NOUN
ct-10092	92	42	was	be	AUX
ct-10092	92	43	safe	safe	ADJ
ct-10092	92	44	and	and	CCONJ
ct-10092	92	45	effective	effective	ADJ
ct-10092	92	46	for	for	ADP
ct-10092	92	47	modulating	modulate	VERB
ct-10092	92	48	persistent	persistent	ADJ
ct-10092	92	49	mating	mating	NOUN
ct-10092	92	50	-	-	PUNCT
ct-10092	92	51	induced	induce	VERB
ct-10092	92	52	endometritis	endometritis	NOUN
ct-10092	92	53	in	in	ADP
ct-10092	92	54	susceptible	susceptible	ADJ
ct-10092	92	55	mares	mare	NOUN
ct-10092	92	56	;	;	PUNCT
ct-10092	92	57	the	the	DET
ct-10092	92	58	glucocorticoid	glucocorticoid	ADJ
ct-10092	92	59	treatment	treatment	NOUN
ct-10092	92	60	decreased	decrease	VERB
ct-10092	92	61	endometrial	endometrial	ADJ
ct-10092	92	62	edema	edema	NOUN
ct-10092	92	63	,	,	PUNCT
ct-10092	92	64	accumulation	accumulation	NOUN
ct-10092	92	65	of	of	ADP
ct-10092	92	66	intraluminal	intraluminal	ADJ
ct-10092	92	67	uterine	uterine	ADJ
ct-10092	92	68	fluid	fluid	NOUN
ct-10092	92	69	and	and	CCONJ
ct-10092	92	70	its	its	PRON
ct-10092	92	71	turbidity	turbidity	NOUN
ct-10092	92	72	,	,	PUNCT
ct-10092	92	73	without	without	ADP
ct-10092	92	74	altering	alter	VERB
ct-10092	92	75	the	the	DET
ct-10092	92	76	amount	amount	NOUN
ct-10092	92	77	of	of	ADP
ct-10092	92	78	polymorphonuclear	polymorphonuclear	NOUN
ct-10092	92	79	cells	cell	NOUN
ct-10092	92	80	seen	see	VERB
ct-10092	92	81	in	in	ADP
ct-10092	92	82	preparations	preparation	NOUN
ct-10092	92	83	obtained	obtain	VERB
ct-10092	92	84	from	from	ADP
ct-10092	92	85	endometrial	endometrial	ADJ
ct-10092	92	86	cytology	cytology	NOUN
ct-10092	92	87	and	and	CCONJ
ct-10092	92	88	increased	increase	VERB
ct-10092	92	89	fertility	fertility	NOUN
ct-10092	92	90	in	in	ADP
ct-10092	92	91	mares	mare	NOUN
ct-10092	92	92	displaying	display	VERB
ct-10092	92	93	multiple	multiple	ADJ
ct-10092	92	94	risk	risk	NOUN
ct-10092	92	95	factors	factor	NOUN
ct-10092	92	96	for	for	ADP
ct-10092	92	97	developing	develop	VERB
ct-10092	92	98	post	post	ADJ
ct-10092	92	99	-	-	ADJ
ct-10092	92	100	breeding	breeding	ADJ
ct-10092	92	101	inflammation	inflammation	NOUN
ct-10092	92	102	.	.	PUNCT
ct-10092	93	1	ferris	ferris	PROPN
ct-10092	93	2	and	and	CCONJ
ct-10092	93	3	mccue	mccue	PROPN
ct-10092	93	4	studied	study	VERB
ct-10092	93	5	the	the	DET
ct-10092	93	6	effects	effect	NOUN
ct-10092	93	7	of	of	ADP
ct-10092	93	8	multiple	multiple	ADJ
ct-10092	93	9	(	(	PUNCT
ct-10092	93	10	twice	twice	ADV
ct-10092	93	11	daily	daily	ADV
ct-10092	93	12	for	for	ADP
ct-10092	93	13	five	five	NUM
ct-10092	93	14	days	day	NOUN
ct-10092	93	15	)	)	PUNCT
ct-10092	93	16	glucocorticoid	glucocorticoid	ADJ
ct-10092	93	17	treatments	treatment	NOUN
ct-10092	93	18	(	(	PUNCT
ct-10092	93	19	prednisolone	prednisolone	PROPN
ct-10092	93	20	or	or	CCONJ
ct-10092	93	21	dexamethasone	dexamethasone	NOUN
ct-10092	93	22	)	)	PUNCT
ct-10092	93	23	in	in	ADP
ct-10092	93	24	mares	mare	NOUN
ct-10092	93	25	during	during	ADP
ct-10092	93	26	early	early	ADJ
ct-10092	93	27	estrus.64	estrus.64	PROPN
ct-10092	93	28	they	they	PRON
ct-10092	93	29	reported	report	VERB
ct-10092	93	30	that	that	SCONJ
ct-10092	93	31	mares	mare	NOUN
ct-10092	93	32	treated	treat	VERB
ct-10092	93	33	with	with	ADP
ct-10092	93	34	dexamethasone	dexamethasone	NOUN
ct-10092	93	35	showed	show	VERB
ct-10092	93	36	reduced	reduce	VERB
ct-10092	93	37	uterine	uterine	ADJ
ct-10092	93	38	edema	edema	NOUN
ct-10092	93	39	and	and	CCONJ
ct-10092	93	40	ovulation	ovulation	NOUN
ct-10092	93	41	rate	rate	NOUN
ct-10092	93	42	(	(	PUNCT
ct-10092	93	43	40	40	NUM
ct-10092	93	44	%	%	NOUN
ct-10092	93	45	vs.	vs.	ADP
ct-10092	93	46	83	83	NUM
ct-10092	93	47	%	%	NOUN
ct-10092	93	48	,	,	PUNCT
ct-10092	93	49	respectively	respectively	ADV
ct-10092	93	50	)	)	PUNCT
ct-10092	93	51	than	than	ADP
ct-10092	93	52	mares	mare	NOUN
ct-10092	93	53	treated	treat	VERB
ct-10092	93	54	with	with	ADP
ct-10092	93	55	prednisolone	prednisolone	PROPN
ct-10092	93	56	.	.	PUNCT
ct-10092	94	1	in	in	ADP
ct-10092	94	2	addition	addition	NOUN
ct-10092	94	3	,	,	PUNCT
ct-10092	94	4	only	only	ADV
ct-10092	94	5	two	two	NUM
ct-10092	94	6	out	out	ADV
ct-10092	94	7	five	five	NUM
ct-10092	94	8	dexamethasone	dexamethasone	NOUN
ct-10092	94	9	-	-	PUNCT
ct-10092	94	10	treated	treat	VERB
ct-10092	94	11	mares	mare	NOUN
ct-10092	94	12	had	have	AUX
ct-10092	94	13	unaltered	unaltere	VERB
ct-10092	94	14	lh	lh	ADJ
ct-10092	94	15	hormonal	hormonal	ADJ
ct-10092	94	16	profiles	profile	NOUN
ct-10092	94	17	,	,	PUNCT
ct-10092	94	18	whereas	whereas	SCONJ
ct-10092	94	19	five	five	NUM
ct-10092	94	20	out	out	ADP
ct-10092	94	21	of	of	ADP
ct-10092	94	22	six	six	NUM
ct-10092	94	23	mares	mare	NOUN
ct-10092	94	24	treated	treat	VERB
ct-10092	94	25	with	with	ADP
ct-10092	94	26	prednisolone	prednisolone	PROPN
ct-10092	94	27	had	have	AUX
ct-10092	94	28	lh	lh	PROPN
ct-10092	94	29	surges	surge	NOUN
ct-10092	94	30	within	within	ADP
ct-10092	94	31	normal	normal	ADJ
ct-10092	94	32	limits	limit	NOUN
ct-10092	94	33	.	.	PUNCT
ct-10092	95	1	the	the	DET
ct-10092	95	2	differences	difference	NOUN
ct-10092	95	3	noted	note	VERB
ct-10092	95	4	between	between	ADP
ct-10092	95	5	dexamethasone	dexamethasone	NOUN
ct-10092	95	6	and	and	CCONJ
ct-10092	95	7	prednisolone	prednisolone	PROPN
ct-10092	95	8	may	may	AUX
ct-10092	95	9	derive	derive	VERB
ct-10092	95	10	from	from	ADP
ct-10092	95	11	their	their	PRON
ct-10092	95	12	differences	difference	NOUN
ct-10092	95	13	in	in	ADP
ct-10092	95	14	relative	relative	ADJ
ct-10092	95	15	potencies	potency	NOUN
ct-10092	95	16	in	in	ADP
ct-10092	95	17	relation	relation	NOUN
ct-10092	95	18	to	to	ADP
ct-10092	95	19	cortisol	cortisol	NOUN
ct-10092	95	20	(	(	PUNCT
ct-10092	95	21	dexamethasone	dexamethasone	NOUN
ct-10092	95	22	=	=	SYM
ct-10092	95	23	30	30	NUM
ct-10092	95	24	;	;	PUNCT
ct-10092	95	25	prednisolone	prednisolone	PROPN
ct-10092	95	26	=	=	PROPN
ct-10092	95	27	4	4	NUM
ct-10092	95	28	)	)	PUNCT
ct-10092	95	29	.	.	PUNCT
ct-10092	96	1	nevertheless	nevertheless	ADV
ct-10092	96	2	,	,	PUNCT
ct-10092	96	3	it	it	PRON
ct-10092	96	4	is	be	AUX
ct-10092	96	5	unlikely	unlikely	ADJ
ct-10092	96	6	that	that	SCONJ
ct-10092	96	7	a	a	DET
ct-10092	96	8	single	single	ADJ
ct-10092	96	9	treatment	treatment	NOUN
ct-10092	96	10	with	with	ADP
ct-10092	96	11	dexamethasone	dexamethasone	NOUN
ct-10092	96	12	as	as	SCONJ
ct-10092	96	13	prescribed	prescribe	VERB
ct-10092	96	14	by	by	ADP
ct-10092	96	15	bucca	bucca	NOUN
ct-10092	96	16	and	and	CCONJ
ct-10092	96	17	carli	carli	PROPN
ct-10092	96	18	would	would	AUX
ct-10092	96	19	result	result	VERB
ct-10092	96	20	in	in	ADP
ct-10092	96	21	ovulation	ovulation	NOUN
ct-10092	96	22	failure	failure	NOUN
ct-10092	96	23	as	as	SCONJ
ct-10092	96	24	only	only	ADV
ct-10092	96	25	mares	mare	NOUN
ct-10092	96	26	with	with	ADP
ct-10092	96	27	multiple	multiple	ADJ
ct-10092	96	28	,	,	PUNCT
ct-10092	96	29	daily	daily	ADJ
ct-10092	96	30	treatments	treatment	NOUN
ct-10092	96	31	with	with	ADP
ct-10092	96	32	dexamethasone	dexamethasone	NOUN
ct-10092	96	33	have	have	AUX
ct-10092	96	34	been	be	AUX
ct-10092	96	35	shown	show	VERB
ct-10092	96	36	to	to	PART
ct-10092	96	37	have	have	AUX
ct-10092	96	38	altered	alter	VERB
ct-10092	96	39	endogenous	endogenous	ADJ
ct-10092	96	40	lh	lh	PROPN
ct-10092	96	41	release	release	NOUN
ct-10092	96	42	that	that	PRON
ct-10092	96	43	resulted	result	VERB
ct-10092	96	44	in	in	ADP
ct-10092	96	45	significant	significant	ADJ
ct-10092	96	46	ovulation	ovulation	NOUN
ct-10092	96	47	failures.65	failures.65	NOUN
ct-10092	96	48	it	it	PRON
ct-10092	96	49	is	be	AUX
ct-10092	96	50	important	important	ADJ
ct-10092	96	51	,	,	PUNCT
ct-10092	96	52	however	however	ADV
ct-10092	96	53	,	,	PUNCT
ct-10092	96	54	to	to	PART
ct-10092	96	55	ensure	ensure	VERB
ct-10092	96	56	that	that	SCONJ
ct-10092	96	57	mares	mare	NOUN
ct-10092	96	58	being	be	AUX
ct-10092	96	59	treated	treat	VERB
ct-10092	96	60	with	with	ADP
ct-10092	96	61	glucocorticoids	glucocorticoid	NOUN
ct-10092	96	62	during	during	ADP
ct-10092	96	63	estrus	estrus	NOUN
ct-10092	96	64	are	be	AUX
ct-10092	96	65	also	also	ADV
ct-10092	96	66	treated	treat	VERB
ct-10092	96	67	with	with	ADP
ct-10092	96	68	ovulation	ovulation	NOUN
ct-10092	96	69	-	-	PUNCT
ct-10092	96	70	inducing	induce	VERB
ct-10092	96	71	agents	agent	NOUN
ct-10092	96	72	to	to	PART
ct-10092	96	73	prevent	prevent	VERB
ct-10092	96	74	any	any	DET
ct-10092	96	75	potential	potential	ADJ
ct-10092	96	76	negative	negative	ADJ
ct-10092	96	77	effects	effect	NOUN
ct-10092	96	78	of	of	ADP
ct-10092	96	79	glucorticoid	glucorticoid	NOUN
ct-10092	96	80	agents	agent	NOUN
ct-10092	96	81	on	on	ADP
ct-10092	96	82	the	the	DET
ct-10092	96	83	hypothalamic	hypothalamic	ADJ
ct-10092	96	84	-	-	PUNCT
ct-10092	96	85	hypophyseal	hypophyseal	ADJ
ct-10092	96	86	axis	axis	NOUN
ct-10092	96	87	that	that	PRON
ct-10092	96	88	may	may	AUX
ct-10092	96	89	result	result	VERB
ct-10092	96	90	in	in	ADP
ct-10092	96	91	anovulation	anovulation	NOUN
ct-10092	96	92	.	.	PUNCT
ct-10092	97	1	bucca	bucca	NOUN
ct-10092	97	2	et	et	PROPN
ct-10092	97	3	al	al	PROPN
ct-10092	97	4	provided	provide	VERB
ct-10092	97	5	supporting	support	VERB
ct-10092	97	6	evidence	evidence	NOUN
ct-10092	97	7	to	to	ADP
ct-10092	97	8	the	the	DET
ct-10092	97	9	efficacy	efficacy	NOUN
ct-10092	97	10	of	of	ADP
ct-10092	97	11	associating	associate	VERB
ct-10092	97	12	induction	induction	NOUN
ct-10092	97	13	of	of	ADP
ct-10092	97	14	ovulation	ovulation	NOUN
ct-10092	97	15	with	with	ADP
ct-10092	97	16	glucocorticoid	glucocorticoid	ADJ
ct-10092	97	17	treatment	treatment	NOUN
ct-10092	97	18	in	in	ADP
ct-10092	97	19	mares	mare	NOUN
ct-10092	97	20	susceptible	susceptible	ADJ
ct-10092	97	21	to	to	ADP
ct-10092	97	22	persistent	persistent	ADJ
ct-10092	97	23	post	post	ADJ
ct-10092	97	24	-	-	ADJ
ct-10092	97	25	mating	mating	ADJ
ct-10092	97	26	endometritis.65	endometritis.65	ADV
ct-10092	97	27	mares	mare	NOUN
ct-10092	97	28	treated	treat	VERB
ct-10092	97	29	with	with	ADP
ct-10092	97	30	a	a	DET
ct-10092	97	31	single	single	ADJ
ct-10092	97	32	bolus	bolus	ADJ
ct-10092	97	33	intravenous	intravenous	ADJ
ct-10092	97	34	injection	injection	NOUN
ct-10092	97	35	of	of	ADP
ct-10092	97	36	50	50	NUM
ct-10092	97	37	mg	mg	NOUN
ct-10092	97	38	of	of	ADP
ct-10092	97	39	dexamethasone	dexamethasone	NOUN
ct-10092	97	40	within	within	ADP
ct-10092	97	41	one	one	NUM
ct-10092	97	42	hour	hour	NOUN
ct-10092	97	43	of	of	ADP
ct-10092	97	44	breeding	breeding	NOUN
ct-10092	97	45	and	and	CCONJ
ct-10092	97	46	concurrent	concurrent	ADJ
ct-10092	97	47	induction	induction	NOUN
ct-10092	97	48	of	of	ADP
ct-10092	97	49	ovulation	ovulation	NOUN
ct-10092	97	50	with	with	ADP
ct-10092	97	51	1,500	1,500	NUM
ct-10092	97	52	iu	iu	NOUN
ct-10092	97	53	of	of	ADP
ct-10092	97	54	hcg	hcg	PROPN
ct-10092	97	55	exhibited	exhibit	VERB
ct-10092	97	56	normal	normal	ADJ
ct-10092	97	57	ovulation	ovulation	NOUN
ct-10092	97	58	rates	rate	NOUN
ct-10092	97	59	(	(	PUNCT
ct-10092	97	60	≈	≈	PROPN
ct-10092	97	61	97	97	NUM
ct-10092	97	62	%	%	NOUN
ct-10092	97	63	of	of	ADP
ct-10092	97	64	mares	mare	NOUN
ct-10092	97	65	ovulated	ovulate	VERB
ct-10092	97	66	within	within	ADP
ct-10092	97	67	48	48	NUM
ct-10092	97	68	hours	hour	NOUN
ct-10092	97	69	)	)	PUNCT
ct-10092	97	70	.	.	PUNCT
ct-10092	98	1	the	the	DET
ct-10092	98	2	minimal	minimal	ADJ
ct-10092	98	3	dose	dose	NOUN
ct-10092	98	4	of	of	ADP
ct-10092	98	5	prednisolone	prednisolone	PROPN
ct-10092	98	6	and	and	CCONJ
ct-10092	98	7	dexamethasone	dexamethasone	NOUN
ct-10092	98	8	to	to	PART
ct-10092	98	9	combat	combat	VERB
ct-10092	98	10	inflammation	inflammation	NOUN
ct-10092	98	11	in	in	ADP
ct-10092	98	12	mares	mare	NOUN
ct-10092	98	13	during	during	ADP
ct-10092	98	14	estrus	estrus	NOUN
ct-10092	98	15	has	have	VERB
ct-10092	98	16	yet	yet	ADV
ct-10092	98	17	to	to	PART
ct-10092	98	18	be	be	AUX
ct-10092	98	19	determined	determine	VERB
ct-10092	98	20	.	.	PUNCT
ct-10092	99	1	conclusions	conclusion	NOUN
ct-10092	99	2	several	several	ADJ
ct-10092	99	3	pharmacologic	pharmacologic	ADJ
ct-10092	99	4	agents	agent	NOUN
ct-10092	99	5	are	be	AUX
ct-10092	99	6	now	now	ADV
ct-10092	99	7	available	available	ADJ
ct-10092	99	8	for	for	ADP
ct-10092	99	9	use	use	NOUN
ct-10092	99	10	in	in	ADP
ct-10092	99	11	the	the	DET
ct-10092	99	12	breeding	breeding	NOUN
ct-10092	99	13	management	management	NOUN
ct-10092	99	14	of	of	ADP
ct-10092	99	15	broodmares	broodmare	NOUN
ct-10092	99	16	.	.	PUNCT
ct-10092	100	1	shortening	shortening	NOUN
ct-10092	100	2	of	of	ADP
ct-10092	100	3	the	the	DET
ct-10092	100	4	diestrus	diestrus	NOUN
ct-10092	100	5	stage	stage	NOUN
ct-10092	100	6	and	and	CCONJ
ct-10092	100	7	induction	induction	NOUN
ct-10092	100	8	of	of	ADP
ct-10092	100	9	estrus	estrus	NOUN
ct-10092	100	10	with	with	ADP
ct-10092	100	11	pgf2α	pgf2α	PROPN
ct-10092	100	12	can	can	AUX
ct-10092	100	13	be	be	AUX
ct-10092	100	14	routinely	routinely	ADV
ct-10092	100	15	achieved	achieve	VERB
ct-10092	100	16	at	at	ADP
ct-10092	100	17	virtually	virtually	ADV
ct-10092	100	18	any	any	DET
ct-10092	100	19	stage	stage	NOUN
ct-10092	100	20	of	of	ADP
ct-10092	100	21	the	the	DET
ct-10092	100	22	cycle	cycle	NOUN
ct-10092	100	23	.	.	PUNCT
ct-10092	101	1	strategic	strategic	ADJ
ct-10092	101	2	utilization	utilization	NOUN
ct-10092	101	3	of	of	ADP
ct-10092	101	4	hormones	hormone	NOUN
ct-10092	101	5	to	to	PART
ct-10092	101	6	induce	induce	VERB
ct-10092	101	7	estrus	estrus	NOUN
ct-10092	101	8	and	and	CCONJ
ct-10092	101	9	ovulation	ovulation	NOUN
ct-10092	101	10	and	and	CCONJ
ct-10092	101	11	to	to	PART
ct-10092	101	12	modulate	modulate	VERB
ct-10092	101	13	/	/	SYM
ct-10092	101	14	prevent	prevent	VERB
ct-10092	101	15	inflammatory	inflammatory	ADJ
ct-10092	101	16	processes	process	NOUN
ct-10092	101	17	in	in	ADP
ct-10092	101	18	mares	mare	NOUN
ct-10092	101	19	susceptible	susceptible	ADJ
ct-10092	101	20	to	to	ADP
ct-10092	101	21	mating	mating	NOUN
ct-10092	101	22	-	-	PUNCT
ct-10092	101	23	induced	induce	VERB
ct-10092	101	24	endometritis	endometritis	NOUN
ct-10092	101	25	and	and	CCONJ
ct-10092	101	26	delayed	delay	VERB
ct-10092	101	27	uterine	uterine	ADJ
ct-10092	101	28	clearance	clearance	NOUN
ct-10092	101	29	can	can	AUX
ct-10092	101	30	significantly	significantly	ADV
ct-10092	101	31	impact	impact	VERB
ct-10092	101	32	the	the	DET
ct-10092	101	33	outcome	outcome	NOUN
ct-10092	101	34	of	of	ADP
ct-10092	101	35	breedings	breeding	NOUN
ct-10092	101	36	by	by	ADP
ct-10092	101	37	increasing	increase	VERB
ct-10092	101	38	the	the	DET
ct-10092	101	39	odds	odd	NOUN
ct-10092	101	40	of	of	ADP
ct-10092	101	41	timed	time	VERB
ct-10092	101	42	ovulation	ovulation	NOUN
ct-10092	101	43	and	and	CCONJ
ct-10092	101	44	pregnancy	pregnancy	NOUN
ct-10092	101	45	.	.	PUNCT
ct-10092	102	1	footnotes	footnote	NOUN
ct-10092	102	2	*	*	PUNCT
ct-10092	102	3	dinoprost	dinoprost	PROPN
ct-10092	102	4	tromethamine	tromethamine	NOUN
ct-10092	102	5	;	;	PUNCT
ct-10092	102	6	lutalyse	lutalyse	PROPN
ct-10092	102	7	®	®	PROPN
ct-10092	102	8	;	;	PUNCT
ct-10092	102	9	pfizer	pfizer	NOUN
ct-10092	102	10	animal	animal	NOUN
ct-10092	102	11	health	health	PROPN
ct-10092	102	12	,	,	PUNCT
ct-10092	102	13	kalamazoo	kalamazoo	PROPN
ct-10092	102	14	,	,	PUNCT
ct-10092	102	15	mi	mi	PROPN
ct-10092	102	16	†	†	PROPN
ct-10092	102	17	d	d	PROPN
ct-10092	102	18	,	,	PUNCT
ct-10092	102	19	l	l	PROPN
ct-10092	102	20	cloprostenol	cloprostenol	NOUN
ct-10092	102	21	sodium	sodium	NOUN
ct-10092	102	22	;	;	PUNCT
ct-10092	102	23	estrumate	estrumate	ADJ
ct-10092	102	24	®	®	PROPN
ct-10092	102	25	;	;	PUNCT
ct-10092	102	26	merck	merck	PROPN
ct-10092	102	27	animal	animal	NOUN
ct-10092	102	28	health	health	NOUN
ct-10092	102	29	,	,	PUNCT
ct-10092	102	30	union	union	NOUN
ct-10092	102	31	,	,	PUNCT
ct-10092	102	32	nj	nj	PROPN
ct-10092	102	33	‡	‡	X
ct-10092	103	1	d	d	NOUN
ct-10092	103	2	,	,	PUNCT
ct-10092	103	3	cloprostenol	cloprostenol	NOUN
ct-10092	103	4	;	;	PUNCT
ct-10092	103	5	genestran	genestran	NOUN
ct-10092	103	6	®	®	NOUN
ct-10092	103	7	;	;	PUNCT
ct-10092	103	8	forte	forte	PROPN
ct-10092	103	9	healthcare	healthcare	PROPN
ct-10092	103	10	limited	limit	VERB
ct-10092	103	11	;	;	PUNCT
ct-10092	103	12	naul	naul	PROPN
ct-10092	103	13	,	,	PUNCT
ct-10092	103	14	dublin	dublin	PROPN
ct-10092	103	15	,	,	PUNCT
ct-10092	103	16	republic	republic	NOUN
ct-10092	103	17	of	of	ADP
ct-10092	103	18	ireland	ireland	PROPN
ct-10092	103	19	§	§	PROPN
ct-10092	103	20	human	human	ADJ
ct-10092	103	21	chorionic	chorionic	ADJ
ct-10092	103	22	gonadotropin	gonadotropin	NOUN
ct-10092	103	23	;	;	PUNCT
ct-10092	103	24	chorulon	chorulon	NOUN
ct-10092	103	25	®	®	NOUN
ct-10092	103	26	;	;	PUNCT
ct-10092	103	27	merck	merck	PROPN
ct-10092	103	28	animal	animal	PROPN
ct-10092	103	29	health	health	PROPN
ct-10092	103	30	,	,	PUNCT
ct-10092	103	31	millsboro	millsboro	PROPN
ct-10092	103	32	,	,	PUNCT
ct-10092	103	33	de	de	PROPN
ct-10092	103	34	¶	¶	PROPN
ct-10092	103	35	deslorelin	deslorelin	NOUN
ct-10092	103	36	acetate	acetate	NOUN
ct-10092	103	37	;	;	PUNCT
ct-10092	103	38	sucromatetm	sucromatetm	NOUN
ct-10092	103	39	equine	equine	NOUN
ct-10092	103	40	;	;	PUNCT
ct-10092	103	41	manufactured	manufacture	VERB
ct-10092	103	42	by	by	ADP
ct-10092	103	43	thorn	thorn	NOUN
ct-10092	103	44	bioscience	bioscience	NOUN
ct-10092	103	45	,	,	PUNCT
ct-10092	103	46	louisville	louisville	PROPN
ct-10092	103	47	,	,	PUNCT
ct-10092	103	48	ky	ky	PROPN
ct-10092	103	49	;	;	PUNCT
ct-10092	103	50	marketed	market	VERB
ct-10092	103	51	by	by	ADP
ct-10092	103	52	bioniche	bioniche	NOUN
ct-10092	103	53	animal	animal	PROPN
ct-10092	103	54	health	health	PROPN
ct-10092	103	55	usa	usa	PROPN
ct-10092	103	56	,	,	PUNCT
ct-10092	103	57	inc	inc	PROPN
ct-10092	103	58	.	.	PROPN
ct-10092	103	59	,	,	PUNCT
ct-10092	103	60	athens	athens	PROPN
ct-10092	103	61	,	,	PUNCT
ct-10092	103	62	ga	ga	PROPN
ct-10092	103	63	references	reference	NOUN
ct-10092	103	64	1	1	NUM
ct-10092	103	65	.	.	PUNCT
ct-10092	103	66	allen	allen	PROPN
ct-10092	103	67	wr	wr	PROPN
ct-10092	103	68	,	,	PUNCT
ct-10092	103	69	cooper	cooper	PROPN
ct-10092	103	70	mj	mj	PROPN
ct-10092	103	71	:	:	PUNCT
ct-10092	103	72	use	use	NOUN
ct-10092	103	73	of	of	ADP
ct-10092	103	74	synthetic	synthetic	ADJ
ct-10092	103	75	analogues	analogue	NOUN
ct-10092	103	76	of	of	ADP
ct-10092	103	77	prostaglandins	prostaglandin	NOUN
ct-10092	103	78	for	for	ADP
ct-10092	103	79	inducing	induce	VERB
ct-10092	103	80	luteolysis	luteolysis	NOUN
ct-10092	103	81	in	in	ADP
ct-10092	103	82	mares	mare	NOUN
ct-10092	103	83	.	.	PUNCT
ct-10092	104	1	ann	ann	PROPN
ct-10092	104	2	biol	biol	PROPN
ct-10092	104	3	anim	anim	PROPN
ct-10092	104	4	bioch	bioch	PROPN
ct-10092	104	5	1975;15:461	1975;15:461	PROPN
ct-10092	104	6	-	-	SYM
ct-10092	104	7	469	469	NUM
ct-10092	104	8	.	.	NOUN
ct-10092	104	9	2	2	NUM
ct-10092	104	10	.	.	X
ct-10092	104	11	nelson	nelson	PROPN
ct-10092	104	12	am	be	AUX
ct-10092	104	13	:	:	PUNCT
ct-10092	104	14	the	the	DET
ct-10092	104	15	therapeutic	therapeutic	ADJ
ct-10092	104	16	activity	activity	NOUN
ct-10092	104	17	,	,	PUNCT
ct-10092	104	18	post	post	ADJ
ct-10092	104	19	-	-	ADJ
ct-10092	104	20	treatment	treatment	ADJ
ct-10092	104	21	fertility	fertility	NOUN
ct-10092	104	22	and	and	CCONJ
ct-10092	104	23	safety	safety	NOUN
ct-10092	104	24	of	of	ADP
ct-10092	104	25	prostaglandin	prostaglandin	VERB
ct-10092	104	26	f2alpha	f2alpha	NOUN
ct-10092	104	27	-	-	PUNCT
ct-10092	104	28	tham	tham	NOUN
ct-10092	104	29	salt	salt	NOUN
ct-10092	104	30	in	in	ADP
ct-10092	104	31	clinically	clinically	ADV
ct-10092	104	32	anoestrous	anoestrous	ADJ
ct-10092	104	33	mares	mare	NOUN
ct-10092	104	34	:	:	PUNCT
ct-10092	104	35	a	a	DET
ct-10092	104	36	review	review	NOUN
ct-10092	104	37	.	.	PUNCT
ct-10092	105	1	equine	equine	NOUN
ct-10092	105	2	vet	vet	PROPN
ct-10092	105	3	j	j	PROPN
ct-10092	105	4	1976;8:75	1976;8:75	PROPN
ct-10092	105	5	-	-	PUNCT
ct-10092	105	6	77	77	NUM
ct-10092	105	7	.	.	PUNCT
ct-10092	106	1	3	3	X
ct-10092	106	2	.	.	X
ct-10092	106	3	burns	burns	PROPN
ct-10092	106	4	sj	sj	PROPN
ct-10092	106	5	,	,	PUNCT
ct-10092	106	6	irvine	irvine	PROPN
ct-10092	106	7	ch	ch	PROPN
ct-10092	106	8	,	,	PUNCT
ct-10092	106	9	amoss	amoss	PROPN
ct-10092	106	10	ms	ms	NOUN
ct-10092	106	11	:	:	PUNCT
ct-10092	106	12	fertility	fertility	NOUN
ct-10092	106	13	of	of	ADP
ct-10092	106	14	prostaglandin	prostaglandin	NOUN
ct-10092	106	15	-	-	PUNCT
ct-10092	106	16	induced	induce	VERB
ct-10092	106	17	oestrus	oestrus	NOUN
ct-10092	106	18	compared	compare	VERB
ct-10092	106	19	to	to	ADP
ct-10092	106	20	normal	normal	ADJ
ct-10092	106	21	post	post	ADJ
ct-10092	106	22	-	-	ADJ
ct-10092	106	23	partum	partum	ADJ
ct-10092	106	24	oestrus	oestrus	NOUN
ct-10092	106	25	.	.	PUNCT
ct-10092	107	1	j	j	PROPN
ct-10092	107	2	reprod	reprod	PROPN
ct-10092	107	3	fertil	fertil	VERB
ct-10092	107	4	suppl	suppl	ADJ
ct-10092	107	5	1979	1979	NUM
ct-10092	107	6	;	;	PUNCT
ct-10092	107	7	27:245	27:245	NUM
ct-10092	107	8	-	-	SYM
ct-10092	107	9	250	250	NUM
ct-10092	107	10	.	.	PUNCT
ct-10092	108	1	clinical	clinical	ADJ
ct-10092	108	2	theriogenology	theriogenology	NOUN
ct-10092	108	3	•	•	NOUN
ct-10092	108	4	volume	volume	NOUN
ct-10092	108	5	7	7	NUM
ct-10092	108	6	,	,	PUNCT
ct-10092	108	7	number	number	NOUN
ct-10092	108	8	1	1	NUM
ct-10092	108	9	•	•	NUM
ct-10092	108	10	march	march	PROPN
ct-10092	108	11	2015	2015	NUM
ct-10092	108	12	50	50	NUM
ct-10092	108	13	4	4	NUM
ct-10092	108	14	.	.	PUNCT
ct-10092	109	1	ginther	ginther	PROPN
ct-10092	109	2	oj	oj	PROPN
ct-10092	109	3	,	,	PUNCT
ct-10092	109	4	jacob	jacob	PROPN
ct-10092	109	5	jc	jc	PROPN
ct-10092	109	6	,	,	PUNCT
ct-10092	109	7	gastal	gastal	PROPN
ct-10092	109	8	mo	mo	PROPN
ct-10092	109	9	,	,	PUNCT
ct-10092	109	10	et	et	PROPN
ct-10092	109	11	al	al	PROPN
ct-10092	109	12	:	:	PUNCT
ct-10092	109	13	follicle	follicle	NOUN
ct-10092	109	14	and	and	CCONJ
ct-10092	109	15	systemic	systemic	ADJ
ct-10092	109	16	hormone	hormone	NOUN
ct-10092	109	17	interrelationships	interrelationship	NOUN
ct-10092	109	18	during	during	ADP
ct-10092	109	19	spontaneous	spontaneous	ADJ
ct-10092	109	20	and	and	CCONJ
ct-10092	109	21	ablation	ablation	NOUN
ct-10092	109	22	-	-	PUNCT
ct-10092	109	23	induced	induce	VERB
ct-10092	109	24	ovulatory	ovulatory	ADJ
ct-10092	109	25	waves	wave	NOUN
ct-10092	109	26	in	in	ADP
ct-10092	109	27	mares	mare	NOUN
ct-10092	109	28	.	.	PUNCT
ct-10092	110	1	anim	anim	PROPN
ct-10092	110	2	reprod	reprod	PROPN
ct-10092	110	3	sci	sci	PROPN
ct-10092	110	4	2008;106:181	2008;106:181	PROPN
ct-10092	110	5	-	-	PROPN
ct-10092	110	6	187	187	NUM
ct-10092	110	7	.	.	PUNCT
ct-10092	110	8	5	5	NUM
ct-10092	110	9	.	.	X
ct-10092	110	10	ginther	ginther	PROPN
ct-10092	110	11	oj	oj	PROPN
ct-10092	110	12	,	,	PUNCT
ct-10092	110	13	al	al	PROPN
ct-10092	110	14	-	-	PUNCT
ct-10092	110	15	mamun	mamun	PROPN
ct-10092	110	16	m	m	PROPN
ct-10092	110	17	:	:	PUNCT
ct-10092	110	18	increased	increase	VERB
ct-10092	110	19	frequency	frequency	NOUN
ct-10092	110	20	of	of	ADP
ct-10092	110	21	double	double	ADJ
ct-10092	110	22	ovulations	ovulation	NOUN
ct-10092	110	23	after	after	ADP
ct-10092	110	24	induction	induction	NOUN
ct-10092	110	25	of	of	ADP
ct-10092	110	26	luteolysis	luteolysis	NOUN
ct-10092	110	27	with	with	ADP
ct-10092	110	28	exogenous	exogenous	ADJ
ct-10092	110	29	prostaglandin	prostaglandin	ADJ
ct-10092	110	30	f2	f2	PROPN
ct-10092	110	31	alpha	alpha	NOUN
ct-10092	110	32	.	.	PUNCT
ct-10092	111	1	j	j	PROPN
ct-10092	111	2	equine	equine	PROPN
ct-10092	111	3	vet	vet	NOUN
ct-10092	111	4	sci	sci	PROPN
ct-10092	111	5	2009;29:581	2009;29:581	PROPN
ct-10092	111	6	-	-	PUNCT
ct-10092	111	7	583	583	NUM
ct-10092	111	8	.	.	PUNCT
ct-10092	112	1	6	6	NUM
ct-10092	112	2	.	.	X
ct-10092	112	3	cuervo	cuervo	PROPN
ct-10092	112	4	-	-	PUNCT
ct-10092	112	5	arango	arango	PROPN
ct-10092	112	6	j	j	PROPN
ct-10092	112	7	,	,	PUNCT
ct-10092	112	8	newcombe	newcombe	PROPN
ct-10092	112	9	jr	jr	PROPN
ct-10092	112	10	:	:	PUNCT
ct-10092	112	11	the	the	DET
ct-10092	112	12	effect	effect	NOUN
ct-10092	112	13	of	of	ADP
ct-10092	112	14	hormone	hormone	NOUN
ct-10092	112	15	treatments	treatment	NOUN
ct-10092	112	16	(	(	PUNCT
ct-10092	112	17	hcg	hcg	PROPN
ct-10092	112	18	and	and	CCONJ
ct-10092	112	19	cloprostenol	cloprostenol	NOUN
ct-10092	112	20	)	)	PUNCT
ct-10092	112	21	and	and	CCONJ
ct-10092	112	22	season	season	NOUN
ct-10092	112	23	on	on	ADP
ct-10092	112	24	the	the	DET
ct-10092	112	25	incidence	incidence	NOUN
ct-10092	112	26	of	of	ADP
ct-10092	112	27	hemorrhagic	hemorrhagic	NOUN
ct-10092	112	28	anovulatory	anovulatory	NOUN
ct-10092	112	29	follicles	follicle	NOUN
ct-10092	112	30	in	in	ADP
ct-10092	112	31	the	the	DET
ct-10092	112	32	mare	mare	NOUN
ct-10092	112	33	:	:	PUNCT
ct-10092	112	34	a	a	DET
ct-10092	112	35	field	field	NOUN
ct-10092	112	36	study	study	NOUN
ct-10092	112	37	.	.	PUNCT
ct-10092	113	1	theriogenology	theriogenology	NOUN
ct-10092	113	2	2009;72:1262	2009;72:1262	NUM
ct-10092	113	3	-	-	SYM
ct-10092	113	4	1267	1267	NUM
ct-10092	113	5	.	.	PUNCT
ct-10092	114	1	7	7	X
ct-10092	114	2	.	.	X
ct-10092	114	3	oxender	oxender	PROPN
ct-10092	114	4	wd	wd	PROPN
ct-10092	114	5	,	,	PUNCT
ct-10092	114	6	noden	noden	PROPN
ct-10092	114	7	pa	pa	PROPN
ct-10092	114	8	,	,	PUNCT
ct-10092	114	9	louis	louis	PROPN
ct-10092	114	10	tm	tm	PROPN
ct-10092	114	11	,	,	PUNCT
ct-10092	114	12	et	et	PROPN
ct-10092	114	13	al	al	PROPN
ct-10092	114	14	:	:	PUNCT
ct-10092	114	15	a	a	DET
ct-10092	114	16	review	review	NOUN
ct-10092	114	17	of	of	ADP
ct-10092	114	18	prostaglandin	prostaglandin	VERB
ct-10092	114	19	f2alpha	f2alpha	NOUN
ct-10092	114	20	for	for	ADP
ct-10092	114	21	ovulation	ovulation	NOUN
ct-10092	114	22	control	control	NOUN
ct-10092	114	23	in	in	ADP
ct-10092	114	24	cows	cow	NOUN
ct-10092	114	25	and	and	CCONJ
ct-10092	114	26	mares	mare	NOUN
ct-10092	114	27	.	.	PUNCT
ct-10092	114	28	am	be	AUX
ct-10092	114	29	j	j	PROPN
ct-10092	114	30	vet	vet	NOUN
ct-10092	114	31	res	re	NOUN
ct-10092	114	32	1974;35:997	1974;35:997	PROPN
ct-10092	114	33	-	-	SYM
ct-10092	114	34	1001	1001	NUM
ct-10092	114	35	.	.	PUNCT
ct-10092	115	1	8	8	X
ct-10092	115	2	.	.	PUNCT
ct-10092	116	1	douglas	douglas	PROPN
ct-10092	116	2	rh	rh	PROPN
ct-10092	116	3	,	,	PUNCT
ct-10092	116	4	ginther	ginther	PROPN
ct-10092	116	5	oj	oj	PROPN
ct-10092	116	6	:	:	PUNCT
ct-10092	116	7	effect	effect	NOUN
ct-10092	116	8	of	of	ADP
ct-10092	116	9	prostaglandin	prostaglandin	VERB
ct-10092	116	10	f2alpha	f2alpha	NOUN
ct-10092	116	11	on	on	ADP
ct-10092	116	12	length	length	NOUN
ct-10092	116	13	of	of	ADP
ct-10092	116	14	diestrus	diestrus	NOUN
ct-10092	116	15	in	in	ADP
ct-10092	116	16	mares	mare	NOUN
ct-10092	116	17	.	.	PUNCT
ct-10092	117	1	prostaglandins	prostaglandin	NOUN
ct-10092	117	2	1972;2:265268	1972;2:265268	NUM
ct-10092	117	3	.	.	PUNCT
ct-10092	118	1	9	9	X
ct-10092	118	2	.	.	X
ct-10092	118	3	douglas	douglas	PROPN
ct-10092	118	4	rh	rh	PROPN
ct-10092	118	5	,	,	PUNCT
ct-10092	118	6	ginther	ginther	PROPN
ct-10092	118	7	oj	oj	PROPN
ct-10092	118	8	:	:	PUNCT
ct-10092	118	9	route	route	NOUN
ct-10092	118	10	of	of	ADP
ct-10092	118	11	prostaglandin	prostaglandin	VERB
ct-10092	118	12	f2alpha	f2alpha	NOUN
ct-10092	118	13	injection	injection	NOUN
ct-10092	118	14	and	and	CCONJ
ct-10092	118	15	luteolysis	luteolysis	NOUN
ct-10092	118	16	in	in	ADP
ct-10092	118	17	mares	mare	NOUN
ct-10092	118	18	(	(	PUNCT
ct-10092	118	19	38519	38519	NUM
ct-10092	118	20	)	)	PUNCT
ct-10092	118	21	.	.	PUNCT
ct-10092	119	1	proc	proc	PROPN
ct-10092	119	2	soc	soc	PROPN
ct-10092	119	3	exp	exp	PROPN
ct-10092	119	4	biol	biol	PROPN
ct-10092	119	5	med	me	VERB
ct-10092	119	6	1975;148:263	1975;148:263	NUM
ct-10092	119	7	-	-	SYM
ct-10092	119	8	269	269	NUM
ct-10092	119	9	.	.	NOUN
ct-10092	119	10	10	10	NUM
ct-10092	119	11	.	.	PUNCT
ct-10092	120	1	kiefer	kiefer	PROPN
ct-10092	120	2	bl	bl	PROPN
ct-10092	120	3	,	,	PUNCT
ct-10092	120	4	roser	roser	PROPN
ct-10092	120	5	jf	jf	PROPN
ct-10092	120	6	,	,	PUNCT
ct-10092	120	7	evans	evans	PROPN
ct-10092	120	8	jw	jw	PROPN
ct-10092	120	9	,	,	PUNCT
ct-10092	120	10	et	et	PROPN
ct-10092	120	11	al	al	PROPN
ct-10092	120	12	:	:	PUNCT
ct-10092	120	13	progesterone	progesterone	NOUN
ct-10092	120	14	patterns	pattern	NOUN
ct-10092	120	15	observed	observe	VERB
ct-10092	120	16	with	with	ADP
ct-10092	120	17	multiple	multiple	ADJ
ct-10092	120	18	injections	injection	NOUN
ct-10092	120	19	of	of	ADP
ct-10092	120	20	a	a	DET
ct-10092	120	21	pgf-2	pgf-2	X
ct-10092	120	22	alpha	alpha	NOUN
ct-10092	120	23	analogue	analogue	NOUN
ct-10092	120	24	in	in	ADP
ct-10092	120	25	the	the	DET
ct-10092	120	26	cyclic	cyclic	ADJ
ct-10092	120	27	mare	mare	NOUN
ct-10092	120	28	.	.	PUNCT
ct-10092	121	1	j	j	PROPN
ct-10092	121	2	reprod	reprod	PROPN
ct-10092	121	3	fertil	fertil	VERB
ct-10092	121	4	suppl	suppl	ADJ
ct-10092	121	5	1979	1979	NUM
ct-10092	121	6	;	;	PUNCT
ct-10092	121	7	27:237	27:237	NUM
ct-10092	121	8	-	-	SYM
ct-10092	121	9	244	244	NUM
ct-10092	121	10	.	.	PUNCT
ct-10092	121	11	11	11	NUM
ct-10092	121	12	.	.	PUNCT
ct-10092	122	1	gastal	gastal	PROPN
ct-10092	122	2	el	el	PROPN
ct-10092	122	3	,	,	PUNCT
ct-10092	122	4	rodrigues	rodrigues	PROPN
ct-10092	122	5	bl	bl	PROPN
ct-10092	122	6	,	,	PUNCT
ct-10092	122	7	gastal	gastal	PROPN
ct-10092	122	8	mo	mo	PROPN
ct-10092	122	9	,	,	PUNCT
ct-10092	122	10	et	et	PROPN
ct-10092	122	11	al	al	PROPN
ct-10092	122	12	:	:	PUNCT
ct-10092	122	13	responsiveness	responsiveness	NOUN
ct-10092	122	14	of	of	ADP
ct-10092	122	15	the	the	DET
ct-10092	122	16	early	early	ADJ
ct-10092	122	17	corpus	corpus	NOUN
ct-10092	122	18	luteum	luteum	NOUN
ct-10092	122	19	to	to	ADP
ct-10092	122	20	pgf2	pgf2	PROPN
ct-10092	122	21	alpha	alpha	NOUN
ct-10092	122	22	and	and	CCONJ
ct-10092	122	23	resulting	result	VERB
ct-10092	122	24	progesterone	progesterone	NOUN
ct-10092	122	25	,	,	PUNCT
ct-10092	122	26	lh	lh	PROPN
ct-10092	122	27	,	,	PUNCT
ct-10092	122	28	and	and	CCONJ
ct-10092	122	29	fsh	fsh	PROPN
ct-10092	122	30	interrelationships	interrelationship	NOUN
ct-10092	122	31	in	in	ADP
ct-10092	122	32	mares	mare	NOUN
ct-10092	122	33	.	.	PUNCT
ct-10092	123	1	anim	anim	PROPN
ct-10092	123	2	reprod	reprod	PROPN
ct-10092	123	3	2005;2:240	2005;2:240	PROPN
ct-10092	123	4	-	-	PROPN
ct-10092	123	5	249	249	NUM
ct-10092	123	6	.	.	PUNCT
ct-10092	123	7	12	12	NUM
ct-10092	123	8	.	.	PUNCT
ct-10092	124	1	ginther	ginther	PROPN
ct-10092	124	2	oj	oj	PROPN
ct-10092	124	3	,	,	PUNCT
ct-10092	124	4	gastal	gastal	PROPN
ct-10092	124	5	el	el	PROPN
ct-10092	124	6	,	,	PUNCT
ct-10092	124	7	gastal	gastal	PROPN
ct-10092	124	8	mo	mo	PROPN
ct-10092	124	9	,	,	PUNCT
ct-10092	124	10	et	et	PROPN
ct-10092	124	11	al	al	PROPN
ct-10092	124	12	:	:	PUNCT
ct-10092	124	13	effect	effect	NOUN
ct-10092	124	14	of	of	ADP
ct-10092	124	15	prostaglandin	prostaglandin	VERB
ct-10092	124	16	f2alpha	f2alpha	NOUN
ct-10092	124	17	on	on	ADP
ct-10092	124	18	ovarian	ovarian	ADJ
ct-10092	124	19	,	,	PUNCT
ct-10092	124	20	adrenal	adrenal	ADJ
ct-10092	124	21	,	,	PUNCT
ct-10092	124	22	and	and	CCONJ
ct-10092	124	23	pituitary	pituitary	ADJ
ct-10092	124	24	hormones	hormone	NOUN
ct-10092	124	25	and	and	CCONJ
ct-10092	124	26	on	on	ADP
ct-10092	124	27	luteal	luteal	ADJ
ct-10092	124	28	blood	blood	NOUN
ct-10092	124	29	flow	flow	NOUN
ct-10092	124	30	in	in	ADP
ct-10092	124	31	mares	mare	NOUN
ct-10092	124	32	.	.	PUNCT
ct-10092	125	1	domest	domest	PROPN
ct-10092	125	2	anim	anim	PROPN
ct-10092	125	3	endocrinol	endocrinol	NOUN
ct-10092	125	4	2007;32:315	2007;32:315	PROPN
ct-10092	125	5	-	-	PROPN
ct-10092	125	6	328	328	NUM
ct-10092	125	7	.	.	PUNCT
ct-10092	125	8	13	13	NUM
ct-10092	125	9	.	.	X
ct-10092	125	10	utt	utt	PROPN
ct-10092	125	11	md	md	PROPN
ct-10092	125	12	,	,	PUNCT
ct-10092	125	13	acosta	acosta	PROPN
ct-10092	125	14	tj	tj	PROPN
ct-10092	125	15	,	,	PUNCT
ct-10092	125	16	wiltbank	wiltbank	PROPN
ct-10092	125	17	mc	mc	PROPN
ct-10092	125	18	,	,	PUNCT
ct-10092	125	19	et	et	PROPN
ct-10092	125	20	al	al	PROPN
ct-10092	125	21	:	:	PUNCT
ct-10092	125	22	acute	acute	ADJ
ct-10092	125	23	effects	effect	NOUN
ct-10092	125	24	of	of	ADP
ct-10092	125	25	prostaglandin	prostaglandin	VERB
ct-10092	125	26	f-2alpha	f-2alpha	NOUN
ct-10092	125	27	on	on	ADP
ct-10092	125	28	systemic	systemic	ADJ
ct-10092	125	29	oxytocin	oxytocin	NOUN
ct-10092	125	30	and	and	CCONJ
ct-10092	125	31	progesterone	progesterone	NOUN
ct-10092	125	32	concentrations	concentration	NOUN
ct-10092	125	33	during	during	ADP
ct-10092	125	34	the	the	DET
ct-10092	125	35	midor	midor	ADJ
ct-10092	125	36	late	late	ADJ
ct-10092	125	37	-	-	PUNCT
ct-10092	125	38	luteal	luteal	ADJ
ct-10092	125	39	phase	phase	NOUN
ct-10092	125	40	in	in	ADP
ct-10092	125	41	mares	mare	NOUN
ct-10092	125	42	.	.	PUNCT
ct-10092	126	1	anim	anim	NOUN
ct-10092	126	2	reprod	reprod	PROPN
ct-10092	126	3	sci	sci	PROPN
ct-10092	126	4	2007;97:63	2007;97:63	NUM
ct-10092	126	5	-	-	SYM
ct-10092	126	6	73	73	NUM
ct-10092	126	7	.	.	PUNCT
ct-10092	126	8	14	14	NUM
ct-10092	126	9	.	.	PUNCT
ct-10092	127	1	holland	holland	PROPN
ct-10092	127	2	be	be	AUX
ct-10092	127	3	,	,	PUNCT
ct-10092	127	4	pinto	pinto	NOUN
ct-10092	127	5	crf	crf	PROPN
ct-10092	127	6	:	:	PUNCT
ct-10092	127	7	luteal	luteal	ADJ
ct-10092	127	8	function	function	NOUN
ct-10092	127	9	and	and	CCONJ
ct-10092	127	10	ovulation	ovulation	NOUN
ct-10092	127	11	in	in	ADP
ct-10092	127	12	mares	mare	NOUN
ct-10092	127	13	treated	treat	VERB
ct-10092	127	14	with	with	ADP
ct-10092	127	15	pgf2alpha	pgf2alpha	PROPN
ct-10092	127	16	during	during	ADP
ct-10092	127	17	early	early	ADJ
ct-10092	127	18	and	and	CCONJ
ct-10092	127	19	mid	mid	NOUN
ct-10092	127	20	-	-	NOUN
ct-10092	127	21	diestrus	diestrus	NOUN
ct-10092	127	22	.	.	PUNCT
ct-10092	128	1	reprod	reprod	PROPN
ct-10092	128	2	domest	domest	PROPN
ct-10092	128	3	anim	anim	NOUN
ct-10092	128	4	2008;43:111	2008;43:111	PROPN
ct-10092	128	5	.	.	PUNCT
ct-10092	129	1	15	15	NUM
ct-10092	129	2	.	.	X
ct-10092	129	3	rubio	rubio	PROPN
ct-10092	129	4	c	c	NOUN
ct-10092	129	5	,	,	PUNCT
ct-10092	129	6	pinto	pinto	NOUN
ct-10092	129	7	cr	cr	PROPN
ct-10092	129	8	,	,	PUNCT
ct-10092	129	9	holland	holland	PROPN
ct-10092	129	10	be	be	VERB
ct-10092	129	11	,	,	PUNCT
ct-10092	129	12	et	et	PROPN
ct-10092	129	13	al	al	PROPN
ct-10092	129	14	:	:	PUNCT
ct-10092	129	15	anti	anti	ADJ
ct-10092	129	16	-	-	ADJ
ct-10092	129	17	luteogenic	luteogenic	ADJ
ct-10092	129	18	and	and	CCONJ
ct-10092	129	19	luteolytic	luteolytic	ADJ
ct-10092	129	20	effects	effect	NOUN
ct-10092	129	21	of	of	ADP
ct-10092	129	22	pgf2a	pgf2a	PROPN
ct-10092	129	23	during	during	ADP
ct-10092	129	24	the	the	DET
ct-10092	129	25	post	post	ADJ
ct-10092	129	26	-	-	ADJ
ct-10092	129	27	ovulatory	ovulatory	ADJ
ct-10092	129	28	period	period	NOUN
ct-10092	129	29	in	in	ADP
ct-10092	129	30	mares	mare	NOUN
ct-10092	129	31	.	.	PUNCT
ct-10092	130	1	theriogenology	theriogenology	NOUN
ct-10092	130	2	2008;70:587	2008;70:587	PROPN
ct-10092	130	3	.	.	PROPN
ct-10092	130	4	16	16	NUM
ct-10092	130	5	.	.	PUNCT
ct-10092	130	6	samper	samper	PROPN
ct-10092	130	7	jc	jc	PROPN
ct-10092	130	8	:	:	PUNCT
ct-10092	130	9	induction	induction	NOUN
ct-10092	130	10	of	of	ADP
ct-10092	130	11	estrus	estrus	NOUN
ct-10092	130	12	and	and	CCONJ
ct-10092	130	13	ovulation	ovulation	NOUN
ct-10092	130	14	:	:	PUNCT
ct-10092	130	15	why	why	SCONJ
ct-10092	130	16	some	some	DET
ct-10092	130	17	mares	mare	NOUN
ct-10092	130	18	respond	respond	VERB
ct-10092	130	19	and	and	CCONJ
ct-10092	130	20	others	other	NOUN
ct-10092	130	21	do	do	VERB
ct-10092	130	22	not	not	PART
ct-10092	130	23	.	.	PUNCT
ct-10092	131	1	theriogenology	theriogenology	NOUN
ct-10092	131	2	2008;70:445	2008;70:445	NOUN
ct-10092	131	3	-	-	SYM
ct-10092	131	4	447	447	NUM
ct-10092	131	5	.	.	NOUN
ct-10092	132	1	17	17	NUM
ct-10092	132	2	.	.	PUNCT
ct-10092	133	1	ginther	ginther	PROPN
ct-10092	133	2	oj	oj	PROPN
ct-10092	133	3	,	,	PUNCT
ct-10092	133	4	siddiqui	siddiqui	PROPN
ct-10092	133	5	ma	ma	PROPN
ct-10092	133	6	,	,	PUNCT
ct-10092	133	7	beg	beg	VERB
ct-10092	133	8	ma	ma	PROPN
ct-10092	133	9	:	:	PUNCT
ct-10092	133	10	physiologic	physiologic	ADJ
ct-10092	133	11	and	and	CCONJ
ct-10092	133	12	nonphysiologic	nonphysiologic	ADJ
ct-10092	133	13	effects	effect	NOUN
ct-10092	133	14	of	of	ADP
ct-10092	133	15	exogenous	exogenous	ADJ
ct-10092	133	16	prostaglandin	prostaglandin	NOUN
ct-10092	133	17	f2alpha	f2alpha	NOUN
ct-10092	133	18	on	on	ADP
ct-10092	133	19	reproductive	reproductive	ADJ
ct-10092	133	20	hormones	hormone	NOUN
ct-10092	133	21	in	in	ADP
ct-10092	133	22	mares	mare	NOUN
ct-10092	133	23	.	.	PUNCT
ct-10092	134	1	theriogenology	theriogenology	NOUN
ct-10092	134	2	2009;72:417	2009;72:417	PROPN
ct-10092	134	3	-	-	SYM
ct-10092	134	4	424	424	NUM
ct-10092	134	5	.	.	NOUN
ct-10092	134	6	18	18	NUM
ct-10092	134	7	.	.	PUNCT
ct-10092	135	1	cuervo	cuervo	PROPN
ct-10092	135	2	-	-	PUNCT
ct-10092	135	3	arango	arango	PROPN
ct-10092	135	4	j	j	PROPN
ct-10092	135	5	,	,	PUNCT
ct-10092	135	6	newcombe	newcombe	PROPN
ct-10092	135	7	jr	jr	PROPN
ct-10092	135	8	:	:	PUNCT
ct-10092	135	9	relationship	relationship	NOUN
ct-10092	135	10	between	between	ADP
ct-10092	135	11	dose	dose	PROPN
ct-10092	135	12	of	of	ADP
ct-10092	135	13	cloprostenol	cloprostenol	NOUN
ct-10092	135	14	and	and	CCONJ
ct-10092	135	15	age	age	NOUN
ct-10092	135	16	of	of	ADP
ct-10092	135	17	corpus	corpus	PROPN
ct-10092	135	18	luteum	luteum	NOUN
ct-10092	135	19	on	on	ADP
ct-10092	135	20	the	the	DET
ct-10092	135	21	luteolytic	luteolytic	ADJ
ct-10092	135	22	response	response	NOUN
ct-10092	135	23	of	of	ADP
ct-10092	135	24	early	early	ADJ
ct-10092	135	25	dioestrous	dioestrous	ADJ
ct-10092	135	26	mares	mare	NOUN
ct-10092	135	27	:	:	PUNCT
ct-10092	135	28	a	a	DET
ct-10092	135	29	field	field	NOUN
ct-10092	135	30	study	study	NOUN
ct-10092	135	31	.	.	PUNCT
ct-10092	136	1	reprod	reprod	PROPN
ct-10092	136	2	domest	domest	PROPN
ct-10092	136	3	anim	anim	PROPN
ct-10092	136	4	2012;47:660	2012;47:660	PROPN
ct-10092	136	5	-	-	PUNCT
ct-10092	136	6	665	665	NUM
ct-10092	136	7	.	.	PUNCT
ct-10092	137	1	19	19	NUM
ct-10092	137	2	.	.	PUNCT
ct-10092	137	3	barker	barker	PROPN
ct-10092	138	1	c	c	PROPN
ct-10092	138	2	,	,	PUNCT
ct-10092	138	3	echeverria	echeverria	PROPN
ct-10092	138	4	k	k	PROPN
ct-10092	138	5	,	,	PUNCT
ct-10092	138	6	davis	davis	PROPN
ct-10092	138	7	m	m	PROPN
ct-10092	138	8	,	,	PUNCT
ct-10092	138	9	et	et	PROPN
ct-10092	138	10	al	al	PROPN
ct-10092	138	11	:	:	PUNCT
ct-10092	138	12	effects	effect	NOUN
ct-10092	138	13	of	of	ADP
ct-10092	138	14	different	different	ADJ
ct-10092	138	15	doses	dose	NOUN
ct-10092	138	16	of	of	ADP
ct-10092	138	17	pgf2alpha	pgf2alpha	PROPN
ct-10092	138	18	on	on	ADP
ct-10092	138	19	luteal	luteal	ADJ
ct-10092	138	20	function	function	NOUN
ct-10092	138	21	and	and	CCONJ
ct-10092	138	22	on	on	ADP
ct-10092	138	23	the	the	DET
ct-10092	138	24	subsequent	subsequent	ADJ
ct-10092	138	25	estrous	estrous	ADJ
ct-10092	138	26	cycle	cycle	NOUN
ct-10092	138	27	.	.	PUNCT
ct-10092	139	1	anim	anim	NOUN
ct-10092	139	2	reprod	reprod	PROPN
ct-10092	139	3	sci	sci	PROPN
ct-10092	139	4	2006;94:207	2006;94:207	PROPN
ct-10092	139	5	-	-	SYM
ct-10092	139	6	209	209	NUM
ct-10092	139	7	.	.	PUNCT
ct-10092	140	1	20	20	NUM
ct-10092	140	2	.	.	PUNCT
ct-10092	141	1	coffman	coffman	PROPN
ct-10092	141	2	ea	ea	PROPN
ct-10092	141	3	,	,	PUNCT
ct-10092	141	4	pinto	pinto	NOUN
ct-10092	141	5	cr	cr	PROPN
ct-10092	141	6	,	,	PUNCT
ct-10092	141	7	snyder	snyder	PROPN
ct-10092	141	8	hk	hk	PROPN
ct-10092	141	9	,	,	PUNCT
ct-10092	141	10	et	et	PROPN
ct-10092	141	11	al	al	PROPN
ct-10092	141	12	:	:	PUNCT
ct-10092	141	13	antiluteogenic	antiluteogenic	ADJ
ct-10092	141	14	effects	effect	NOUN
ct-10092	141	15	of	of	ADP
ct-10092	141	16	serial	serial	ADJ
ct-10092	141	17	prostaglandin	prostaglandin	PROPN
ct-10092	141	18	f	f	PROPN
ct-10092	141	19	administration	administration	NOUN
ct-10092	141	20	in	in	ADP
ct-10092	141	21	cycling	cycling	NOUN
ct-10092	141	22	mares	mare	NOUN
ct-10092	141	23	.	.	PUNCT
ct-10092	142	1	theriogenology	theriogenology	NOUN
ct-10092	142	2	2014;82:1241	2014;82:1241	PROPN
ct-10092	142	3	-	-	SYM
ct-10092	142	4	1245	1245	NUM
ct-10092	142	5	.	.	PUNCT
ct-10092	143	1	21	21	NUM
ct-10092	143	2	.	.	X
ct-10092	143	3	shrestha	shrestha	PROPN
ct-10092	143	4	hk	hk	PROPN
ct-10092	143	5	,	,	PUNCT
ct-10092	143	6	beg	beg	VERB
ct-10092	143	7	ma	ma	PROPN
ct-10092	143	8	,	,	PUNCT
ct-10092	143	9	burnette	burnette	PROPN
ct-10092	143	10	rr	rr	PROPN
ct-10092	143	11	,	,	PUNCT
ct-10092	143	12	et	et	PROPN
ct-10092	143	13	al	al	PROPN
ct-10092	143	14	:	:	PUNCT
ct-10092	143	15	plasma	plasma	NOUN
ct-10092	143	16	clearance	clearance	NOUN
ct-10092	143	17	and	and	CCONJ
ct-10092	143	18	half	half	ADJ
ct-10092	143	19	-	-	PUNCT
ct-10092	143	20	life	life	NOUN
ct-10092	143	21	of	of	ADP
ct-10092	143	22	prostaglandin	prostaglandin	VERB
ct-10092	143	23	f2alpha	f2alpha	NOUN
ct-10092	143	24	:	:	PUNCT
ct-10092	143	25	a	a	DET
ct-10092	143	26	comparison	comparison	NOUN
ct-10092	143	27	between	between	ADP
ct-10092	143	28	mares	mare	NOUN
ct-10092	143	29	and	and	CCONJ
ct-10092	143	30	heifers	heifer	NOUN
ct-10092	143	31	.	.	PUNCT
ct-10092	144	1	biol	biol	PROPN
ct-10092	144	2	reprod	reprod	PROPN
ct-10092	144	3	2012;87:18	2012;87:18	NUM
ct-10092	144	4	.	.	PUNCT
ct-10092	145	1	22	22	NUM
ct-10092	145	2	.	.	PUNCT
ct-10092	146	1	mccue	mccue	PROPN
ct-10092	146	2	pm	pm	PROPN
ct-10092	146	3	,	,	PUNCT
ct-10092	146	4	hudson	hudson	PROPN
ct-10092	146	5	jj	jj	PROPN
ct-10092	146	6	,	,	PUNCT
ct-10092	146	7	bruemmer	bruemmer	PROPN
ct-10092	146	8	je	je	PROPN
ct-10092	146	9	,	,	PUNCT
ct-10092	146	10	et	et	PROPN
ct-10092	146	11	al	al	PROPN
ct-10092	146	12	:	:	PUNCT
ct-10092	146	13	efficacy	efficacy	NOUN
ct-10092	146	14	of	of	ADP
ct-10092	146	15	hcg	hcg	PROPN
ct-10092	146	16	at	at	ADP
ct-10092	146	17	inducing	induce	VERB
ct-10092	146	18	ovulation	ovulation	NOUN
ct-10092	146	19	:	:	PUNCT
ct-10092	146	20	a	a	DET
ct-10092	146	21	new	new	ADJ
ct-10092	146	22	look	look	NOUN
ct-10092	146	23	at	at	ADP
ct-10092	146	24	an	an	DET
ct-10092	146	25	old	old	ADJ
ct-10092	146	26	issue	issue	NOUN
ct-10092	146	27	.	.	PUNCT
ct-10092	147	1	proc	proc	PROPN
ct-10092	147	2	am	be	AUX
ct-10092	147	3	assoc	assoc	PROPN
ct-10092	147	4	equine	equine	PROPN
ct-10092	147	5	pract	pract	NOUN
ct-10092	147	6	;	;	PUNCT
ct-10092	147	7	2004	2004	NUM
ct-10092	147	8	.	.	PUNCT
ct-10092	148	1	23	23	NUM
ct-10092	148	2	.	.	PUNCT
ct-10092	149	1	mccue	mccue	PROPN
ct-10092	149	2	pm	pm	PROPN
ct-10092	149	3	,	,	PUNCT
ct-10092	149	4	magee	magee	PROPN
ct-10092	149	5	c	c	PROPN
ct-10092	149	6	,	,	PUNCT
ct-10092	149	7	gee	gee	INTJ
ct-10092	149	8	ek	ek	ADJ
ct-10092	149	9	:	:	PUNCT
ct-10092	149	10	comparison	comparison	NOUN
ct-10092	149	11	of	of	ADP
ct-10092	149	12	compounded	compound	VERB
ct-10092	149	13	deslorelin	deslorelin	NOUN
ct-10092	149	14	and	and	CCONJ
ct-10092	149	15	hcg	hcg	PROPN
ct-10092	149	16	for	for	ADP
ct-10092	149	17	induction	induction	NOUN
ct-10092	149	18	of	of	ADP
ct-10092	149	19	ovulation	ovulation	NOUN
ct-10092	149	20	in	in	ADP
ct-10092	149	21	mares	mare	NOUN
ct-10092	149	22	.	.	PUNCT
ct-10092	150	1	j	j	PROPN
ct-10092	150	2	equine	equine	PROPN
ct-10092	150	3	vet	vet	NOUN
ct-10092	150	4	sci	sci	PROPN
ct-10092	150	5	2007;27:58	2007;27:58	PROPN
ct-10092	150	6	-	-	PUNCT
ct-10092	150	7	61	61	NUM
ct-10092	150	8	.	.	PUNCT
ct-10092	150	9	24	24	NUM
ct-10092	150	10	.	.	PUNCT
ct-10092	150	11	day	day	NOUN
ct-10092	150	12	ft	ft	NOUN
ct-10092	150	13	:	:	PUNCT
ct-10092	150	14	clinical	clinical	ADJ
ct-10092	150	15	and	and	CCONJ
ct-10092	150	16	experimental	experimental	ADJ
ct-10092	150	17	observations	observation	NOUN
ct-10092	150	18	on	on	ADP
ct-10092	150	19	reproduction	reproduction	NOUN
ct-10092	150	20	in	in	ADP
ct-10092	150	21	the	the	DET
ct-10092	150	22	mare	mare	NOUN
ct-10092	150	23	.	.	PUNCT
ct-10092	151	1	j	j	PROPN
ct-10092	151	2	agr	agr	PROPN
ct-10092	151	3	sci	sci	PROPN
ct-10092	151	4	.	.	PUNCT
ct-10092	152	1	1940;30:244	1940;30:244	PROPN
ct-10092	152	2	-	-	PUNCT
ct-10092	152	3	261	261	NUM
ct-10092	152	4	.	.	PUNCT
ct-10092	153	1	25	25	NUM
ct-10092	153	2	.	.	PUNCT
ct-10092	154	1	katzman	katzman	PROPN
ct-10092	154	2	pa	pa	PROPN
ct-10092	154	3	,	,	PUNCT
ct-10092	154	4	doisy	doisy	ADJ
ct-10092	154	5	ea	ea	NUM
ct-10092	154	6	:	:	PUNCT
ct-10092	154	7	preparation	preparation	NOUN
ct-10092	154	8	of	of	ADP
ct-10092	154	9	extracts	extract	NOUN
ct-10092	154	10	of	of	ADP
ct-10092	154	11	the	the	DET
ct-10092	154	12	anterior	anterior	ADJ
ct-10092	154	13	pituitary	pituitary	ADJ
ct-10092	154	14	-	-	PUNCT
ct-10092	154	15	like	like	ADJ
ct-10092	154	16	substance	substance	NOUN
ct-10092	154	17	of	of	ADP
ct-10092	154	18	urine	urine	NOUN
ct-10092	154	19	of	of	ADP
ct-10092	154	20	pregnancy	pregnancy	NOUN
ct-10092	154	21	.	.	PUNCT
ct-10092	155	1	j	j	PROPN
ct-10092	155	2	biol	biol	PROPN
ct-10092	155	3	chem	chem	NOUN
ct-10092	155	4	1932;98:739	1932;98:739	NOUN
ct-10092	155	5	-	-	NOUN
ct-10092	155	6	754	754	NUM
ct-10092	155	7	.	.	NOUN
ct-10092	155	8	26	26	NUM
ct-10092	155	9	.	.	NOUN
ct-10092	155	10	day	day	NOUN
ct-10092	155	11	ft	ft	PROPN
ct-10092	155	12	:	:	PUNCT
ct-10092	155	13	ovulation	ovulation	NOUN
ct-10092	155	14	and	and	CCONJ
ct-10092	155	15	the	the	DET
ct-10092	155	16	descent	descent	NOUN
ct-10092	155	17	of	of	ADP
ct-10092	155	18	the	the	DET
ct-10092	155	19	ovum	ovum	NOUN
ct-10092	155	20	in	in	ADP
ct-10092	155	21	the	the	DET
ct-10092	155	22	fallopian	fallopian	ADJ
ct-10092	155	23	tube	tube	NOUN
ct-10092	155	24	of	of	ADP
ct-10092	155	25	the	the	DET
ct-10092	155	26	mare	mare	NOUN
ct-10092	155	27	after	after	ADP
ct-10092	155	28	treatment	treatment	NOUN
ct-10092	155	29	with	with	ADP
ct-10092	155	30	gonadotrophic	gonadotrophic	ADJ
ct-10092	155	31	hormones	hormone	NOUN
ct-10092	155	32	.	.	PUNCT
ct-10092	156	1	j	j	PROPN
ct-10092	156	2	agr	agr	PROPN
ct-10092	156	3	sci	sci	PROPN
ct-10092	156	4	1939;29:459	1939;29:459	PROPN
ct-10092	156	5	-	-	SYM
ct-10092	156	6	469	469	NUM
ct-10092	156	7	.	.	PROPN
ct-10092	156	8	27	27	NUM
ct-10092	156	9	.	.	PUNCT
ct-10092	157	1	hamilton	hamilton	PROPN
ct-10092	157	2	wj	wj	PROPN
ct-10092	157	3	,	,	PUNCT
ct-10092	157	4	day	day	NOUN
ct-10092	157	5	ft	ft	NOUN
ct-10092	157	6	:	:	PUNCT
ct-10092	157	7	cleavage	cleavage	NOUN
ct-10092	157	8	stages	stage	NOUN
ct-10092	157	9	of	of	ADP
ct-10092	157	10	the	the	DET
ct-10092	157	11	ova	ova	NOUN
ct-10092	157	12	of	of	ADP
ct-10092	157	13	the	the	DET
ct-10092	157	14	horse	horse	NOUN
ct-10092	157	15	,	,	PUNCT
ct-10092	157	16	with	with	ADP
ct-10092	157	17	notes	note	NOUN
ct-10092	157	18	on	on	ADP
ct-10092	157	19	ovulation	ovulation	NOUN
ct-10092	157	20	.	.	PUNCT
ct-10092	158	1	j	j	PROPN
ct-10092	158	2	anat	anat	PROPN
ct-10092	158	3	1945;79:127	1945;79:127	PROPN
ct-10092	158	4	-	-	PUNCT
ct-10092	158	5	130	130	NUM
ct-10092	158	6	.	.	PUNCT
ct-10092	158	7	28	28	NUM
ct-10092	158	8	.	.	PUNCT
ct-10092	159	1	ascoli	ascoli	PROPN
ct-10092	159	2	m	m	PROPN
ct-10092	159	3	,	,	PUNCT
ct-10092	159	4	segaloff	segaloff	PROPN
ct-10092	159	5	dl	dl	PROPN
ct-10092	159	6	:	:	PUNCT
ct-10092	159	7	on	on	ADP
ct-10092	159	8	the	the	DET
ct-10092	159	9	structure	structure	NOUN
ct-10092	159	10	of	of	ADP
ct-10092	159	11	the	the	DET
ct-10092	159	12	luteinizing	luteinizing	NOUN
ct-10092	159	13	-	-	PUNCT
ct-10092	159	14	hormone	hormone	NOUN
ct-10092	159	15	chorionic	chorionic	ADJ
ct-10092	159	16	-	-	PUNCT
ct-10092	159	17	gonadotropin	gonadotropin	NOUN
ct-10092	159	18	receptor	receptor	NOUN
ct-10092	159	19	.	.	PUNCT
ct-10092	160	1	endocrinol	endocrinol	NOUN
ct-10092	160	2	rev	rev	PROPN
ct-10092	160	3	1989;10:27	1989;10:27	NUM
ct-10092	160	4	-	-	SYM
ct-10092	160	5	44	44	NUM
ct-10092	160	6	.	.	PUNCT
ct-10092	160	7	29	29	NUM
ct-10092	160	8	.	.	PUNCT
ct-10092	161	1	bollwein	bollwein	PROPN
ct-10092	161	2	h	h	PROPN
ct-10092	161	3	,	,	PUNCT
ct-10092	161	4	braun	braun	PROPN
ct-10092	161	5	j	j	PROPN
ct-10092	161	6	:	:	PUNCT
ct-10092	161	7	follicular	follicular	ADJ
ct-10092	161	8	dynamics	dynamic	NOUN
ct-10092	161	9	after	after	ADP
ct-10092	161	10	treatment	treatment	NOUN
ct-10092	161	11	with	with	ADP
ct-10092	161	12	hcg	hcg	PROPN
ct-10092	161	13	for	for	ADP
ct-10092	161	14	ovulation	ovulation	NOUN
ct-10092	161	15	induction	induction	NOUN
ct-10092	161	16	in	in	ADP
ct-10092	161	17	mares	mare	NOUN
ct-10092	161	18	.	.	PUNCT
ct-10092	162	1	tierarztl	tierarztl	PROPN
ct-10092	162	2	prax	prax	PROPN
ct-10092	162	3	ausg	ausg	PROPN
ct-10092	162	4	g	g	PROPN
ct-10092	162	5	grosstiere	grosstiere	ADV
ct-10092	162	6	nutztiere	nutztiere	ADV
ct-10092	162	7	1999;27:47	1999;27:47	NUM
ct-10092	162	8	-	-	SYM
ct-10092	162	9	51	51	NUM
ct-10092	162	10	.	.	PUNCT
ct-10092	162	11	30	30	NUM
ct-10092	162	12	.	.	PUNCT
ct-10092	163	1	morel	morel	NOUN
ct-10092	163	2	mcgd	mcgd	NOUN
ct-10092	163	3	,	,	PUNCT
ct-10092	163	4	newcombe	newcombe	PROPN
ct-10092	163	5	jr	jr	PROPN
ct-10092	163	6	:	:	PUNCT
ct-10092	163	7	the	the	DET
ct-10092	163	8	efficacy	efficacy	NOUN
ct-10092	163	9	of	of	ADP
ct-10092	163	10	different	different	ADJ
ct-10092	163	11	hcg	hcg	PROPN
ct-10092	163	12	dose	dose	NOUN
ct-10092	163	13	rates	rate	NOUN
ct-10092	163	14	and	and	CCONJ
ct-10092	163	15	the	the	DET
ct-10092	163	16	effect	effect	NOUN
ct-10092	163	17	of	of	ADP
ct-10092	163	18	hcg	hcg	PROPN
ct-10092	163	19	treatment	treatment	NOUN
ct-10092	163	20	on	on	ADP
ct-10092	163	21	ovarian	ovarian	ADJ
ct-10092	163	22	activity	activity	NOUN
ct-10092	163	23	:	:	PUNCT
ct-10092	163	24	ovulation	ovulation	NOUN
ct-10092	163	25	,	,	PUNCT
ct-10092	163	26	multiple	multiple	ADJ
ct-10092	163	27	ovulation	ovulation	NOUN
ct-10092	163	28	,	,	PUNCT
ct-10092	163	29	pregnancy	pregnancy	NOUN
ct-10092	163	30	,	,	PUNCT
ct-10092	163	31	multiple	multiple	ADJ
ct-10092	163	32	pregnancy	pregnancy	NOUN
ct-10092	163	33	,	,	PUNCT
ct-10092	163	34	synchrony	synchrony	NOUN
ct-10092	163	35	of	of	ADP
ct-10092	163	36	multiple	multiple	ADJ
ct-10092	163	37	ovulation	ovulation	NOUN
ct-10092	163	38	;	;	PUNCT
ct-10092	163	39	in	in	ADP
ct-10092	163	40	the	the	DET
ct-10092	163	41	mare	mare	PROPN
ct-10092	163	42	.	.	PUNCT
ct-10092	164	1	anim	anim	PROPN
ct-10092	164	2	reprod	reprod	PROPN
ct-10092	164	3	sci	sci	PROPN
ct-10092	164	4	2008;109:189	2008;109:189	NUM
ct-10092	164	5	-	-	SYM
ct-10092	164	6	199	199	NUM
ct-10092	164	7	.	.	PUNCT
ct-10092	164	8	31	31	NUM
ct-10092	164	9	.	.	PUNCT
ct-10092	165	1	roser	roser	PROPN
ct-10092	165	2	jf	jf	PROPN
ct-10092	165	3	,	,	PUNCT
ct-10092	165	4	kiefer	kiefer	PROPN
ct-10092	165	5	bl	bl	PROPN
ct-10092	165	6	,	,	PUNCT
ct-10092	165	7	evans	evans	PROPN
ct-10092	165	8	jw	jw	PROPN
ct-10092	165	9	,	,	PUNCT
ct-10092	165	10	et	et	PROPN
ct-10092	165	11	al	al	PROPN
ct-10092	165	12	:	:	PUNCT
ct-10092	165	13	the	the	DET
ct-10092	165	14	development	development	NOUN
ct-10092	165	15	of	of	ADP
ct-10092	165	16	antibodies	antibody	NOUN
ct-10092	165	17	to	to	ADP
ct-10092	165	18	human	human	ADJ
ct-10092	165	19	chorionic	chorionic	ADJ
ct-10092	165	20	gonadotrophin	gonadotrophin	NOUN
ct-10092	165	21	following	follow	VERB
ct-10092	165	22	its	its	PRON
ct-10092	165	23	repeated	repeat	VERB
ct-10092	165	24	injection	injection	NOUN
ct-10092	165	25	in	in	ADP
ct-10092	165	26	the	the	DET
ct-10092	165	27	cyclic	cyclic	ADJ
ct-10092	165	28	mare	mare	NOUN
ct-10092	165	29	.	.	PUNCT
ct-10092	166	1	j	j	PROPN
ct-10092	166	2	reprod	reprod	PROPN
ct-10092	166	3	fertil	fertil	PROPN
ct-10092	166	4	suppl	suppl	ADJ
ct-10092	166	5	1979;27:173	1979;27:173	PROPN
ct-10092	166	6	-	-	SYM
ct-10092	166	7	179	179	NUM
ct-10092	166	8	.	.	PUNCT
ct-10092	167	1	32	32	NUM
ct-10092	167	2	.	.	PUNCT
ct-10092	168	1	chavatte	chavatte	PROPN
ct-10092	168	2	p	p	X
ct-10092	168	3	,	,	PUNCT
ct-10092	168	4	palmer	palmer	PROPN
ct-10092	168	5	e	e	NOUN
ct-10092	168	6	:	:	PUNCT
ct-10092	168	7	induction	induction	NOUN
ct-10092	168	8	of	of	ADP
ct-10092	168	9	ovulation	ovulation	NOUN
ct-10092	168	10	in	in	ADP
ct-10092	168	11	the	the	DET
ct-10092	168	12	mare	mare	NOUN
ct-10092	168	13	.	.	PUNCT
ct-10092	169	1	equine	equine	NOUN
ct-10092	169	2	vet	vet	NOUN
ct-10092	169	3	educ	educ	VERB
ct-10092	169	4	1998;10:26	1998;10:26	NUM
ct-10092	169	5	-	-	SYM
ct-10092	169	6	30	30	NUM
ct-10092	169	7	.	.	PUNCT
ct-10092	170	1	33	33	NUM
ct-10092	170	2	.	.	PUNCT
ct-10092	171	1	johnson	johnson	PROPN
ct-10092	171	2	al	al	PROPN
ct-10092	171	3	:	:	PUNCT
ct-10092	171	4	pulsatile	pulsatile	NOUN
ct-10092	171	5	administration	administration	NOUN
ct-10092	171	6	of	of	ADP
ct-10092	171	7	gonadotropin	gonadotropin	NOUN
ct-10092	171	8	-	-	PUNCT
ct-10092	171	9	releasing	releasing	NOUN
ct-10092	171	10	-	-	PUNCT
ct-10092	171	11	hormone	hormone	NOUN
ct-10092	171	12	advances	advance	NOUN
ct-10092	171	13	ovulation	ovulation	NOUN
ct-10092	171	14	in	in	ADP
ct-10092	171	15	cycling	cycling	NOUN
ct-10092	171	16	mares	mare	NOUN
ct-10092	171	17	.	.	PUNCT
ct-10092	172	1	biol	biol	PROPN
ct-10092	172	2	reprod	reprod	PROPN
ct-10092	172	3	1986;35:1123	1986;35:1123	NUM
ct-10092	172	4	-	-	SYM
ct-10092	172	5	1130	1130	NUM
ct-10092	172	6	.	.	PUNCT
ct-10092	173	1	34	34	NUM
ct-10092	173	2	.	.	PUNCT
ct-10092	174	1	burgus	burgus	PROPN
ct-10092	174	2	r	r	PROPN
ct-10092	174	3	,	,	PUNCT
ct-10092	174	4	butcher	butcher	NOUN
ct-10092	174	5	m	m	PROPN
ct-10092	174	6	,	,	PUNCT
ct-10092	174	7	ling	ling	PROPN
ct-10092	174	8	n	n	CCONJ
ct-10092	174	9	,	,	PUNCT
ct-10092	174	10	et	et	PROPN
ct-10092	174	11	al	al	PROPN
ct-10092	174	12	:	:	PUNCT
ct-10092	175	1	[	[	X
ct-10092	175	2	molecular	molecular	ADJ
ct-10092	175	3	structure	structure	NOUN
ct-10092	175	4	of	of	ADP
ct-10092	175	5	the	the	DET
ct-10092	175	6	hypothalamic	hypothalamic	ADJ
ct-10092	175	7	factor	factor	NOUN
ct-10092	175	8	(	(	PUNCT
ct-10092	175	9	lrf	lrf	NOUN
ct-10092	175	10	)	)	PUNCT
ct-10092	175	11	of	of	ADP
ct-10092	175	12	ovine	ovine	ADJ
ct-10092	175	13	origin	origin	NOUN
ct-10092	175	14	monitoring	monitor	VERB
ct-10092	175	15	the	the	DET
ct-10092	175	16	secretion	secretion	NOUN
ct-10092	175	17	of	of	ADP
ct-10092	175	18	pituitary	pituitary	ADJ
ct-10092	175	19	gonadotropic	gonadotropic	NOUN
ct-10092	175	20	hormone	hormone	NOUN
ct-10092	175	21	of	of	ADP
ct-10092	175	22	luteinization	luteinization	NOUN
ct-10092	175	23	(	(	PUNCT
ct-10092	175	24	lh	lh	PROPN
ct-10092	175	25	)	)	PUNCT
ct-10092	175	26	]	]	PUNCT
ct-10092	175	27	.	.	PUNCT
ct-10092	176	1	comptes	compte	VERB
ct-10092	176	2	rendus	rendus	PROPN
ct-10092	176	3	hebdomadaires	hebdomadaires	PROPN
ct-10092	176	4	des	des	PROPN
ct-10092	176	5	seances	seance	NOUN
ct-10092	176	6	de	de	X
ct-10092	176	7	l	l	X
ct-10092	176	8	academie	academie	PROPN
ct-10092	176	9	des	des	PROPN
ct-10092	176	10	scienc	scienc	PROPN
ct-10092	176	11	1971;273:1611	1971;273:1611	PROPN
ct-10092	176	12	-	-	SYM
ct-10092	176	13	1613	1613	NUM
ct-10092	176	14	.	.	PUNCT
ct-10092	177	1	clinical	clinical	ADJ
ct-10092	177	2	theriogenology	theriogenology	NOUN
ct-10092	177	3	•	•	NOUN
ct-10092	177	4	volume	volume	NOUN
ct-10092	177	5	7	7	NUM
ct-10092	177	6	,	,	PUNCT
ct-10092	177	7	number	number	NOUN
ct-10092	177	8	1	1	NUM
ct-10092	177	9	•	•	NUM
ct-10092	177	10	march	march	PROPN
ct-10092	177	11	201551	201551	NUM
ct-10092	177	12	35	35	NUM
ct-10092	177	13	.	.	PUNCT
ct-10092	178	1	matsuo	matsuo	PROPN
ct-10092	178	2	h	h	PROPN
ct-10092	178	3	,	,	PUNCT
ct-10092	178	4	baba	baba	PROPN
ct-10092	178	5	y	y	PROPN
ct-10092	178	6	,	,	PUNCT
ct-10092	178	7	nair	nair	PROPN
ct-10092	178	8	rm	rm	PROPN
ct-10092	178	9	,	,	PUNCT
ct-10092	178	10	et	et	PROPN
ct-10092	178	11	al	al	PROPN
ct-10092	178	12	:	:	PUNCT
ct-10092	178	13	structure	structure	NOUN
ct-10092	178	14	of	of	ADP
ct-10092	178	15	the	the	DET
ct-10092	178	16	porcine	porcine	NOUN
ct-10092	178	17	lhand	lhand	NOUN
ct-10092	178	18	fsh	fsh	ADV
ct-10092	178	19	-	-	PUNCT
ct-10092	178	20	releasing	release	VERB
ct-10092	178	21	hormone	hormone	NOUN
ct-10092	178	22	.	.	PUNCT
ct-10092	179	1	i.	i.	PROPN
ct-10092	179	2	the	the	DET
ct-10092	179	3	proposed	propose	VERB
ct-10092	179	4	amino	amino	NOUN
ct-10092	179	5	acid	acid	NOUN
ct-10092	179	6	sequence	sequence	NOUN
ct-10092	179	7	.	.	PUNCT
ct-10092	180	1	biochem	biochem	PROPN
ct-10092	180	2	biophys	biophys	PROPN
ct-10092	180	3	res	re	NOUN
ct-10092	180	4	commun	commun	PROPN
ct-10092	180	5	1971;43:1334	1971;43:1334	PROPN
ct-10092	180	6	-	-	SYM
ct-10092	180	7	1339	1339	NUM
ct-10092	180	8	.	.	PUNCT
ct-10092	181	1	36	36	NUM
ct-10092	181	2	.	.	PUNCT
ct-10092	181	3	nair	nair	PROPN
ct-10092	181	4	rm	rm	PROPN
ct-10092	181	5	,	,	PUNCT
ct-10092	181	6	kastin	kastin	PROPN
ct-10092	181	7	aj	aj	PROPN
ct-10092	181	8	,	,	PUNCT
ct-10092	181	9	schally	schally	ADV
ct-10092	181	10	av	av	PRON
ct-10092	181	11	:	:	PUNCT
ct-10092	181	12	isolation	isolation	NOUN
ct-10092	181	13	and	and	CCONJ
ct-10092	181	14	structure	structure	NOUN
ct-10092	181	15	of	of	ADP
ct-10092	181	16	hypothalamic	hypothalamic	PROPN
ct-10092	181	17	msh	msh	PROPN
ct-10092	181	18	release	release	NOUN
ct-10092	181	19	-	-	PUNCT
ct-10092	181	20	inhibition	inhibition	NOUN
ct-10092	181	21	hormone	hormone	NOUN
ct-10092	181	22	.	.	PUNCT
ct-10092	182	1	biochem	biochem	PROPN
ct-10092	182	2	biophys	biophys	PROPN
ct-10092	182	3	res	res	PROPN
ct-10092	182	4	commun	commun	PROPN
ct-10092	182	5	1971;43:1376	1971;43:1376	PROPN
ct-10092	182	6	-	-	SYM
ct-10092	182	7	1381	1381	NUM
ct-10092	182	8	.	.	PUNCT
ct-10092	183	1	37	37	NUM
ct-10092	183	2	.	.	NOUN
ct-10092	183	3	padula	padula	PROPN
ct-10092	183	4	am	be	AUX
ct-10092	183	5	:	:	PUNCT
ct-10092	183	6	gnrh	gnrh	NOUN
ct-10092	183	7	analogues	analogue	NOUN
ct-10092	183	8	agonists	agonist	NOUN
ct-10092	183	9	and	and	CCONJ
ct-10092	183	10	antagonists	antagonist	NOUN
ct-10092	183	11	.	.	PUNCT
ct-10092	184	1	anim	anim	NOUN
ct-10092	184	2	reprod	reprod	PROPN
ct-10092	184	3	sci	sci	PROPN
ct-10092	184	4	2005;88:115	2005;88:115	PROPN
ct-10092	184	5	-	-	SYM
ct-10092	184	6	126	126	NUM
ct-10092	184	7	.	.	PUNCT
ct-10092	184	8	38	38	NUM
ct-10092	184	9	.	.	PUNCT
ct-10092	185	1	andreyko	andreyko	PROPN
ct-10092	185	2	jl	jl	PROPN
ct-10092	185	3	,	,	PUNCT
ct-10092	185	4	marshall	marshall	PROPN
ct-10092	185	5	la	la	PROPN
ct-10092	185	6	,	,	PUNCT
ct-10092	185	7	dumesic	dumesic	PROPN
ct-10092	185	8	da	da	PROPN
ct-10092	185	9	,	,	PUNCT
ct-10092	185	10	et	et	PROPN
ct-10092	185	11	al	al	PROPN
ct-10092	185	12	:	:	PUNCT
ct-10092	185	13	therapeutic	therapeutic	ADJ
ct-10092	185	14	uses	use	NOUN
ct-10092	185	15	of	of	ADP
ct-10092	185	16	gonadotropin	gonadotropin	NOUN
ct-10092	185	17	-	-	PUNCT
ct-10092	185	18	releasing	release	VERB
ct-10092	185	19	hormone	hormone	NOUN
ct-10092	185	20	analogs	analog	NOUN
ct-10092	185	21	.	.	PUNCT
ct-10092	186	1	obstet	obstet	PROPN
ct-10092	186	2	gynecol	gynecol	PROPN
ct-10092	186	3	surv	surv	PROPN
ct-10092	186	4	1987;42:1	1987;42:1	NUM
ct-10092	186	5	-	-	SYM
ct-10092	186	6	21	21	NUM
ct-10092	186	7	.	.	PUNCT
ct-10092	186	8	39	39	NUM
ct-10092	186	9	.	.	PUNCT
ct-10092	187	1	ferris	ferris	PROPN
ct-10092	187	2	ra	ra	PROPN
ct-10092	187	3	,	,	PUNCT
ct-10092	187	4	hatzel	hatzel	PROPN
ct-10092	187	5	jn	jn	PROPN
ct-10092	187	6	,	,	PUNCT
ct-10092	187	7	lindholm	lindholm	PROPN
ct-10092	187	8	arg	arg	PROPN
ct-10092	187	9	,	,	PUNCT
ct-10092	187	10	et	et	PROPN
ct-10092	187	11	al	al	PROPN
ct-10092	187	12	:	:	PUNCT
ct-10092	187	13	efficacy	efficacy	NOUN
ct-10092	187	14	of	of	ADP
ct-10092	187	15	deslorelin	deslorelin	NOUN
ct-10092	187	16	acetate	acetate	NOUN
ct-10092	187	17	(	(	PUNCT
ct-10092	187	18	sucromate	sucromate	NOUN
ct-10092	187	19	)	)	PUNCT
ct-10092	187	20	on	on	ADP
ct-10092	187	21	induction	induction	NOUN
ct-10092	187	22	of	of	ADP
ct-10092	187	23	ovulation	ovulation	NOUN
ct-10092	187	24	in	in	ADP
ct-10092	187	25	american	american	ADJ
ct-10092	187	26	quarter	quarter	NOUN
ct-10092	187	27	horse	horse	NOUN
ct-10092	187	28	mares	mare	NOUN
ct-10092	187	29	.	.	PUNCT
ct-10092	188	1	j	j	PROPN
ct-10092	188	2	equine	equine	PROPN
ct-10092	188	3	vet	vet	NOUN
ct-10092	188	4	sci	sci	PROPN
ct-10092	188	5	2012;32:285	2012;32:285	PROPN
ct-10092	188	6	-	-	NOUN
ct-10092	188	7	288	288	NUM
ct-10092	188	8	.	.	PUNCT
ct-10092	189	1	40	40	NUM
ct-10092	189	2	.	.	PUNCT
ct-10092	190	1	mckinnon	mckinnon	PROPN
ct-10092	190	2	ao	ao	PROPN
ct-10092	190	3	,	,	PUNCT
ct-10092	190	4	nobelius	nobelius	PROPN
ct-10092	190	5	am	am	PROPN
ct-10092	190	6	,	,	PUNCT
ct-10092	190	7	figueroa	figueroa	PROPN
ct-10092	190	8	std	std	PROPN
ct-10092	190	9	,	,	PUNCT
ct-10092	190	10	et	et	PROPN
ct-10092	190	11	al	al	PROPN
ct-10092	190	12	:	:	PUNCT
ct-10092	190	13	predictable	predictable	ADJ
ct-10092	190	14	ovulation	ovulation	NOUN
ct-10092	190	15	in	in	ADP
ct-10092	190	16	mares	mare	NOUN
ct-10092	190	17	treated	treat	VERB
ct-10092	190	18	with	with	ADP
ct-10092	190	19	an	an	DET
ct-10092	190	20	implant	implant	NOUN
ct-10092	190	21	of	of	ADP
ct-10092	190	22	the	the	DET
ct-10092	190	23	gnrh	gnrh	NOUN
ct-10092	190	24	analog	analog	NOUN
ct-10092	190	25	deslorelin	deslorelin	NOUN
ct-10092	190	26	.	.	PUNCT
ct-10092	191	1	equine	equine	PROPN
ct-10092	191	2	vet	vet	NOUN
ct-10092	191	3	j	j	PROPN
ct-10092	191	4	1993;25:321	1993;25:321	PROPN
ct-10092	191	5	-	-	SYM
ct-10092	191	6	323	323	NUM
ct-10092	191	7	.	.	PUNCT
ct-10092	191	8	41	41	NUM
ct-10092	191	9	.	.	PUNCT
ct-10092	192	1	meinert	meinert	PROPN
ct-10092	192	2	c	c	PROPN
ct-10092	192	3	,	,	PUNCT
ct-10092	192	4	silva	silva	PROPN
ct-10092	192	5	jf	jf	PROPN
ct-10092	192	6	,	,	PUNCT
ct-10092	192	7	kroetz	kroetz	VERB
ct-10092	192	8	i	i	PRON
ct-10092	192	9	,	,	PUNCT
ct-10092	192	10	et	et	PROPN
ct-10092	192	11	al	al	PROPN
ct-10092	192	12	:	:	PUNCT
ct-10092	192	13	advancing	advance	VERB
ct-10092	192	14	the	the	DET
ct-10092	192	15	time	time	NOUN
ct-10092	192	16	of	of	ADP
ct-10092	192	17	ovulation	ovulation	NOUN
ct-10092	192	18	in	in	ADP
ct-10092	192	19	the	the	DET
ct-10092	192	20	mare	mare	NOUN
ct-10092	192	21	with	with	ADP
ct-10092	192	22	a	a	DET
ct-10092	192	23	short	short	ADJ
ct-10092	192	24	-	-	PUNCT
ct-10092	192	25	term	term	NOUN
ct-10092	192	26	implant	implant	NOUN
ct-10092	192	27	releasing	release	VERB
ct-10092	192	28	the	the	DET
ct-10092	192	29	gnrh	gnrh	NOUN
ct-10092	192	30	analogue	analogue	NOUN
ct-10092	192	31	deslorelin	deslorelin	NOUN
ct-10092	192	32	.	.	PUNCT
ct-10092	193	1	equine	equine	PROPN
ct-10092	193	2	vet	vet	NOUN
ct-10092	193	3	j	j	PROPN
ct-10092	193	4	1993;25:65	1993;25:65	NUM
ct-10092	193	5	-	-	SYM
ct-10092	193	6	68	68	NUM
ct-10092	193	7	.	.	PUNCT
ct-10092	193	8	42	42	NUM
ct-10092	193	9	.	.	PUNCT
ct-10092	194	1	jochle	jochle	PROPN
ct-10092	194	2	w	w	PROPN
ct-10092	194	3	,	,	PUNCT
ct-10092	194	4	trigg	trigg	VERB
ct-10092	194	5	te	te	PROPN
ct-10092	194	6	:	:	PUNCT
ct-10092	194	7	control	control	NOUN
ct-10092	194	8	of	of	ADP
ct-10092	194	9	ovulation	ovulation	NOUN
ct-10092	194	10	in	in	ADP
ct-10092	194	11	the	the	DET
ct-10092	194	12	mare	mare	NOUN
ct-10092	194	13	with	with	ADP
ct-10092	194	14	ovuplanttm	ovuplanttm	NOUN
ct-10092	194	15	a	a	DET
ct-10092	194	16	short	short	ADJ
ct-10092	194	17	-	-	PUNCT
ct-10092	194	18	term	term	NOUN
ct-10092	194	19	release	release	NOUN
ct-10092	194	20	implant	implant	NOUN
ct-10092	194	21	(	(	PUNCT
ct-10092	194	22	sti	sti	PROPN
ct-10092	194	23	)	)	PUNCT
ct-10092	194	24	containing	contain	VERB
ct-10092	194	25	the	the	DET
ct-10092	194	26	gnrh	gnrh	NOUN
ct-10092	194	27	analog	analog	NOUN
ct-10092	194	28	deslorelin	deslorelin	NOUN
ct-10092	194	29	acetate	acetate	NOUN
ct-10092	194	30	studies	study	NOUN
ct-10092	194	31	from	from	ADP
ct-10092	194	32	1990	1990	NUM
ct-10092	194	33	to	to	ADP
ct-10092	194	34	1994	1994	NUM
ct-10092	194	35	.	.	PUNCT
ct-10092	195	1	j	j	PROPN
ct-10092	195	2	equine	equine	PROPN
ct-10092	195	3	vet	vet	NOUN
ct-10092	195	4	sci	sci	PROPN
ct-10092	195	5	1994;14:632	1994;14:632	PROPN
ct-10092	195	6	-	-	PUNCT
ct-10092	195	7	644	644	NUM
ct-10092	195	8	.	.	PUNCT
ct-10092	196	1	43	43	NUM
ct-10092	196	2	.	.	PUNCT
ct-10092	197	1	johnson	johnson	PROPN
ct-10092	197	2	ca	ca	PROPN
ct-10092	197	3	,	,	PUNCT
ct-10092	197	4	thompson	thompson	PROPN
ct-10092	197	5	dl	dl	PROPN
ct-10092	197	6	,	,	PUNCT
ct-10092	197	7	kulinski	kulinski	NOUN
ct-10092	197	8	km	km	PROPN
ct-10092	197	9	,	,	PUNCT
ct-10092	197	10	et	et	PROPN
ct-10092	197	11	al	al	PROPN
ct-10092	197	12	:	:	PUNCT
ct-10092	197	13	prolonged	prolong	VERB
ct-10092	197	14	interovulatory	interovulatory	ADJ
ct-10092	197	15	interval	interval	NOUN
ct-10092	197	16	and	and	CCONJ
ct-10092	197	17	hormonal	hormonal	ADJ
ct-10092	197	18	changes	change	NOUN
ct-10092	197	19	in	in	ADP
ct-10092	197	20	mares	mare	NOUN
ct-10092	197	21	following	follow	VERB
ct-10092	197	22	the	the	DET
ct-10092	197	23	use	use	NOUN
ct-10092	197	24	of	of	ADP
ct-10092	197	25	ovuplanttm	ovuplanttm	NOUN
ct-10092	197	26	to	to	PART
ct-10092	197	27	hasten	hasten	VERB
ct-10092	197	28	ovulation	ovulation	NOUN
ct-10092	197	29	.	.	PUNCT
ct-10092	198	1	j	j	PROPN
ct-10092	198	2	equine	equine	PROPN
ct-10092	198	3	vet	vet	NOUN
ct-10092	198	4	sci	sci	PROPN
ct-10092	199	1	2000;20:331	2000;20:331	PROPN
ct-10092	199	2	-	-	PUNCT
ct-10092	199	3	336	336	NUM
ct-10092	199	4	.	.	PUNCT
ct-10092	200	1	44	44	NUM
ct-10092	200	2	.	.	PUNCT
ct-10092	201	1	mccue	mccue	PROPN
ct-10092	201	2	pm	pm	PROPN
ct-10092	201	3	,	,	PUNCT
ct-10092	201	4	farquhar	farquhar	PROPN
ct-10092	201	5	vj	vj	PROPN
ct-10092	201	6	,	,	PUNCT
ct-10092	201	7	carnevale	carnevale	VERB
ct-10092	201	8	em	em	PRON
ct-10092	201	9	,	,	PUNCT
ct-10092	201	10	et	et	PROPN
ct-10092	201	11	al	al	PROPN
ct-10092	201	12	:	:	PUNCT
ct-10092	201	13	removal	removal	NOUN
ct-10092	201	14	of	of	ADP
ct-10092	201	15	deslorelin	deslorelin	NOUN
ct-10092	201	16	(	(	PUNCT
ct-10092	201	17	ovuplant	ovuplant	ADJ
ct-10092	201	18	)	)	PUNCT
ct-10092	201	19	implant	implant	ADJ
ct-10092	201	20	48	48	NUM
ct-10092	201	21	h	h	NOUN
ct-10092	201	22	after	after	SCONJ
ct-10092	201	23	administration	administration	NOUN
ct-10092	201	24	results	result	VERB
ct-10092	201	25	in	in	ADP
ct-10092	201	26	normal	normal	ADJ
ct-10092	201	27	interovulatory	interovulatory	ADJ
ct-10092	201	28	intervals	interval	NOUN
ct-10092	201	29	in	in	ADP
ct-10092	201	30	mares	mare	NOUN
ct-10092	201	31	.	.	PUNCT
ct-10092	202	1	theriogenology	theriogenology	NOUN
ct-10092	202	2	2002;58:865	2002;58:865	NOUN
ct-10092	202	3	-	-	NUM
ct-10092	202	4	870	870	NUM
ct-10092	202	5	.	.	PUNCT
ct-10092	203	1	45	45	NUM
ct-10092	203	2	.	.	PUNCT
ct-10092	204	1	johnson	johnson	PROPN
ct-10092	204	2	ca	ca	PROPN
ct-10092	204	3	,	,	PUNCT
ct-10092	204	4	thompson	thompson	PROPN
ct-10092	204	5	dl	dl	PROPN
ct-10092	204	6	,	,	PUNCT
ct-10092	204	7	cartmill	cartmill	NOUN
ct-10092	204	8	ja	ja	PROPN
ct-10092	204	9	:	:	PUNCT
ct-10092	204	10	pituitary	pituitary	ADJ
ct-10092	204	11	responsiveness	responsiveness	NOUN
ct-10092	204	12	to	to	ADP
ct-10092	204	13	gnrh	gnrh	NOUN
ct-10092	204	14	in	in	ADP
ct-10092	204	15	mares	mare	NOUN
ct-10092	204	16	following	follow	VERB
ct-10092	204	17	deslorelin	deslorelin	NOUN
ct-10092	204	18	acetate	acetate	NOUN
ct-10092	204	19	implantation	implantation	NOUN
ct-10092	204	20	to	to	PART
ct-10092	204	21	hasten	hasten	VERB
ct-10092	204	22	ovulation	ovulation	NOUN
ct-10092	204	23	.	.	PUNCT
ct-10092	205	1	j	j	PROPN
ct-10092	205	2	anim	anim	NOUN
ct-10092	205	3	sci	sci	PROPN
ct-10092	205	4	2002;80:2681	2002;80:2681	PROPN
ct-10092	205	5	-	-	SYM
ct-10092	205	6	7	7	NUM
ct-10092	205	7	.	.	NOUN
ct-10092	205	8	46	46	NUM
ct-10092	205	9	.	.	PUNCT
ct-10092	205	10	voge	voge	PROPN
ct-10092	205	11	jl	jl	PROPN
ct-10092	205	12	,	,	PUNCT
ct-10092	205	13	sudderth	sudderth	ADV
ct-10092	205	14	ak	ak	PROPN
ct-10092	205	15	,	,	PUNCT
ct-10092	205	16	brinkso	brinkso	PROPN
ct-10092	205	17	sp	sp	PROPN
ct-10092	205	18	,	,	PUNCT
ct-10092	205	19	et	et	PROPN
ct-10092	205	20	al	al	PROPN
ct-10092	205	21	:	:	PUNCT
ct-10092	205	22	comparison	comparison	NOUN
ct-10092	205	23	of	of	ADP
ct-10092	205	24	the	the	DET
ct-10092	205	25	efficacy	efficacy	NOUN
ct-10092	205	26	of	of	ADP
ct-10092	205	27	two	two	NUM
ct-10092	205	28	dose	dose	NOUN
ct-10092	205	29	rates	rate	NOUN
ct-10092	205	30	of	of	ADP
ct-10092	205	31	histrelin	histrelin	PROPN
ct-10092	205	32	to	to	ADP
ct-10092	205	33	human	human	ADJ
ct-10092	205	34	chorionic	chorionic	ADJ
ct-10092	205	35	gonadotropin	gonadotropin	NOUN
ct-10092	205	36	for	for	ADP
ct-10092	205	37	inducing	induce	VERB
ct-10092	205	38	ovulation	ovulation	NOUN
ct-10092	205	39	in	in	ADP
ct-10092	205	40	broodmares	broodmare	NOUN
ct-10092	205	41	.	.	PUNCT
ct-10092	206	1	j	j	PROPN
ct-10092	206	2	equine	equine	PROPN
ct-10092	206	3	vet	vet	NOUN
ct-10092	206	4	sci	sci	PROPN
ct-10092	206	5	2012;32:208	2012;32:208	NUM
ct-10092	206	6	-	-	SYM
ct-10092	206	7	210	210	NUM
ct-10092	206	8	.	.	PUNCT
ct-10092	207	1	47	47	NUM
ct-10092	207	2	.	.	PUNCT
ct-10092	208	1	lindholm	lindholm	PROPN
ct-10092	208	2	arg	arg	PROPN
ct-10092	208	3	,	,	PUNCT
ct-10092	208	4	ferris	ferris	PROPN
ct-10092	208	5	ra	ra	PROPN
ct-10092	208	6	,	,	PUNCT
ct-10092	208	7	scofield	scofield	PROPN
ct-10092	208	8	rb	rb	PROPN
ct-10092	208	9	,	,	PUNCT
ct-10092	208	10	et	et	PROPN
ct-10092	208	11	al	al	PROPN
ct-10092	208	12	:	:	PUNCT
ct-10092	208	13	comparison	comparison	NOUN
ct-10092	208	14	of	of	ADP
ct-10092	208	15	deslorelin	deslorelin	NOUN
ct-10092	208	16	and	and	CCONJ
ct-10092	208	17	histrelin	histrelin	NOUN
ct-10092	208	18	for	for	ADP
ct-10092	208	19	induction	induction	NOUN
ct-10092	208	20	of	of	ADP
ct-10092	208	21	ovulation	ovulation	NOUN
ct-10092	208	22	in	in	ADP
ct-10092	208	23	mares	mare	NOUN
ct-10092	208	24	.	.	PUNCT
ct-10092	209	1	j	j	PROPN
ct-10092	209	2	equine	equine	PROPN
ct-10092	209	3	vet	vet	NOUN
ct-10092	209	4	sci	sci	PROPN
ct-10092	209	5	2011;31:312	2011;31:312	PROPN
ct-10092	209	6	-	-	PUNCT
ct-10092	209	7	313	313	NUM
ct-10092	209	8	.	.	PUNCT
ct-10092	210	1	48	48	NUM
ct-10092	210	2	.	.	PUNCT
ct-10092	211	1	kiser	kiser	PROPN
ct-10092	211	2	am	be	AUX
ct-10092	211	3	,	,	PUNCT
ct-10092	211	4	sudderth	sudderth	ADV
ct-10092	211	5	ak	ak	PROPN
ct-10092	211	6	,	,	PUNCT
ct-10092	211	7	brinsko	brinsko	PROPN
ct-10092	211	8	sp	sp	NOUN
ct-10092	211	9	,	,	PUNCT
ct-10092	211	10	et	et	PROPN
ct-10092	211	11	al	al	PROPN
ct-10092	211	12	:	:	PUNCT
ct-10092	211	13	comparison	comparison	NOUN
ct-10092	211	14	of	of	ADP
ct-10092	211	15	efficacy	efficacy	NOUN
ct-10092	211	16	of	of	ADP
ct-10092	211	17	two	two	NUM
ct-10092	211	18	dose	dose	NOUN
ct-10092	211	19	rates	rate	NOUN
ct-10092	211	20	of	of	ADP
ct-10092	211	21	histrelin	histrelin	NOUN
ct-10092	211	22	for	for	ADP
ct-10092	211	23	inducing	induce	VERB
ct-10092	211	24	ovulation	ovulation	NOUN
ct-10092	211	25	in	in	ADP
ct-10092	211	26	broodmares	broodmare	NOUN
ct-10092	211	27	.	.	PUNCT
ct-10092	212	1	j	j	PROPN
ct-10092	212	2	equine	equine	PROPN
ct-10092	212	3	vet	vet	NOUN
ct-10092	212	4	sci	sci	PROPN
ct-10092	212	5	2013;33:820	2013;33:820	NUM
ct-10092	212	6	-	-	PUNCT
ct-10092	212	7	822	822	NUM
ct-10092	212	8	.	.	PUNCT
ct-10092	213	1	49	49	NUM
ct-10092	213	2	.	.	PUNCT
ct-10092	214	1	barrier	barrier	NOUN
ct-10092	214	2	-	-	PUNCT
ct-10092	214	3	battut	battut	NOUN
ct-10092	214	4	i	i	PRON
ct-10092	214	5	,	,	PUNCT
ct-10092	214	6	le	le	X
ct-10092	214	7	poutre	poutre	NOUN
ct-10092	214	8	n	n	CCONJ
ct-10092	214	9	,	,	PUNCT
ct-10092	214	10	trocherie	trocherie	ADJ
ct-10092	214	11	e	e	NOUN
ct-10092	214	12	,	,	PUNCT
ct-10092	214	13	et	et	PROPN
ct-10092	214	14	al	al	PROPN
ct-10092	214	15	:	:	PUNCT
ct-10092	214	16	use	use	NOUN
ct-10092	214	17	of	of	ADP
ct-10092	214	18	buserelin	buserelin	NOUN
ct-10092	214	19	to	to	PART
ct-10092	214	20	induce	induce	VERB
ct-10092	214	21	ovulation	ovulation	NOUN
ct-10092	214	22	in	in	ADP
ct-10092	214	23	the	the	DET
ct-10092	214	24	cyclic	cyclic	ADJ
ct-10092	214	25	mare	mare	NOUN
ct-10092	214	26	.	.	PUNCT
ct-10092	215	1	theriogenology	theriogenology	NOUN
ct-10092	215	2	2001;55:1679	2001;55:1679	NUM
ct-10092	215	3	-	-	SYM
ct-10092	215	4	1695	1695	NUM
ct-10092	215	5	.	.	PUNCT
ct-10092	216	1	50	50	NUM
ct-10092	216	2	.	.	X
ct-10092	216	3	harrison	harrison	PROPN
ct-10092	216	4	la	la	PROPN
ct-10092	216	5	,	,	PUNCT
ct-10092	216	6	squires	squires	PROPN
ct-10092	216	7	el	el	PROPN
ct-10092	216	8	,	,	PUNCT
ct-10092	216	9	mckinnon	mckinnon	PROPN
ct-10092	216	10	ao	ao	PROPN
ct-10092	216	11	:	:	PUNCT
ct-10092	216	12	comparison	comparison	NOUN
ct-10092	216	13	of	of	ADP
ct-10092	216	14	hcg	hcg	PROPN
ct-10092	216	15	,	,	PUNCT
ct-10092	216	16	buserelin	buserelin	NOUN
ct-10092	216	17	and	and	CCONJ
ct-10092	216	18	luprostiol	luprostiol	NOUN
ct-10092	216	19	for	for	ADP
ct-10092	216	20	induction	induction	NOUN
ct-10092	216	21	of	of	ADP
ct-10092	216	22	ovulation	ovulation	NOUN
ct-10092	216	23	in	in	ADP
ct-10092	216	24	cycling	cycling	NOUN
ct-10092	216	25	mares	mare	NOUN
ct-10092	216	26	.	.	PUNCT
ct-10092	217	1	j	j	PROPN
ct-10092	217	2	equine	equine	PROPN
ct-10092	217	3	vet	vet	NOUN
ct-10092	217	4	sci	sci	PROPN
ct-10092	217	5	1991;11:163	1991;11:163	PROPN
ct-10092	217	6	-	-	PUNCT
ct-10092	217	7	166	166	NUM
ct-10092	217	8	.	.	PUNCT
ct-10092	218	1	51	51	NUM
ct-10092	218	2	.	.	PUNCT
ct-10092	219	1	levy	levy	PROPN
ct-10092	219	2	i	i	PRON
ct-10092	219	3	,	,	PUNCT
ct-10092	219	4	duchamp	duchamp	NOUN
ct-10092	219	5	g	g	PROPN
ct-10092	219	6	:	:	PUNCT
ct-10092	219	7	a	a	DET
ct-10092	219	8	single	single	ADJ
ct-10092	219	9	subcutaneous	subcutaneous	ADJ
ct-10092	219	10	administration	administration	NOUN
ct-10092	219	11	of	of	ADP
ct-10092	219	12	buserelin	buserelin	PROPN
ct-10092	219	13	induces	induce	VERB
ct-10092	219	14	ovulation	ovulation	NOUN
ct-10092	219	15	in	in	ADP
ct-10092	219	16	the	the	DET
ct-10092	219	17	mare	mare	NOUN
ct-10092	219	18	:	:	PUNCT
ct-10092	219	19	field	field	NOUN
ct-10092	219	20	data	data	PROPN
ct-10092	219	21	.	.	PUNCT
ct-10092	220	1	reprod	reprod	PROPN
ct-10092	220	2	domest	domest	PROPN
ct-10092	220	3	anim	anim	NOUN
ct-10092	220	4	2007;42:550	2007;42:550	PROPN
ct-10092	220	5	-	-	SYM
ct-10092	220	6	554	554	NUM
ct-10092	220	7	.	.	PUNCT
ct-10092	221	1	52	52	NUM
ct-10092	221	2	.	.	X
ct-10092	221	3	brinsko	brinsko	PROPN
ct-10092	221	4	sp	sp	PROPN
ct-10092	221	5	,	,	PUNCT
ct-10092	221	6	varner	varner	PROPN
ct-10092	221	7	dd	dd	PROPN
ct-10092	221	8	,	,	PUNCT
ct-10092	221	9	blanchard	blanchard	PROPN
ct-10092	221	10	tl	tl	PROPN
ct-10092	221	11	:	:	PUNCT
ct-10092	221	12	the	the	DET
ct-10092	221	13	effect	effect	NOUN
ct-10092	221	14	of	of	ADP
ct-10092	221	15	uterine	uterine	ADJ
ct-10092	221	16	lavage	lavage	NOUN
ct-10092	221	17	performed	perform	VERB
ct-10092	221	18	4	4	NUM
ct-10092	221	19	hours	hour	NOUN
ct-10092	221	20	post	post	NOUN
ct-10092	221	21	insemination	insemination	NOUN
ct-10092	221	22	on	on	ADP
ct-10092	221	23	pregnancy	pregnancy	NOUN
ct-10092	221	24	rate	rate	NOUN
ct-10092	221	25	in	in	ADP
ct-10092	221	26	mares	mare	NOUN
ct-10092	221	27	.	.	PUNCT
ct-10092	222	1	theriogenology	theriogenology	NOUN
ct-10092	222	2	1991;35:1111	1991;35:1111	NUM
ct-10092	222	3	-	-	SYM
ct-10092	222	4	1119	1119	NUM
ct-10092	222	5	.	.	PUNCT
ct-10092	223	1	53	53	NUM
ct-10092	223	2	.	.	PUNCT
ct-10092	224	1	troedsson	troedsson	PROPN
ct-10092	224	2	mht	mht	PROPN
ct-10092	224	3	,	,	PUNCT
ct-10092	224	4	liu	liu	PROPN
ct-10092	224	5	ikm	ikm	PROPN
ct-10092	224	6	,	,	PUNCT
ct-10092	224	7	crabo	crabo	ADJ
ct-10092	224	8	bg	bg	NOUN
ct-10092	224	9	:	:	PUNCT
ct-10092	224	10	sperm	sperm	NOUN
ct-10092	224	11	transport	transport	NOUN
ct-10092	224	12	and	and	CCONJ
ct-10092	224	13	survival	survival	NOUN
ct-10092	224	14	in	in	ADP
ct-10092	224	15	the	the	DET
ct-10092	224	16	mare	mare	NOUN
ct-10092	224	17	:	:	PUNCT
ct-10092	224	18	a	a	DET
ct-10092	224	19	review	review	NOUN
ct-10092	224	20	.	.	PUNCT
ct-10092	225	1	theriogenology	theriogenology	NOUN
ct-10092	225	2	1998;50:807	1998;50:807	NUM
ct-10092	225	3	-	-	PUNCT
ct-10092	225	4	818	818	NUM
ct-10092	225	5	.	.	PUNCT
ct-10092	226	1	54	54	NUM
ct-10092	226	2	.	.	X
ct-10092	227	1	paccamonti	paccamonti	PROPN
ct-10092	227	2	dl	dl	PROPN
ct-10092	227	3	,	,	PUNCT
ct-10092	227	4	pycock	pycock	PROPN
ct-10092	227	5	jf	jf	PROPN
ct-10092	227	6	,	,	PUNCT
ct-10092	227	7	taverne	taverne	PROPN
ct-10092	227	8	ma	ma	PROPN
ct-10092	227	9	,	,	PUNCT
ct-10092	227	10	et	et	PROPN
ct-10092	227	11	al	al	PROPN
ct-10092	227	12	:	:	PUNCT
ct-10092	227	13	pgfm	pgfm	VERB
ct-10092	227	14	response	response	NOUN
ct-10092	227	15	to	to	ADP
ct-10092	227	16	exogenous	exogenous	ADJ
ct-10092	227	17	oxytocin	oxytocin	NOUN
ct-10092	227	18	and	and	CCONJ
ct-10092	227	19	determination	determination	NOUN
ct-10092	227	20	of	of	ADP
ct-10092	227	21	the	the	DET
ct-10092	227	22	halflife	halflife	NOUN
ct-10092	227	23	of	of	ADP
ct-10092	227	24	oxytocin	oxytocin	PROPN
ct-10092	227	25	in	in	ADP
ct-10092	227	26	nonpregnant	nonpregnant	ADJ
ct-10092	227	27	mares	mare	NOUN
ct-10092	227	28	.	.	PUNCT
ct-10092	228	1	equine	equine	PROPN
ct-10092	228	2	vet	vet	NOUN
ct-10092	228	3	j	j	PROPN
ct-10092	228	4	1999;31:285	1999;31:285	PROPN
ct-10092	228	5	-	-	SYM
ct-10092	228	6	288	288	NUM
ct-10092	228	7	.	.	PUNCT
ct-10092	229	1	55	55	NUM
ct-10092	229	2	.	.	X
ct-10092	230	1	bader	bader	PROPN
ct-10092	230	2	h	h	PROPN
ct-10092	230	3	:	:	PUNCT
ct-10092	230	4	an	an	DET
ct-10092	230	5	investigation	investigation	NOUN
ct-10092	230	6	of	of	ADP
ct-10092	230	7	sperm	sperm	NOUN
ct-10092	230	8	migration	migration	NOUN
ct-10092	230	9	into	into	ADP
ct-10092	230	10	the	the	DET
ct-10092	230	11	oviducts	oviduct	NOUN
ct-10092	230	12	of	of	ADP
ct-10092	230	13	the	the	DET
ct-10092	230	14	mare	mare	NOUN
ct-10092	230	15	.	.	PUNCT
ct-10092	231	1	j	j	PROPN
ct-10092	231	2	reprod	reprod	PROPN
ct-10092	231	3	fertil	fertil	PROPN
ct-10092	231	4	suppl	suppl	ADJ
ct-10092	231	5	1982;32:59	1982;32:59	NUM
ct-10092	231	6	-	-	SYM
ct-10092	231	7	64	64	NUM
ct-10092	231	8	.	.	PUNCT
ct-10092	232	1	56	56	NUM
ct-10092	232	2	.	.	PUNCT
ct-10092	232	3	schramme	schramme	PROPN
ct-10092	232	4	ar	ar	PROPN
ct-10092	232	5	,	,	PUNCT
ct-10092	232	6	pinto	pinto	NOUN
ct-10092	232	7	cr	cr	PROPN
ct-10092	232	8	,	,	PUNCT
ct-10092	232	9	davis	davis	PROPN
ct-10092	232	10	j	j	PROPN
ct-10092	232	11	,	,	PUNCT
ct-10092	232	12	et	et	PROPN
ct-10092	232	13	al	al	PROPN
ct-10092	232	14	:	:	PUNCT
ct-10092	232	15	pharmacokinetics	pharmacokinetic	NOUN
ct-10092	232	16	of	of	ADP
ct-10092	232	17	carbetocin	carbetocin	PROPN
ct-10092	232	18	,	,	PUNCT
ct-10092	232	19	a	a	DET
ct-10092	232	20	long	long	ADV
ct-10092	232	21	-	-	PUNCT
ct-10092	232	22	acting	act	VERB
ct-10092	232	23	oxytocin	oxytocin	NOUN
ct-10092	232	24	analogue	analogue	NOUN
ct-10092	232	25	,	,	PUNCT
ct-10092	232	26	following	follow	VERB
ct-10092	232	27	intravenous	intravenous	ADJ
ct-10092	232	28	administration	administration	NOUN
ct-10092	232	29	in	in	ADP
ct-10092	232	30	horses	horse	NOUN
ct-10092	232	31	.	.	PUNCT
ct-10092	233	1	equine	equine	NOUN
ct-10092	233	2	vet	vet	PROPN
ct-10092	233	3	j	j	PROPN
ct-10092	233	4	2008;40:658	2008;40:658	X
ct-10092	233	5	-	-	PUNCT
ct-10092	233	6	661	661	NUM
ct-10092	233	7	.	.	PUNCT
ct-10092	233	8	57	57	NUM
ct-10092	233	9	.	.	X
ct-10092	234	1	steckler	steckler	NOUN
ct-10092	234	2	d	d	PROPN
ct-10092	234	3	,	,	PUNCT
ct-10092	234	4	naidoo	naidoo	PROPN
ct-10092	234	5	v	v	PROPN
ct-10092	234	6	,	,	PUNCT
ct-10092	234	7	gerber	gerber	PROPN
ct-10092	234	8	d	d	PROPN
ct-10092	234	9	,	,	PUNCT
ct-10092	234	10	et	et	PROPN
ct-10092	234	11	al	al	PROPN
ct-10092	234	12	:	:	PUNCT
ct-10092	234	13	ex	ex	X
ct-10092	234	14	vivo	vivo	ADJ
ct-10092	234	15	influence	influence	NOUN
ct-10092	234	16	of	of	ADP
ct-10092	234	17	carbetocin	carbetocin	PROPN
ct-10092	234	18	on	on	ADP
ct-10092	234	19	equine	equine	NOUN
ct-10092	234	20	myometrial	myometrial	ADJ
ct-10092	234	21	muscles	muscle	NOUN
ct-10092	234	22	and	and	CCONJ
ct-10092	234	23	comparison	comparison	NOUN
ct-10092	234	24	with	with	ADP
ct-10092	234	25	oxytocin	oxytocin	PROPN
ct-10092	234	26	.	.	PUNCT
ct-10092	235	1	theriogenology	theriogenology	NOUN
ct-10092	235	2	2012;78:502	2012;78:502	PROPN
ct-10092	235	3	-	-	PUNCT
ct-10092	235	4	509	509	NUM
ct-10092	235	5	.	.	PUNCT
ct-10092	236	1	58	58	NUM
ct-10092	236	2	.	.	PUNCT
ct-10092	237	1	troedsson	troedsson	PROPN
ct-10092	237	2	mht	mht	PROPN
ct-10092	237	3	,	,	PUNCT
ct-10092	237	4	liu	liu	PROPN
ct-10092	237	5	ikm	ikm	PROPN
ct-10092	237	6	:	:	PUNCT
ct-10092	237	7	managing	manage	VERB
ct-10092	237	8	mares	mare	NOUN
ct-10092	237	9	with	with	ADP
ct-10092	237	10	chronic	chronic	ADJ
ct-10092	237	11	uterine	uterine	ADJ
ct-10092	237	12	inflammation	inflammation	NOUN
ct-10092	237	13	.	.	PUNCT
ct-10092	238	1	j	j	PROPN
ct-10092	238	2	equine	equine	PROPN
ct-10092	238	3	vet	vet	NOUN
ct-10092	238	4	sci	sci	PROPN
ct-10092	238	5	1995;15:305	1995;15:305	PROPN
ct-10092	238	6	-	-	SYM
ct-10092	238	7	306	306	NUM
ct-10092	238	8	.	.	PUNCT
ct-10092	239	1	59	59	NUM
ct-10092	239	2	.	.	PUNCT
ct-10092	240	1	troedsson	troedsson	PROPN
ct-10092	240	2	mh	mh	PROPN
ct-10092	240	3	,	,	PUNCT
ct-10092	240	4	ababneh	ababneh	PROPN
ct-10092	240	5	mm	mm	INTJ
ct-10092	240	6	,	,	PUNCT
ct-10092	240	7	ohlgren	ohlgren	PROPN
ct-10092	240	8	af	af	PROPN
ct-10092	240	9	,	,	PUNCT
ct-10092	240	10	et	et	PROPN
ct-10092	240	11	al	al	PROPN
ct-10092	240	12	:	:	PUNCT
ct-10092	240	13	effect	effect	NOUN
ct-10092	240	14	of	of	ADP
ct-10092	240	15	periovulatory	periovulatory	ADJ
ct-10092	240	16	prostaglandin	prostaglandin	NOUN
ct-10092	240	17	f2alpha	f2alpha	NOUN
ct-10092	240	18	on	on	ADP
ct-10092	240	19	pregnancy	pregnancy	NOUN
ct-10092	240	20	rates	rate	NOUN
ct-10092	240	21	and	and	CCONJ
ct-10092	240	22	luteal	luteal	ADJ
ct-10092	240	23	function	function	NOUN
ct-10092	240	24	in	in	ADP
ct-10092	240	25	the	the	DET
ct-10092	240	26	mare	mare	NOUN
ct-10092	240	27	.	.	PUNCT
ct-10092	241	1	theriogenology	theriogenology	NOUN
ct-10092	241	2	2001;55:1891	2001;55:1891	NUM
ct-10092	241	3	-	-	SYM
ct-10092	241	4	899	899	NUM
ct-10092	241	5	.	.	PUNCT
ct-10092	241	6	60	60	NUM
ct-10092	241	7	.	.	PUNCT
ct-10092	241	8	nie	nie	PROPN
ct-10092	241	9	gj	gj	PROPN
ct-10092	241	10	,	,	PUNCT
ct-10092	241	11	johnson	johnson	PROPN
ct-10092	241	12	ke	ke	PROPN
ct-10092	241	13	,	,	PUNCT
ct-10092	241	14	wenzel	wenzel	PROPN
ct-10092	241	15	jg	jg	PROPN
ct-10092	241	16	,	,	PUNCT
ct-10092	241	17	et	et	PROPN
ct-10092	241	18	al	al	PROPN
ct-10092	241	19	:	:	PUNCT
ct-10092	241	20	luteal	luteal	ADJ
ct-10092	241	21	function	function	NOUN
ct-10092	241	22	in	in	ADP
ct-10092	241	23	mares	mare	NOUN
ct-10092	241	24	following	follow	VERB
ct-10092	241	25	administration	administration	NOUN
ct-10092	241	26	of	of	ADP
ct-10092	241	27	oxytocin	oxytocin	PROPN
ct-10092	241	28	,	,	PUNCT
ct-10092	241	29	cloprostenol	cloprostenol	NOUN
ct-10092	241	30	or	or	CCONJ
ct-10092	241	31	saline	saline	VERB
ct-10092	241	32	on	on	ADP
ct-10092	241	33	day	day	NOUN
ct-10092	241	34	0	0	NUM
ct-10092	241	35	,	,	PUNCT
ct-10092	241	36	1	1	NUM
ct-10092	241	37	or	or	CCONJ
ct-10092	241	38	2	2	NUM
ct-10092	241	39	post	post	NOUN
ct-10092	241	40	-	-	NOUN
ct-10092	241	41	ovulation	ovulation	NOUN
ct-10092	241	42	.	.	PUNCT
ct-10092	242	1	theriogenology	theriogenology	NOUN
ct-10092	242	2	2003;60:1119	2003;60:1119	NUM
ct-10092	242	3	-	-	SYM
ct-10092	242	4	1125	1125	NUM
ct-10092	242	5	.	.	PUNCT
ct-10092	242	6	61	61	NUM
ct-10092	242	7	.	.	PUNCT
ct-10092	243	1	bergfelt	bergfelt	PROPN
ct-10092	243	2	dr	dr	PROPN
ct-10092	243	3	,	,	PUNCT
ct-10092	243	4	pierson	pierson	PROPN
ct-10092	243	5	ra	ra	PROPN
ct-10092	243	6	,	,	PUNCT
ct-10092	243	7	ginther	ginther	PROPN
ct-10092	243	8	oj	oj	PROPN
ct-10092	243	9	:	:	PUNCT
ct-10092	243	10	regression	regression	NOUN
ct-10092	243	11	and	and	CCONJ
ct-10092	243	12	resurgence	resurgence	NOUN
ct-10092	243	13	of	of	ADP
ct-10092	243	14	the	the	DET
ct-10092	243	15	cl	cl	NOUN
ct-10092	243	16	following	follow	VERB
ct-10092	243	17	pgf2alpha	pgf2alpha	ADP
ct-10092	243	18	treatment	treatment	NOUN
ct-10092	243	19	3	3	NUM
ct-10092	243	20	days	day	NOUN
ct-10092	243	21	after	after	ADP
ct-10092	243	22	ovulation	ovulation	NOUN
ct-10092	243	23	in	in	ADP
ct-10092	243	24	mares	mare	NOUN
ct-10092	243	25	.	.	PUNCT
ct-10092	244	1	theriogenology	theriogenology	NOUN
ct-10092	244	2	2006;65:1605	2006;65:1605	NUM
ct-10092	244	3	-	-	SYM
ct-10092	244	4	1619	1619	NUM
ct-10092	244	5	.	.	PUNCT
ct-10092	245	1	62	62	NUM
ct-10092	245	2	.	.	PUNCT
ct-10092	246	1	dell'aqua	dell'aqua	PROPN
ct-10092	246	2	ja	ja	PROPN
ct-10092	246	3	,	,	PUNCT
ct-10092	246	4	papa	papa	NOUN
ct-10092	246	5	fo	fo	PROPN
ct-10092	246	6	,	,	PUNCT
ct-10092	246	7	lopes	lopes	PROPN
ct-10092	246	8	md	md	PROPN
ct-10092	246	9	,	,	PUNCT
ct-10092	246	10	et	et	PROPN
ct-10092	246	11	al	al	PROPN
ct-10092	246	12	:	:	PUNCT
ct-10092	246	13	modulation	modulation	NOUN
ct-10092	246	14	of	of	ADP
ct-10092	246	15	acute	acute	ADJ
ct-10092	246	16	uterine	uterine	ADJ
ct-10092	246	17	inflammatory	inflammatory	ADJ
ct-10092	246	18	response	response	NOUN
ct-10092	246	19	after	after	ADP
ct-10092	246	20	artificial	artificial	ADJ
ct-10092	246	21	insemiation	insemiation	NOUN
ct-10092	246	22	with	with	ADP
ct-10092	246	23	equine	equine	NOUN
ct-10092	246	24	frozen	frozen	ADJ
ct-10092	246	25	semen	semen	NOUN
ct-10092	246	26	.	.	PUNCT
ct-10092	247	1	anim	anim	PROPN
ct-10092	247	2	reprod	reprod	PROPN
ct-10092	247	3	sci	sci	PROPN
ct-10092	247	4	2006;94:270	2006;94:270	PROPN
ct-10092	247	5	-	-	PUNCT
ct-10092	247	6	273	273	NUM
ct-10092	247	7	.	.	PUNCT
ct-10092	247	8	63	63	NUM
ct-10092	247	9	.	.	PUNCT
ct-10092	248	1	bucca	bucca	PROPN
ct-10092	248	2	s	s	PROPN
ct-10092	248	3	,	,	PUNCT
ct-10092	248	4	carli	carli	PROPN
ct-10092	248	5	a	a	NOUN
ct-10092	248	6	,	,	PUNCT
ct-10092	248	7	buckley	buckley	PROPN
ct-10092	248	8	t	t	PROPN
ct-10092	248	9	,	,	PUNCT
ct-10092	248	10	et	et	PROPN
ct-10092	248	11	al	al	PROPN
ct-10092	248	12	:	:	PUNCT
ct-10092	248	13	the	the	DET
ct-10092	248	14	use	use	NOUN
ct-10092	248	15	of	of	ADP
ct-10092	248	16	dexamethasone	dexamethasone	NOUN
ct-10092	248	17	administered	administer	VERB
ct-10092	248	18	to	to	ADP
ct-10092	248	19	mares	mare	NOUN
ct-10092	248	20	at	at	ADP
ct-10092	248	21	breeding	breeding	NOUN
ct-10092	248	22	time	time	NOUN
ct-10092	248	23	in	in	ADP
ct-10092	248	24	the	the	DET
ct-10092	248	25	modulation	modulation	NOUN
ct-10092	248	26	of	of	ADP
ct-10092	248	27	persistent	persistent	ADJ
ct-10092	248	28	mating	mating	NOUN
ct-10092	248	29	induced	induce	VERB
ct-10092	248	30	endometritis	endometritis	NOUN
ct-10092	248	31	.	.	PUNCT
ct-10092	249	1	theriogenology	theriogenology	NOUN
ct-10092	249	2	2008;70:1093	2008;70:1093	NUM
ct-10092	249	3	-	-	SYM
ct-10092	249	4	1100	1100	NUM
ct-10092	249	5	.	.	PUNCT
ct-10092	250	1	64	64	NUM
ct-10092	250	2	.	.	PUNCT
ct-10092	251	1	ferris	ferris	PROPN
ct-10092	251	2	ra	ra	PROPN
ct-10092	251	3	,	,	PUNCT
ct-10092	251	4	mccue	mccue	PROPN
ct-10092	251	5	pm	pm	PROPN
ct-10092	251	6	:	:	PUNCT
ct-10092	251	7	the	the	DET
ct-10092	251	8	effects	effect	NOUN
ct-10092	251	9	of	of	ADP
ct-10092	251	10	dexamethasone	dexamethasone	NOUN
ct-10092	251	11	and	and	CCONJ
ct-10092	251	12	prednisolone	prednisolone	PROPN
ct-10092	251	13	on	on	ADP
ct-10092	251	14	pituitary	pituitary	ADJ
ct-10092	251	15	and	and	CCONJ
ct-10092	251	16	ovarian	ovarian	ADJ
ct-10092	251	17	function	function	NOUN
ct-10092	251	18	in	in	ADP
ct-10092	251	19	the	the	DET
ct-10092	251	20	mare	mare	NOUN
ct-10092	251	21	.	.	PUNCT
ct-10092	252	1	equine	equine	PROPN
ct-10092	252	2	vet	vet	PROPN
ct-10092	252	3	j	j	PROPN
ct-10092	252	4	2010;42:438	2010;42:438	PROPN
ct-10092	252	5	-	-	NUM
ct-10092	252	6	443	443	NUM
ct-10092	252	7	.	.	NOUN
ct-10092	252	8	65	65	NUM
ct-10092	252	9	.	.	PUNCT
ct-10092	253	1	bucca	bucca	PROPN
ct-10092	253	2	s	s	PROPN
ct-10092	253	3	,	,	PUNCT
ct-10092	253	4	carli	carli	PROPN
ct-10092	253	5	a	a	DET
ct-10092	253	6	:	:	PUNCT
ct-10092	253	7	efficacy	efficacy	NOUN
ct-10092	253	8	of	of	ADP
ct-10092	253	9	human	human	ADJ
ct-10092	253	10	chorionic	chorionic	ADJ
ct-10092	253	11	gonadotropin	gonadotropin	NOUN
ct-10092	253	12	to	to	PART
ct-10092	253	13	induce	induce	VERB
ct-10092	253	14	ovulation	ovulation	NOUN
ct-10092	253	15	in	in	ADP
ct-10092	253	16	the	the	DET
ct-10092	253	17	mare	mare	NOUN
ct-10092	253	18	,	,	PUNCT
ct-10092	253	19	when	when	SCONJ
ct-10092	253	20	associated	associate	VERB
ct-10092	253	21	with	with	ADP
ct-10092	253	22	a	a	DET
ct-10092	253	23	single	single	ADJ
ct-10092	253	24	dose	dose	NOUN
ct-10092	253	25	of	of	ADP
ct-10092	253	26	dexamethasone	dexamethasone	NOUN
ct-10092	253	27	administered	administer	VERB
ct-10092	253	28	at	at	ADP
ct-10092	253	29	breeding	breeding	NOUN
ct-10092	253	30	time	time	NOUN
ct-10092	253	31	.	.	PUNCT
ct-10092	254	1	equine	equine	NOUN
ct-10092	254	2	vet	vet	PROPN
ct-10092	254	3	j	j	PROPN
ct-10092	254	4	suppl	suppl	PROPN
ct-10092	254	5	2011;40:32	2011;40:32	PROPN
ct-10092	254	6	-	-	SYM
ct-10092	254	7	34	34	NUM
ct-10092	254	8	.	.	PUNCT
ct-10092	255	1	clinical	clinical	ADJ
ct-10092	255	2	theriogenology	theriogenology	NOUN
ct-10092	255	3	•	•	NOUN
ct-10092	255	4	volume	volume	NOUN
ct-10092	255	5	7	7	NUM
ct-10092	255	6	,	,	PUNCT
ct-10092	255	7	number	number	NOUN
ct-10092	255	8	1	1	NUM
ct-10092	255	9	•	•	NUM
ct-10092	255	10	march	march	PROPN
ct-10092	255	11	2015	2015	NUM
ct-10092	255	12	52	52	NUM